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1 Introduction 
 
1.1 Impact and distribution of malaria 
 
The term malaria designates the diseases produced by the infection with any parasite 
of the genus Plasmodium. Four of the more than 100 species infect humans: P. falciparum, P. 
vivax, P. ovale and P. malariae 874. Of these four, P. falciparum is the most widespread and 
dangerous because it can cause fatal cerebral malaria if left untreated. 300 – 500 million 
people are infected with malaria each year, predominantly in developing countries, such as 
Africa, Southeast Asia, South and Central America, where inadequate health care systems and 
poor socio-economic conditions further exacerbate the spread of this disease 163. Between 1 
and 3 million people die of malaria each year; 90 % thereof in Africa, with an annual death 
toll of around 1 million among children up to 5 years old 139,888. This makes malaria one of the 
top three killers besides AIDS and tuberculosis among communicable diseases 727. 
Attempts in the 1950’s and 1960’s to eradicate malaria globally were initially 
successful in many countries, but have been abandoned as malaria vectors have become more 
resistant to insecticides, especially DDT (discovered from Julius Wagner-Jauregg) 352,757. 
Moreover, Plasmodia have become resistant to chloroquine and other anti-malarial drugs 
67,138,354,777,792,881
, making prevention and treatment increasingly more difficult and costly 757.  
 
Figure 1.1. Global distribution of malaria.  
The changing global distribution of malaria risk from 1946 to 1994 shows a disease burden increasingly 
confined to tropical regions 727. In almost all temperate zones malaria has been eradicated due to changes in land 
use, environment, agricultural practices, house construction and some targeted vector control 352. 
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1.2 Discovery of Plasmodium  
 
The malaria-like intermittent fevers and other symptoms such as enlarged spleen, 
periods of high fever, headaches, shaking chills, and weakness were already known more than 
3000 years ago in China, Assyria and India. Hippocrates (460 - 370 B.C.) in Greece is 
credited with having accurately described the clinical symptoms in his medical writings 355,760. 
Malaria was widespread in Europe during the Middle Ages, but malaria tropica was endemic 
only in the warmer South Europe. The name is derived from the Italian word mala aria 
(Latin: malus = bad, aeris = air) because the disease often appeared near swamps with their 
typical odor 632. It was thought that “miasma”, which literally means “bad air”, caused the 
disease 916. The “miasma” theory was proved wrong in the 19th century. In 1880 Charles 
Louis Alphonse Laveran identified the parasite in its blood stage in the act of exflagellation 
under the microscope 578,761. In 1897 Sir Ronald Ross, whose teacher was Patrick Manson, 
who discovered the mosquito transmission of filariasis, demonstrated the transmission of 
malaria via mosquitoes 723,722. However, it was only in 1948 that Short and Garnham 
described the liver stage of primate and human malaria (P. vivax) 760. Finally, in 1966 the liver 
stage of P. falciparum was discovered 314.  
 
1.3 Evolution of Plasmodium spp. 
 
Genetic sequence comparisons indicate that the genus Plasmodium may have 
originated some 150 million years ago around the time when birds and reptiles are thought to 
have split 263,265. P. vivax and P. malariae have a low morbidity and lethality and are also 
found in chimpanzees and gorillas. They might therefore have infected humans the earliest 264. 
Morphologically and genetically, P. falciparum was found to be related most closely to the 
bird parasites P. gallinaceum and P. iophurae. P. falciparum is therefore thought to have only 
recently switched from its avian host to humans 590,869,870. Its affliction of humans may have 
started about 10.000 years ago, at the onset of agriculture. This is consistent with the 
hypothesis that relatively new pathogens are less well adapted to their hosts, producing more 
malignant and dangerous diseases. Recent analyses support more the hypothesis that P. 
falciparum emerged only recently through a population bottleneck in Africa 64,190,706,708,707. 
The agricultural revolution and animal domestication probably facilitated the spread of P. 
falciparum in Africa when human agriculture practices brought about changes in speciation 
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and anthropophilic behavior of anopheline mosquito populations. This may have led to an 
increase in malaria transmission and perhaps selection of more aggressive strains of P. 
falciparum parasites 186. According to haplotype analysis, it was in the same timeframe, i.e. 
between 3,000 and 11,000 years ago, that a major glucose-6-phosphate dehydrogenase 
(G6PDH) enzyme deficiency, (G6PDH A-) was selected for as a malaria protective 
polymorphism in the Middle East and Northeast Africa 834. In the Western hemisphere P. 
falciparum probably was introduced only by the colonization of the Americas by Europeans 
and the trade of African slaves 265. 
 
1.4 Life cycle of Plasmodium falciparum  
 
Just as other members of the infraphylum sporozoa, Plasmodia pass through a 
sequence of three different types of reproduction during their life cycle (Fig. 1.2. for P. 
falciparum):  
(1) A single run of sexual reproduction, called the "sporogonic cycle" (sporogony), 
taking place in the Anopheles host that transmits sprorozoites to the human host,  
(2) A single run of asexual reproduction, the "preerythrocytic hepatocytic cycle", in a 
liver cell of the human host, followed by an indefinite number of runs of asexual 
reproduction, the "erythrocytic cycle". Both these cycles produce merozoites, and the act of 
reproduction during this phase is therefore referred to as merogony. 
(3) Alternatively, some parasites will undergo gametogony and differentiate into male 
and female gametocytes, which, if taken in the female Anopheles mosquito midgut with the 
blood meal, will initiate the sporogonic cycle again.   
Plasmodium belongs to the subphylum apicomplexa (classification see appendix), 
because sporozoites and merozoites invade cells with the help of an “apical complex” (Fig 
1.2.C. Invasive stages and 1.2.E.I.). The apical complex is a group of membrane-bound 
organelles located at the anterior, i.e. apical end (AP). The organelles consists of micronemes 
(Mn) (ovoid bodies, 100 nm in length 71, 40 - 60 nm in width), two prominent pear-shaped 
rhoptries (Rh)  (400 - 570 nm in length, 200 - 330 nm in width), and spheroid, rounded dense 
granules (vesicles around 90 - 140 nm in diameter). Surrounded by two polar rings (Pr) at the 
apical end, the rhoptries extend posterior from the plasma membrane. 
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1.4.1 The arthropod vector 
 
Humans contract malaria if bitten by a malaria-infected female mosquito of the genus 
Anopheles. The principal malaria mosquito is Anopheles gambiae 577. There are about 380 
species of Anopheles, but only about 60 are vectors of Plasmodia infecting humans, some 30 
of which being of major importance. They are very selective of their vertebrate host, so that 
human malarias have no animal reservoir, i.e. there are no known zoonoses. All are highly 
active during the night, especially just before sunrise. 
The habitat of the immature Anopheles is water, where eggs are laid on or on the edge 
of water. The eggs hatch after 2-3 days to release larvae (wrigglers) that develop through four 
larval and one pupal aquatic stage until they become adult flying mosquitoes. Together, the 
aquatic stages commonly last between 7 and 20 days, depending on the temperature. The male 
feeds only on vegetable juices whereas the female mosquito bites, as it requires blood for the 
maturation of the eggs. Mating that takes place only once, soon after emergence of the adult 
female. The female stores the spermatozoa in a deposit called spermatheca, from where they 
are released to fertilize successive egg batches. The adult female may live from a few days to 
well over a month, going through several 2-4-day cycles of blood feeds and egg laying (some 
100-200 per batch). Survival and egg development are mainly dependent on temperature and 
relative humidity 632. 
 
1.4.1.1 Sporogony  
 
The mosquito’s blood meal (1 - 2 µl) contains asexual and sexual stages (~ 1 to 105 
gametocytes). (Fig. 1.2.A. and B.: Sexual development in the mosquito of P. falciparum). The 
asexual stages of the erythrocytic cycle are digested in the midgut. Microgametocytes (male) 
exflagellate (b) within 10 – 20 min. Each one forms eight haploid motile microgametes to 
quickly fertilize around 12 macrogametes (a) that has been formed from mature 
macrogametocytes (female). The zygotes, spherical in shape, 6 µm in diameter and non-
motile (d), transform within 18- 24 h into motile palmate shaped ookinetes of approximately 
15- 19 µm length and 1 – 2.7 µm width (e) that penetrate the stomach wall 308,778. 5-6 
ookinetes cross two barriers: the peritrophic matrix (PM) and the midgut epithelium, but 
successfully only in the appropriate vector 458. They pass through up to 6 epithelial midgut 
cells and initiate programmed cell death by peroxidases to reach the extracellular space 
between the midgut epithelium and the overlying basal lamina (membrane) 486. Around two of 
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the 5 - 6 ookinetes transform into oocysts 2 – 7 days later, surrounded by a 0.1 – 1 µm thick 
electron-dense capsule (f), which grows up to approximately 35 µm in diameter as the nucleus 
divides repeatedly into about 2000 - 8000 (211 - 213) motile sporozoites 308,778. (Fig. 1.2.B. 
Micrograph: Mature oocysts of Plasmodium gallinaeceum on the hemocoel surface of the 
midgut of a female Aedes aegypti 805.) The development within the oocysts takes 9 to 35 days 
(g) depending on the temperature. Temperature tolerances are as follows: (20 - 29 °C) for P. 
falciparum; (20 – 27 °C) for P. malariae and (16 -30 °C) for P. vivax. As P. vivax tolerates 
temperatures down to 16 °C, it was widespread in the Mediterranean region and even 
prevalent in the Netherlands, Germany, Poland and Scandinavia in former times 632. The 
sporocysts (around 16000 from two oocysts) burst into the mosquito's body cavity, termed the 
hemocoel. Infection of the salivary gland is dependent on thrombospondin-related anonymous 
protein (TRAP = PfSSP2), which gradually increases during sporozoite maturation 713,196,716. 
The sporozoites (11 µm in length and 1µm in diameter) invade the salivary glands, then to be 
transmitted (~ 10 – 20) via the saliva into the blood stream of a susceptible vertebrate host 
during each subsequent bite made by the infected mosquito (h) 308,778. The enzyme apyrase, 
produced in the three lobes, is secreted during the bite, hindering the aggregation of platelets 
423,833
. 
 
1.4.2 Merogony in the liver 
  
Half an hour after entering the blood stream the sporozoites reach the liver tissue (Fig. 
1.2.D. pre-erythrocytic, hepatocytic stages). They leave the sinusoid capillaries through the 
endothelium and reach the liver parenchyma cells through the perisinusoid lymph space 
(space of Disse) or through Kupffer cells (sessile macrophages in the sinusoids). Each 
successful sporozoite develops into a mature liver schizont and divides 11 – 15 times 
depending on the Plasmodium species (see appendix). Only the last division is an 
endodyogeny, producing 10,000 to 30,000 merozoites that are liberated into the circulation 
and invade the red blood cells (RBCs). P. vivax and P. ovale can remain dormant in the liver 
for months or even years in a form called hypnozoite. This form is responsible for true 
relapses. Development or persistence of the parasite in the liver does not produce any 
symptoms. 
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1.4.3 Erythrocytic cycle: Disease 
 
After penetrating an RBC merozoites initiate the erythrocytic cycle by maturing into 
blood schizonts containing 8 - 32 new merozoites (Fig. 1.2.F.). The blood schizonts burst, 
causing fever in the human host. The merozoites rapidly invade new RBCs. The erythrocytic 
cycle is completed in 48 hours in the so-called tertian malarias (benign in the case of P. vivax 
and P. ovale; malignant in the case of P. falciparum) and in 72 hours in quartan malaria (P. 
malariae). (For the most important characteristics of human malaria see appendix.) 
The manifestations of the disease are primarily the result of the parasitization and 
destruction of RBCs. Initial symptoms are quite variable, particularly in children, and may 
include irregular fever, malaise, headaches, muscular pains, sweats, chills, nausea, vomiting, 
and diarrhea. If left untreated the fever tends to occur in periodic bouts alternating with days 
with less or no fever. 50 % of all human malaria victims suffer from P. falciparum infection 
(malaria tropica), 43 % from P. vivax (malaria tertiana).  
 
1.4.3.1 Invasion of erythrocytes by merozoites  
 
Merozoite invasion is dependent on the presence of Ca2+ 866,868,867. The erythrocytic 
merozoite (Fig. 1.2.E.I.) is an ovoid cell approximately 1.3-1.5 µm in length and 0.9 - 1µm in 
width with an apical complex at the apical end (Ap), and a nucleus (N). Its mitochondria (Mt) 
are located around an apicoplast (Pl). The apicoplast has four membranes, suggesting that it is 
an endosymbiont of prokaryotic origin and related to chloroplasts 592,594,593,699,698. Extracellular 
merozoites are intrinsically short lived and rapidly invade new host erythrocytes within 30 s 
308
. Malaria merozoite invasion can be divided into 4 phases (Fig. 1.2. E.II.):  
(1) Initial recognition, reversible attachment, reorientation by projecting tufts of fine 
filaments 72. They cover the plasma membrane (7.5 nm thick) like a surface coat (15 - 20 nm 
thick) 308 consisting of the MSP1-complex: MSP1, 2, 3, 4, 5, merozoite surface proteins 1, 2, 
3, 4, 5; ABRA; S - antigen. The plasma membrane of the merozoite encases two closely 
fitting inner membranes (Im). Microtubules (M) extend subpellicularly (Fig. 1.2.E.II.(A)).  
(2) Apical reorientation; irreversible attachment, junction formation between the apical 
end (Ap) of the merozoite and the erythrocyte (Fig. 1.2.E.II.(B - C): Release of microneme 
(Mn) contents, e.g. EBA175 (P. falciparum), erythrocyte binding antigen 175, that binds to 
the sialic acids of glycophorins 910. Thus EBA175 mediates high affinity adhesion to the RBC 
membrane. Rhoptries start to discharge proteins: AMA1, apical membrane antigen 1; RAP1, 
INTRODUCTION________________________________________________________________________ 
 22 
2, rhoptry - associated protein 1, 2; RhopH3. Proteins such as Rhop-H interact with vesicles 
of anionic PC and PI, which are preferentially localized on the inner leaflet of the RBC 
membrane. This might disrupt interactions of the RBC cytoskeleton with transmembrane 
proteins, thus initiating the formation of the parasitophorous vacuole membrane (PVM) 859). 
(3) Movement of the tight junction, inducing invagination of the erythrocyte 
membrane around the merozoite with concomitant removal of the merozoite’s surface coat 
(Fig.1.2.E.II.(D - F)): The merozoite passes through the tight junction into a concurrently 
developing PVM. It discharges more rhoptries and micronemes and releases the contents of 
its dense granules (PfSUB-1 and 2) into the PVM. Its inward motion is driven by an 
actomyosin motor (protein myosin A). The surface coat of the merozoite is progressively 
stripped off as it moves through the tight junction by proteolytic shedding of the MSP-1 
complex 786.  
(4) Resealing of the PVM and erythrocyte membrane after completion of merozoite 
invasion (Fig.1.2.E.II.(F - G)). Daughter merozoites released upon schizont rupture develop 
into either all asexual-stage or all sexual-stage parasites. Each sexually committed merozoite 
produces progeny of only one sex: either micro- (male) or macro- (female) gametocytes 783. 
 
1.4.3.2 Asexual replication: trophozoites and schizontes 
 
After invasion, the merozoite becomes round due to rapid degradation of the inner 
membrane complex and subpellicular microtubules of the pellicular complex, and eventually 
tranforms into a trophozoite. Dense granules move towards the merozoite’s pellicle and 
release their contents into the parasitophorous vacuole space 836. The PVM serves as an 
interface between the parasite and host cell cytoplasm 550. The morphology seen in Giemsa 
stained blood smears of a trophozoite until ~ 12 - 15 h post invasion (p.i.) is ring-shaped, 2 to 
3.7 µm in diameter and discoidal, usually with a biconcave shape. This is referred to as the 
ring stage. The predominant position of its ribosomal RNA content is reflected in the 
basophilic methylene blue ring-like appearance in Giemsa-stained preparations. The 
trophozoite ingests host cell cytoplasm via its cytosome (a circular structure possessing a 
double-membrane, the outer (parasite plasma lemma) and inner membrane (PVM) 11). It 
digests hemoglobin (Hb), producing in the process the insoluble waste product hemozoin, also 
referred to as malaria pigment. Methemoglobin and Hb is degraded to toxic free heme [ferri 
(Fe3+) / ferro (Fe2+) protoporphyrin IX (FP IX)]. Around 90 % of the heme is detoxified as 
polymerized β-hematin (crystallized Fe(III) protoporphyrin IX dimers) and stored in food 
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vacuoles (150 to 300 nm across in diameter). Hemozoin contains biomineralized heme, 
plasmodial proteins and DNA 70,252. At around 24 – 36 h p.i. the trophozoite has mitochondria 
(Mt) with few or no cristae and a large number of ribosomes 308. Trophozoites develop into 
schizonts, which release merozoites after 48 h of the asexual cycle.  
In contrast to other human infective Plasmodia, only P. falciparum infected 
erythrocytes become progressively rigid during development. Moreover, mature trophozoites 
and schizonts of P. falciparum are usually not found in the peripheral blood as they are 
sequestered in the postcapillary venules. Sequestration mainly takes place through the 
formation of knobs, which are alterations in the erythrocyte surface membrane induced by the 
parasite. Mature trophozoite and schizont stages 763 express knobs, i.e. evenly distributed 
electron-dense, conical elevations of the erythrocyte surface 10,60,192,357,358,393,522,529,863,906,907. 
They measure 30 – 40 nm in height and 100 nm in width as judged by electron microscopic 
observations 13,60. The knob surface is positively charged and the remainder of the erythrocyte 
surface is negatively charged 12. Parasite-encoded molecules on the knob surface, referred to 
as neoantigens, are responsible for cytoadhesion and resetting 308. Neoantigens adhere to 
adjacent erythrocytes (rosetting) or to the vascular endothelium (cytoadherence) and form 
focal junctions with the endothelial cell membrane 191. Thus these plasmodial proteins cause 
sequestration, hampering blood flow and inducing local hypoxia, in particular in cerebral 
capillaries. The parasite encodes histidine-rich protein (HRP) I and HRP II ( = KAHRP) 
529,636
, P. falciparum erythrocyte membrane protein-1, 2 and 3 (PfEMP-1, 2 and 3) 78,863, ring-
infected erythrocyte membrane surface antigen (Pf155/RESA), rifins, stevor 217, clag 9 
192,191and others 192.The erythrocyte’s adhesion to the vascular endothelium results in organ 
specific failure and lethal syndromes like cerebral malaria 9,307, the main factors responsible 
for the acute severity and mortality of P. falciparum infection. Cerebral, hepatic, renal, 
pulmonary, or gastrointestinal edemas are known symptoms of malaria tropica. In addition, P. 
falciparum multiplies more rapidly than other human Plasmodium species, causing massive 
destruction of erythrocytes with consequent severe anemia and hemoglobinuria or blackwater 
fever 573.  
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Figure 1.2. Life cycle of P.  falciparum. Modified from 197,682,805,879,910 (A) Feeding of the female 
Anopheles mosquito (1-2 µl blood) with uptake of gametocytes (~ 1 – 105) and / or transmission of sporozoites 
(~ 10 – 20 from 16000 in the haemocoel) (B) Gametocytes develop sexually in the mosquito (details see text); 
Micrograph: Example of mature oocysts (of P. gallinaeceum on the haemocoel surface of the midgut of a female 
Aedes aegypti. Magnification x 300) 805. (C) Invasive stages. (D) Sporozoites invade hepatocytes. (E) Merozoites 
invade erythrocytes (details see text). Merozoites develop asexually within erythrocytes (F) or switch to 
gametocytogenesis (G).  
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1.4.4 Gametocytogenesis 
 
Genetically identical clonal haploid asexual-stage parasites transform into sexually 
dimorphic gametocytes, male microgametocytes and female macrogametocytes 70,209,783,810 
(Fig. 1.2.G.). What triggers this alternative development pathway is poorly understood. High 
levels of asexual parasitemia, anemia, antiparasitic immune responses, chemotherapeutic 
agents and, possibly, other environmental stresses contribute to the induction of 
gametocytogenesis 810. As a consequence, a minority of merozoites becomes sexually 
committed. While they still develop into trophozoites, instead of then developing into 
schizonts, these sexually committed parasites transform into gametocytes 70 first detectable 
through sexual-stage-specific gene expression 810,619. In P. falciparum, gametocytogenesis 
takes place over approximately eight days, passing through five morphologically distinct 
substages until the final crescent shape is reached 209,810. Unlike the cycling asexual-stage 
parasites that are adapted to maintaining and perpetuating erythrocytic infection 70, mature 
gametocytes are specialized escapists – arrested in cell-cycle development 458. The 
gametocytes will die within their vertebrate host unless an encounter with a suitable vector 
permits their continued existence 79. 
 
1.5 Development of resistance towards antimalarial drugs 
  
During the last decades 673,881, there has been an increasingly rapid selection for and 
dispersal of P. falciparum parasites resistant to antimalarial drugs 
49,112,354,601,637,871,878,887,886,914
. The reason for this is that these drugs are increasingly being used 
as prophylactics 880 and for self-medication, often in insufficient doses 883.  
The mechanisms underlying Plasmodium drug resistance 288,772,852,864 remain poorly 
understood. In part, resistance is due to polymorphisms in a variety of genes including the 
Plasmodium falciparum chloroquine resistance transporter (pfcrt) 138,882 and the Plasmodium 
falciparum multi-drug resistance transporter pfmdr, a P-glycoprotein variant 235. Pfcrt is a 
molecule that is thought to function as a transporter in the parasite’s digestive (food) vacuole 
membrane 284. It might thus counteract the effect of chloroquine by increased export of the 
drug. 
Moreover, while polymorphisms can confer drug resistance, different strains of P. 
falciparum may also rely on alternative mechanisms of gene regulation to overcome the 
selective pressures of anti-malarial drugs. These mechanisms may include induction of 
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alternative pathways to bypass the effect of the compounds, repression of genes that aggravate 
the drug effects, or overexpression of transporters in response to drug pressure 558. For 
example, mefloquine and sulfadoxin-pyrimethamine resistance might directly be modulated 
by an increased copy number of pfmdr1, resulting in an amplification in the number of 
cellular transcripts 691,771,911. Therefore, regulatory responses may act alone or in concert with 
previously identified polymorphisms in favoring parasite survival under drug exposure 558.  
 
1.6 Erythrocyte ion composition and regulation 
 
Blood cells are suspended in human plasma with an electrolyte composition as shown 
below (Table 1.1) 
 
Cations    mM total: 150 mM 
Na+    142 
K+    4.5 
Ca2+     2.5 
Mg    1 
 
Anions   mM total: 150 mM 
Cl-    104 
HCO3-    24 
HPO42-      2 
Proteins   14  (66 – 83 g/l) 
Other      6 
Table 1.1. Normal values of the major electrolytes of human plasma 110. 
 
Erythrocytes, or RBCs, make up the largest population of blood cells, numbering from 
4.5 million to 6 million per cubic millimeter of blood. A typical erythrocyte has a flattened, 
biconcave shape and measures about 6 - 8 µm in diameter. In human adults, erythropoiesis 
usually occurs within the bone marrow of flat bones. These release immature erythrocytes, 
referred to as reticulocytes. 1 % of the RBCs of a normal healthy adult are reticulocytes.  
Normal erythrocytes contain a 5 mM solution of hemoglobin (Figure 1.3. A), constituting 
97.5 % of the total cell protein by weight 378. The hemoglobin molecule is a tetramer 
consisting of four polypeptide chains:  
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• 2 α chains, each 141 amino acids long 
• 2 β chains, each 146 amino acids long 
Within each chain is an iron containing molecule known as heme (Fig. 1.3. B) that 
binds oxygen. The other erythrocytic proteins support and regulate the integrity of the cell as 
well as the function of hemoglobin 215.  
A B
 
Figure 1.3.A. Structure of hemoglobin. The protein subunits are in red and blue, and the iron-
containing heme groups in green 664. B. Heme group. 
 
1.6.1 Active ion transport  
 
 Most proteins associated with the erythrocyte membrane are involved in active 
and passive ion transport, i.e. processes to maintain erythrocyte homeostasis 542,538.  
 
1.6.2 Na+/K+ pump-leak balance in non-infected erythrocytes 
 
The Na+/K+ pump-leak mechanism of human RBCs is well understood. It builds up 
and maintains a high intracellular K+ ([K+]i) and a low intracellular Na+ ([Na+]i) concentration 
839,687
. The ouabain-sensitive Na+/K+-ATPase in the RBC membrane pumps 2 K+ ions into 
versus 3 Na+ out of the cell, thereby generating opposing chemical gradients for the two ions. 
The pumping helps to build up the membrane potential and counterbalances the "leak" of the 
Na+ and K+ ions down their respective concentration gradients via various cotransporters, 
exchangers, and channels that adjust a steady-state cytoplasmic [Na+]-to-[K+] ratio of 0.12-
0.16 in normal human erythrocytes 98,528. Intraerythrocytic Na+ and K+ concentrations have 
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been determined as approximately 10 to 20 mM and 140 mM, respectively 442,475,331,214. 
Several cation channels that may contribute to the cation leak have been identified 
electrophysiologically. 
 
1.6.3 Ca2+ homeostasis in non-infected erythrocytes 
 
Human RBCs have a low amount of total Ca2+ as compared to nucleated cell types 
117,262,379
. This results from a low cytoplasmic Ca2+ buffering capacity 280,828, the absence of 
Ca2+-sequestering endoplasmic reticulum and mitochondria. Sickle (HbS/S) RBCs contain a 
minimum of endocytotic Ca2+-sequestering vesicles 541,901. Due to the powerful Ca2+ extrusion 
by the Ca2+ ATPase pump 547,740 and the low Ca2+ permeability of non-stressed RBCs, 
physiological free[Ca2+]i remains below 100 nM 208,262,547. 
 
1.6.4 Nonselective cation channels in non-infected erythrocytes 
 
Whole-state and nystatin-perforated patch-clamp single-channel recordings have led to 
the discovery of ~20 pS nonselective cation (NSC) channels in the human RBC membrane 
that are activated by strong depolarization of the membrane potential 177,715. These voltage-
gated NSC channels 438 are stimulated through nicotinic acetylcholine 89 and PGE2 receptors 
437which can be directly activated by clotrimazole and its analogues 74. They are permeable to 
divalent cations such as Ca2+, Ba2+, and Mg2+ 439,437, and exhibit a hysteresis-like voltage-
dependent gating (i.e. half-maximal voltages of activation and deactivation curves differ by 
~25 mV) 90,437. In addition, voltage-independent NSC channels have been discovered. 
Experiments with simultaneous activity of both channel types suggest their differential 
regulation 517.  
Activation of the voltage-independent NSC cation channels occurs within minutes 
upon replacement of extracellular Cl- by gluconate 507,512,511,517,626, similar when extracellular 
Cl- is replaced by NO3-, Br-, or SCN-. Furthermore, voltage-independent NSC channels are 
activated when the ionic strength of the bath solution is lowered by isosmotic substitution of 
NaCl with sorbitol, indicating that the underlying process is probably identical with that of the 
Na+ and K+ permeability increase upon incubation of human erythrocytes in low ionic 
strength medium 97,433,494. Decrease of the extracellular Cl- concentration to 27 mM half-
maximally activates these cation channels 244. Remarkably, the anion channel/transporter 
inhibitor DIDS directly inhibits K+ efflux in low ionic strength medium paralleled by 
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inhibition of Cl- exchange 433. Moreover, whole-cell recordings show that upon extracellular 
Cl- removal DIDS prevents activation of the NSC channel, while having no effect on the 
activated cation channels 244. Furthermore, cation channel activity strongly depends on the 
cytosolic Cl- concentration 408, suggesting that a DIDS-sensitive pathway equilibrates the Cl- 
concentrations between the cytoplasmatic and extracellular membrane face and that 
intracellular rather than extracellular Cl- ions modulate the cation channel activity. A similar 
dependence of fetal and epithelial nonselective channels 585,835 and epithelial Na+ channels 230 
on intracellular Cl- concentration has been demonstrated. In the latter study, the effect of 
intracellular Cl- concentration was mediated via a pertussis toxin-sensitive G protein. The 
activation of the NSC channel is inhibited by intracellular or extracellular Cl- 244,408. During 
continuous whole-cell recordings the voltage-independent cation channels activate reversibly 
within some minutes upon hyperosmotic shrinkage 408,507,512,511 and oxidative stress (1 mM 
tert-butylhydroperoxide; t-BHP) 244. The voltage-independent channels hardly discriminate 
between monovalent cation channels (cation permselectivity in the rank order of Cs+ > K+ > 
Na+ = Li+ >> NMDG+) and have a Ca2+-permeability similar to that of voltage-gated NSC 
channels (Duranton et al., 2002). Amiloride, GdCl3 and EIPA (5-(N-ethyl-N-isopropyl) 
amiloride) inhibit the voltage-independent NSC channels with increasing potency 244,408,511, 
while tetraethylammonium (TEA) (1 mM), 5-Nitro-2-(3-phenylpropylamino) benzoic acid 
(NPPB) (100 µM), or quinidine (500 µM) have no effects on channel activity.  
Thus, human RBCs most probably express at least two types of Ca2+ permeable NSC 
channels. Moreover, there are mechanosensitive Ca2+- channels 131 in aged RBCs, upregulated 
endogenous stretch-activated Ca2+-channels in Plasmodium gallinaceum infected chicken 
erythrocytes 825, and the deoxygenation-induced cation pathway Psickle in HbS/S erythrocytes 
457,539,538,701
.  
 
1.6.5 Ca2+ activated Gardos K+ channels 
 
 The erythrocyte uses at least four well-characterized K+ transport mechanisms: the 
K+Cl- cotransporter, a NaK2Cl cotransporter, a Na+/K+ ATPase (a sodium pump) and a Ca2+ 
activated Gardos K+ channel 313. The gene for the Gardos channel in erythrocytes is the 4th 
member of the potassium intermediate / small conductance calcium-activated channel 
subfamily N (KCNN4; aliases: hsK4 (human small conductance potassium channel 4), hIK1 
(human intermediate conductance potassium channel)) 395,515. Gardos channels have been 
characterized by single channel recordings 176,359,532. They play an important role in the 
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regulation of cell volume 143,144,313,544,674,768 and are major factors in HbS/S RBC dehydration 
121,537,542,538
.   
 Gardos channel activity is dependent on the free Ca2+ concentration at the 
cytoplasmatic membrane face. Concomitant with an increase in free [Ca2+]i from 500 nM to 
60 µM its open probability increases from 0.1 to 0.9. Ca2+ acts via binding to calmodulin 
constitutively associated with the Gardos channels 219. In addition to Ca2+, channel activity is 
dependent on intracellular K+, and inhibited by extracellular Na+, K+, and intracellular Na+. 
Gardos channels are highly K+ over Na+-selective (PK/PNa > 100) and exhibit an inwardly 
rectifying current-voltage relationship (when recorded with symmetrical K+ solutions) with a 
conductance of ~25 pS (at 0 mV voltage). In addition, protein kinase A (PKA) reportedly 
induces a dramatic enhancement of Gardos channel activity, possibly by modulating the Ca2+ 
sensitivity 674,717.  
 In non-stressed and unstimulated human RBCs the fractional Gardos K+ channel 
activity is low. Moreover, human erythrocytes have high intracellular Cl- concentrations 
(around 80 mM 501,929) resulting in a very low membrane potential (≤ -10 mV) 167 close to the 
Cl- equilibrium (zero current, reversal, Nernst) potential 929. Activation of Gardos channels by 
increased intraerythrocytic Ca2+ levels (≥ 150 nM) 106,507,521 leads to hyperpolarization of the 
RBC membrane potential close to the K+ equilibrium potential. This imposes an outwardly 
directed electrochemical Cl- gradient across the RBC membrane, driving Cl- and K+ into the 
extracellular space, followed by osmotically obliged water efflux. The Gardos channel 
inhibitors clotrimazole (IC50 ~50 nM) 145 and charybdotoxin (IC50 ~5 nM) 144,142, or Cl- 
channel blocker NPPB blunt phosphatidylserine (PS) exposure, hyperosmotic and Ca2+-
stimulated isosmotic cell shrinkage 521,627, confirming the contribution of Gardos and anion 
channels to KCl and water efflux during RBC shrinkage. 
Increase in free [Ca2+]i  therefore favors RBC shrinkage (Gardos effect) 507 subsequently 
decreased RBC deformability under isosmostic conditions, measured as decreased cell size or 
filterability 23,440,517,548. The Gardos effect is dependent on the extracellular Ca2+ concentration 
and is sensitive to amiloride 106,507,521. During complement activation a rising cytosolic 
calcium triggers the Gardos effect, thus limiting the colloidosmotic swelling and lysis of 
erythrocytes 369. Cell swelling tends to favor hyperpolarization over depolarization, since the 
resting RBC membrane potential (≤ - 10 mV) is more positive than the expected equilibrium 
potential for the slightly K+ over Na+-permeable NSC cation channel.  
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1.7 Functional significance of the nonselective cation channels, Ca2+ 
signaling, and Gardos channel activity for the volume and 
programmed death of erythrocytes 
 
Programmed cell death is a cell suicide mechanism enabling metazoans to control cell 
number in tissues and to eliminate individual cells that threaten the animal’s survival 347. This 
suicide mechanism is initiated by unique sensors on the cell membrane surface, termed death 
receptors , an example of which is the Fas receptor (Apo-1, CD95) 287,506,504,361. Death 
receptors detect the presence of extracellular death signals (stressors) such as oxidants, 
radiation 721, chemotherapeutics 153,890, energy depletion 689 or osmotic shock 125. This triggers 
the cell’s intrinsic apoptosis machinery. Because erythrocytes lack mitochondria and nuclei, 
key organelles in the apoptotic machinery of other cells, they have been considered unable to 
undergo programmed cell death. Moreover they might be even taken as post-apoptotic, 
because transient mitochondrion-triggered caspase-activation probably leads to enucleation 
during their development 207,925.  
Senescent erythrocytes have to be eliminated after their physiological life span of 120 
days, or when they are defective, similar to other cell types in which the primary mechanism 
of clearance is programmed cell death or apoptosis. There is evidence that sialic acid residues 
of membrane glycoconjugates control the life span of erythrocytes, and that desialylation of 
glycans is responsible for the clearance of senescent erythrocytes. Their capture is mediated 
by a β-galactolectin present in the membrane of macrophages 135. These and other 
observations support the theory that erythrocyte ageing is a form of apoptosis 127,128.  
When human erythrocytes are injured through stressors such as osmotic shock, 
oxidative stress, ligation of cell membrane antigens and energy depletion they undergo a 
terminal form of apoptosis 207, even though it lacks the morphological alterations and DNA 
fragmentation that characterize apoptosis also in single-celled organisms 40,247,285,286. 
Therefore, this process is termed “eryptosis” 207,499.  
 
1.7.1 Erythrocyte death signaling pathways 
 
To date two erythrocyte death signaling pathways have been identifed which are 
activated by oxidative stress and energy depletion (glucose or ATP) and merge to trigger 
eryptosis 507. Both weaken the antioxidative defense of the erythrocyte. Energy depletion 
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presumably impairs the replenishment of gluthathione (GSH) 103,507,588. Activation of 
phospholipase A2 (PLA2) leads to release of lyso-platelet activation factor (lyso-PAF) 509,519 
or / and arachidonate from membrane phospholipids (Fig. 1.16.).  
(1) Loss of cell volume accompanied by break-down of membrane phospholipids 
asymmetry 94,133,256,268,501,511,935 is a prerequisite and an early and fundamental feature of 
programmed cell death 232,337,336,338,347,503,506,505,508,498,497,704,721,802. Released lyso-PAF upon 
hyper- or isosmotic erythrocyte shrinkage is acetylated to PAF by acetyl-CoA and lyso-PAF-
acetyltransferase 353. This leads subsequently to sphingomyelinase activation 
148,380,411,335,616,615,510,511,519,807,930
. Sphingomyelinase cleaves the phosphorylcholine unit of 
sphingomyelin and releases the proapoptotic sphingolipid ceramide, which consists of the 
sphingosine backbone and the fatty acid unit of sphingomyelin (SM). Appearance of ceramide 
at the erythrocyte membrane or increase of cytosolic calcium results in scramblase activation 
and translocase inhibition. This enhances PS migration to the outer leaflet of the bilayer 
membrane 507.  
 
 
Figure 1.4. Synopsis of eryptosis signaling 499,889. 
 
(2) Release of arachidonate and cyclooxygenase (COX) activation increases PGE2 
formation. PGE2 stimulates NSC channels permeable for Ca2+. In particular, increase in 
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cytosolic Ca2+, [Ca2+]i induces eryptosis 22,45,94,133,207,218,517,502,501,521,513,913. Besides the Gardos 
effect (at free [Ca2+]i ≥ 150 nM), Ca2+ activates a membrane-bound polyphosphoinositide 
phosphodiesterase (at free [Ca2+]i ≈ 2 µM) 22, an endogenous transamidase 561, and the neutral 
endopeptidase calpain (at free [Ca2+]i ≥ 10 µM) 94,276,368,499,517,514,773,791,934, fostering 
proteolysis, polypeptide breakdown and aggregation of membrane proteins 19,22,561. The 
phosphodiesterase influences association of protein components of the membrane skeleton 
through loss of polyphosphoinosites 22,43, increasing phosphatidate (phosphorylated 
diacylglycerol) in dense cells 22,702. The transamidase cross-links membrane components, thus 
increasing the amount of high molecular weight polypeptides 561.  Calpain is a Ca2+ -
dependent cysteine protease of the papainase family 276 that degrades the cytoskeleton in 
particular by ankyrin R, fodrin (spectrin) and polypeptide 4.1 cleavage 94,499. These processes 
lead to membrane budding 19,20,22,94,276,784,791,499,517,514,934 and decreased cellular flexibility 875.  
Especially in the dense fractions of HbS/S and HbA/A RBCs microvesiculation, i.e. loss of up 
to 20% of the membrane lipid in form of microvesicles devoid of membrane skeletal proteins, 
leads to echinocytic and spherocytic deterioration of cellular shape 22,240,282,702,884,885. Most 
importantly, increase in intracellular free [Ca2+]i results in breakdown of PS asymmetry by 
downregulation of the ATP-dependent amino-phospholipid translocase and activation of the 
non-specific lipid scramblase [Ca2+]i (see below). 
 
1.7.1.1 The role of nonselective cation channels in eryptosis upon PGE2 formation 
 
Even at physiological concentrations (i.e. 0.1 nM) PGE2 raises free [Ca2+]i via calcium 
influx through a NSC channel in human RBCs 440. Whereas experiments with the dye Fura-2 
were contradictory 484, results obtained with Fluo-4 confirmed Ca2+-influx upon stimulation 
with PGE2 441. (Fluo-4, in contrast to Fura 2 and Indo-1, is more appropriate to measure Ca2+-
levels in erythrocytes, as its excitation and emission properties are the least influenced by 
hemoglobin. Its excitation light does not lead to significant auto-fluorescence of the 
erythrocytes.) Stimulation with PGE2 induces voltage-independent cation channel activity 
even in the presence of high extracellular Cl- concentrations 517. Recent observations revealed 
a pivotal role of PLA2 and PGE2 in the regulation of PS exposure of human erythrocytes 517. 
Low ionic strength (i.e. low Cl- concentration), oxidative stress or hyperosmotic shrinkage 
that activate the RBC NSC channels in human RBCs during patch-clamp recording reportedly 
increase the RBC cation permeability of intact RBCs, as evident from tracer flux studies 
433,494,507
. Activation of the voltage-independent cation channels in human RBCs by 
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hyperosmotic stress or Cl- removal is paralleled by PGE2 formation, obviously an autocrine 
signal to stimulate the NSC channels. Hence, PLA2 inhibitors, palmitoyl-
trifluoromethylketone, an inhibitor of the Ca2+-dependent PLA2, and quinacrine, as well as 
COX inhibitors, acetylsalicylic acid and diclofenac, prevent channel activation by 
hyperosmotic stress or Cl- removal 517. Furthermore, they reduce PS exposure 499. 
Erythropoietin, too, inhibits both stress-induced cation channel activation and PS exposure, 
thus extending the life span of circulating erythrocytes 626. 
 
1.7.1.1.1 Activation of lipid transporters involved in phosphatidylserine movement  
 
Lipids are usually asymmetrically distributed within the transversal plane of biological 
membranes. In human erythrocytes, choline-containing phospholipids, i.e. 
phosphatidylcholine and sphingomyelin, are enriched in the outer leaflet. (PC = 76% and SM 
= 82%), whereas aminophospholipids are either mostly (PE = 80 %) or exclusively (PS = 100 
%) confined to the cytoplasmic inner membrane leaflet 652,858. Any change of this 
composition, for example through migration of the anionic lipids or degradation of SM, can 
have grave physiological and pathophysiological consequences 115,858. A case in point is the 
Ca2+-dependent PS exposure at the outer RBC membrane leaflet that leads to erythrocyte-
endothelium adhesion 179. PS is present only in small amounts in the outer leaflet of the 
plasma membrane of younger RBCs, but increases with erythrocyte age, as assessed by 
increased cell density 137,188,229,386,421,809 and storage time 50,317,351,564,756. In patients with sickle 
cell anemia 297,491,554,756,934, the amount of PS in the outer leaflet can increase 40-fold 763, from 
300 sites per cell in fresh HbA/A to 12000-13000 sites per cell in HbS/S RBCs 114,309,562,809. 
This effect is found in particular in dense, irreversibly sickled cells 173,172,496,661,809 as a result 
of translocase impairment 114,211,212 and / or scramblase activation 211,212,450. Hence, trapping of 
PS-exposing erythrocytes and concomitant impairment of microcirculation has been observed 
in sickle cell disease 920, thalassemia 492, and diabetes 861. Treatment of RBCs with ionomycin, 
a Ca2+ ionophore, leads to exposure of up to 300000 PS sites per cell 309.  
Micromolar concentrations of [Ca2+]i reversibly inhibit the aminophospholipid 
translocase (or flipase) 108,780,832,923, whose Mg2+-ATPase activity is responsible for active 
translocation of aminophospholipids from the outer to the inner leaflet of the membrane 
61,101,184,233,913,922
. The outside-inside translocation rate of PS at 37 ° C has been determined in 
human erythrocytes. Within 15 min, more than 90% of a phosphatidylserine analogue was 
found in the inner monolayer 620. Thus, it is the aminophospholipid translocase that builds up 
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the phospholipid asymmetry of the RBC membrane 189.  
An ATP-dependent floppase transports both aminophospholipids and 
cholinephospholipids from the inner to the outer leaflet, but it has the least influence on the 
composition of phospholipids in the membrane. Its transport rate is about 10 times slower 
than the rates that have been shown for the inward movement of PS and 
phosphatidylethanolamine (PE) 46,107,187. 
Increase in free [Ca2+]i to 63 - 88 µM half-maximally activates the phospholipid 
scramblase 94,218,900,913,926. Elevated ceramide levels stimulate scramblase further 927. 
Scramblase catalyzes bi-directional migration (flip-flop) of all major phospholipid classes at 
comparable rates across the lipid bilayer in a largely non-selective manner 780,900,899 - only the 
reorientation rates of SM are appreciably lower 780. In platelets, scramblase activity is more 
rapid than in other cells (RBCs), leading within minutes to a loss of phospholipid asymmetry 
99,100
. Although the scramblase does not require hydrolysable ATP, its activation partially 
decreases during prolonged ATP depletion 808,582. 
Although PS-exposing subpopulations of HbS/S RBCs do not show sustained high 
cytosolic Ca2+ levels, PS exposure occurs at different stages in the life of the HbS/S RBC and 
correlates with the loss of ATP-dependent aminophospholipid translocase activity, the only 
common characteristic of PS-exposing sickle cells. Therefore, the additional requirement of 
scramblase activation for PS externalization may only apply to the time interval of transient 
increases in cytosolic Ca2+ 212,210. 
Taken together, these data strongly suggest that the activity of the NSC channels does 
regulate free [Ca2+]i in intact RBCs. A central role for the voltage-insensitive NSC in 
scramblase activation and translocase inhibition can be deduced from the following 
observations: All stress stimuli (oxidation, hyperosmotic shrinkage, removal of extracellular 
Cl-, externally added PGE2) that induce cation channel activation, probably via PGE2 
formation and autocrine PGE2 signaling, also stimulate PS exposure. Further, the induced PS 
exposure is inhibited by blockage of the cell volume- and oxidant-sensitive non selective 
cation channels, for example by the putative inhibitors ethylisopropylamiloride (EIPA), 
amiloride and flufenamic acid 444,507,512,517. Therefore calpain, transamidase, 
phosphodiesterase and scramblase probably execute an erythrocyte death program 133, thereby 
fostering phagocytic clearance. It can be concluded that PGE2-stimulated cation channel 
activity senses RBC age or injury in vivo and prevents colloidosmotic hemolysis of the dying 
RBC by triggering RBC shrinkage, leading to PS exposure 15,16,369,384,455,454,453,516,514,635. 
Cell shrinkage facilitates phagocytosis of the dying cells 115,250,169 that are eliminated 
INTRODUCTION________________________________________________________________________ 
 36 
by this mechanism of apoptosis without releasing intracellular proteins that could cause 
inflammation 361,843. Survival of the shrunken RBC may be extended until its encounter with a 
phagocyte. As a matter of fact, one of the earliest manifestations of cell death in erythrocytes 
and even nucleated cells is the exposure of PS at the cell’s outer surface 271,583,856,927. PS 
externalization even precedes DNA fragmentation, loss of membrane integrity, and cell lysis 
271
.  
 
1.7.2 Recognition of phosphatidylserine-exposing erythrocytes by 
macrophages 
 
PS exposure stimulated RBC clearance has been suggested to contribute to the 
dramatically decreased survival of thalassemia and sickle cells in vivo 212,210. Removal of cells 
is mediated by a complex interaction of surface molecules exposed on apoptotic cells with 
their cognate receptors on macrophages or tissue cells 737,738,933. The externalization of PS 
through calcium-quasi-lipoxygenase activity 459,420 is recognized by macrophages equipped 
with CD36, a primary receptor for PS 272,268,269,270,383,598, and leads to subsequent phagocytosis 
272,269
 in a phosphatidyl-L-serine dose-dependant manner 745. RBCs exposing about 1 mol% 
PS are rapidly removed from the circulation, accumulating in splenic macrophages and liver 
Kupffer cells 115,745. PS-containing liposomes bind to macrophages in vitro 744,703 and in vivo 
688
. In addition, serum-opsonized autologous anti-band 3 (AE1) IgG antibodies covalently 
bound to C3b fragments 570,566,567,569,565 as well as loss of CD47 and sialic acids enable 
macrophages to quickly recognize, engulf and degrade senescent or injured RBCs in their 
lysosomes 115,137,250,268,269,499,509. In vitro, these cells eventually hemolyze.  
 
1.8 P. falciparum infection of human red blood cells (RBCs) 
 
 By invading host cells, pathogens protect themselves from the host’s immune 
responses. Erythrocytes seem to be somehow ideal for the protection and survival of the 
parasite Plasmodium. As the erythrocyte has no nucleus or organelles, it is not capable of 
endocytosis, thus the parasite is residing inside the PVM. The erythrocyte has neither 
endolysosomes, not does it present molecules on the surface in the context of MHC I or II that 
would lead to easy detection of a foreign organism inside the RBCs. On invading an 
erythrocyte Plasmodium enters a cell with very limited capabilities which lacks the machinery 
for de novo lipid and protein biosynthesis 308. In addition, in the host cell the pathogen faces a 
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completely different environment in terms of redox state, electrolyte concentrations and 
signaling molecules as compared to before. Moreover, the adequate disposal of potentially 
hazardous metabolic end products in its new intracellular environment can become critical for 
the parasite’s own survival 824. In general, pathogens either adapt themselves to the new 
situation or they modify the host cell compartment to suit their needs. Finally, the increase in 
host cell volume associated with the pathogen’s intracellular amplification must be 
counteracted by an appropriately modified volume regulation of the host cell. Host cell 
volume regulation, pathogen nutrition, and adaptation of the host cytosol require an increased 
solute transport through the plasma membrane of the host cell 407. The RBC membrane is 
naturally endowed with a variety of transporters, mainly geared to optimize oxygen transport 
and maintain cell homeostasis at minimal metabolic cost. If the transport rates of the host cell 
prove insufficient to accomplish these needs, the pathogens have to alter the permeability of 
the host’s membrane.  
 
1.8.1 RBC membrane modifications by P. falciparum to meet its 
environmental needs 
 
In vitro growth of P. falciparum in culture requires a hexose sugar, a purine source 
758,764
, seven amino acids (cysteine, glutamate, glutamine, isoleucine, methionine, proline and 
tyrosine) 686 and panthotenate 231. Dependent as it is on glycolysis as energy source for its 
intense metabolic and biosynthetic activity, the malaria parasite consumes glucose and 
produces lactic acid at a rate 40 - 100 times higher than that of the non-infected RBC. This 
results in intracellular acidification of the host cytosol which has then a pH of ~7.1 126,917. 
Inside P. falciparum the intracellular pH has been estimated to be within the range 7.2 - 7.4. 
In vivo, malaria infection often leads to acidosis of the patient. While the endogenous 
transport capacity of the RBC is probably sufficient to feed the parasite with glucose, the 
capacity to extrude lactic acid by the RBC monocarboxylate transporter may be not. In 
addition, the RBC membrane lacks appropriate transporters for essential nutrients of the 
parasite such as panthotenic acid. 
The parasite completes its transition from the largely inert ‘ring stage’ form to the 
metabolically and biosynthetically active trophozoite stage between 15 and 20 h p.i.. The New 
Permeability Pathways (NPPs) become apparent about 12 – 15 h p.i. of the merozoite into the 
RBC and increase markedly up to a plateau at about 36 h p.i. 259,796. During this time, 
Plasmodium falciparum permeabilizes the host erythrocytes for a wide variety of low-
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molecular weight solutes with a substantial permeability for Cl-, other monovalent inorganic 
anions 202,327,468,466,796, but also for ions with negative and positive charge such as choline 
469,797
, amino acids 259,329,466,470, small peptides 58,257,329,543,730, vitamins, various 
monocarboxylates 80,182,202,466,730, electroneutral solutes (such as nucleosides 322,329,466,759,849, 
and neutral carbohydrates, i.e. monosaccharide sugars and other small polyols 329,466,467. In 
addition, the NPPs represent a low, but significant permeability for cations 
119,243,471,462,463,465,800,796
, including small quaternary ammonium compounds 800 and Ca2+ 
119,224,477,482,813
. Thus, incubation of late-stage infected erythrocytes in isosmotic sorbitol leads 
to cell swelling due to the sorbitol uptake and eventually colloidosmotic hemolysis 328,495, 
which can be quantified photometrically. Isosmotic hemolysis and tracer flux experiments 
(done mainly by Hagai Ginsburg in Jerusalem and Kiaran Kirk in Oxford) have permitted the 
characterization of the substrate specificities of the NPPs 328,330,466,461 and their inhibition 
149,468,466,468,464,489
. Four patch-clamping groups have worked on their electrophysiological 
characterization 407,799,793: Desai 18,223,224,220,222,221; Huber / Lang 244,243,245,242,246,410,409,406,407; 
Thomas / Staines 130,253,254,797,800,798,799,794,793,826 and DeJonge 857.  
Similarly to the infection-induced NSC currents, transport of monovalent cations in 
tracer flux experiments (Na+, Rb+, choline+, and organic quaternary ammonium ions) and 
hemolysis in different isosmotic salt solutions of monovalent cations are strongly dependent 
on the nature of the anion in the suspending medium. The colloid osmotic hemolysis of 
infected RBCs in isosmotic salt solutions is rate-limited by the uptake of the cations, since 
anion permeability exceeds that for cations by several orders of magnitude 465,800,796. In 
particular, replacement of extracellular Cl- by NO3- increases monovalent cation fluxes by 
factors of 2 - 6 while having no effect on fluxes of sorbitol and lactate 465. 
 
1.8.1.1 Molecular nature of the New Permeability Pathways (NPPs) 
 
It is still a matter of discussion and research whether the increased membrane 
permeability is due to an increase in the activity of (1) endogenous RBC proteins 
216,254,330,410,409,815,857
 by oxidation 244,405,410 or if NPPs are generated by (2) parasite-encoded 
xenoproteins exported and trafficked to the RBC membrane 18,81,223,220,222. At present, neither 
the molecular identity of the NPPs nor their origin is defined. However, activation and 
participation of host (3) inwardly rectifying ClC-2 channels 406 and (4) cystic fibrosis 
transmembrane conductance regulator (CFTR) 857 in the altered permeability of Plasmodium-
infected erythrocytes has been shown. Both ClC-2 and CFTR seem not to be essential for 
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parasite growth, as Plasmodium develops well in knockouts 406,857. Furthermore, the 
mechanism of activation of the NPPs involves (4) phosphorylation steps by PKA for an 
inwardly rectifying anion channel (IRAC / IRCC) permeable for Cl- 253,254 and (5) autocrine 
purinoreceptor signaling for an outwardly rectifying anion channel permeable for Cl- and a 
range of organic osmolytes 815 (ORAC / ORCC 85,245,246,798). Moreover, conductances with 
similar properties as the outwardly rectifying osmolyte channel (ORCC) were activated in 
non-infected RBC upon oxidation by peroxides 410. Treatment of infected RBCs by reducing 
agents diminishes these conductances as well as the rate of hemolysis in isosmotic sorbitol. 
This might indicate that NPPs are endogenous human host RBC channels activated upon 
infection by Plasmodium by oxidative stress 244,324,330,405,410. 
 
1.8.1.2.1 Oxidation-induced channel activation 
 
 Plasmodium falciparum trophozoite-infected human RBCs produce about twice as 
much H2O2 and OH radicals as non-infected erythrocytes due to the high metabolic and 
biosynthetic rate of the blood stage P. falciparum parasite. Digestion of host hemoglobin (Hb) 
provides a major source of amino acids required for the parasite’s protein synthesis as well as 
a source of iron, which is required for the synthesis of iron-containing proteins such as 
ribonucleotide reductase or superoxide dismutase. At the same time Hb digestion leads to FP 
IX, redox active by-products, and H2O2 56,325. Most of the free heme (about 90% 252) is 
neutralized by sequestration into a golden-brown crystalline form, the malarial pigment 
termed hemozoin. An appreciable amount of the free heme is bound by proteins such as 
histidin rich protein. About 0.5% of the heme, free, non-neutralized causes redox damage to 
the host erythrocyte membrane and proteins 831. Oxidative stress 86,412 is counter-regulated by 
the parasite’s and host’s hexose monophosphate shunts 59,57, the thioredoxin redox cycle 622, 
which replenish the NADPH pool for the reduction of oxidized gluthathione (GSSG) to 
glutathione (GSH). Moreover, having a high capacity for GSH de novo-synthesis, the parasite 
actively exports GSSG to replenish the glutathione pool in the erythrocyte, whose own GSH 
synthesis is impaired as the combined result of cessation of GSH de novo synthesis and the 
leaks of Glu(-Cys) and GSH 58. In spite of the concerted oxidative defense of the 
intraerythrocytic parasite and the host RBC, GSH/GSSG ratios decrease in the host RBC (but 
not parasite) compartment, indicating a forceful oxidant challenge 58. In addition to the 
decreased GSH/GSSG ratios, oxidative stress is further indicated in Plasmodium-infected 
RBCs by the oxidative alteration of membrane proteins and lipids 332. Remarkably, in 
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Plasmodium cultures in vitro oxidative injury such as membrane lipid peroxidation 552,775 and 
alterations in membrane protein and lipid composition is not restricted to the infected RBCs, 
but is also evident in non-infected cells 649, suggesting possible diffusion of reactive oxygen 
species out of the infected RBC into the blood. Reported oxidative alterations of RBCs 
membrane proteins such as anion exchanger 1 (AE1, band 3) include clustering 237,403), 
methyl-esterification 419, and tyrosine phosphorylation 932, indicating a complex oxidative 
modification of RBC membrane proteins and signaling molecules.  
 
1.9 Physiological roles of the NPPs  
 
1.9.1 Ca2+ influx 
 
 Non-infected erythrocytes have exceedingly low levels of intracellular Ca2+ (below 
100 nM). As the parasite matures, the Ca2+ content of Plasmodium-infected erythrocytes 
increases 126,481. Extracellular Ca2+ passes the membrane of infected erythrocytes, but Ca2+ is 
almost exclusively localized in the parasite while the Ca2+ concentration only changes little in 
the cytosol of the host cell 579,813,811. Up to the mature, late trophozoite stage the RBC Ca2+ 
pump in infected cells is largely intact 830. In addition, the parasite avails itself of the host 
cytosol Ca2+ pool, thereby buffering the free [Ca2+]i in the host. The bulk of the infection-
stimulated Ca2+ uptake accumulates within the parasite where a low cytosolic free[Ca2+]i is 
maintained by Ca2+ sequestration in organelles 312,311, and the cytosolic free Ca2+ 
concentration of the host rises only transiently during the trophozoite/schizont stage 6,311. 
 
1.9.2 Perturbation of the Na+/K+ pump-leak balance in P. falciparum 
infected RBCs  
 
 The interior of the host erythrocyte represents a highly unusual extracellular 
environment for the parasite, as it initially has high K+ concentrations, low levels of Na+ and 
only submicromolar levels of Ca2+. In erythrocytes infected with Plasmodium there is a 
marked perturbation of the normal Na+/K+ ratios 238,326,766,796. However, in the hours following 
invasion (i.e. the ring stage) the [Na+]/[K+] ratio in the erythrocyte cytosol is maintained low 
329,326,528
. The changes in parasite morphology and metabolism after exit of the ring stage are 
paralleled by an increase in the cation permeability of the host RBC membrane. This cation 
permeability exhibits a permselectivity of Cs+ > Rb+ > K+ > Na+, with a K+-to-Na+ 
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permeability ratio of about 2 as determined by tracer flux studies in trophozoite stage infected 
erythrocytes 462,796 (Fig. 1.5.A).  
 
Figure 1.5. Mathematical modeling of the Plasmodium-induced changes in  Na+ and K+ 
transport and the physiological consequences of these changes for the parasite’s 48h 
intra-erythrocytic development cycle. This modeling was carried out using the integrated Lew-
Bookchin erythrocyte model 536. (A) Time-dependent increase in the basal permeabilities of the RBC membrane 
to Na+ (PNa) and K+ (PK) arising from the furosemide-sensitive NPPs. (B) Time-dependent variation in the 
activity of the Na+/K+ - pump. The closed squares show the measured Na+/K+ - pump activity. Predicted changes 
in cytosolic Na+ ([Na+]i) and K+ ([K+]i) concentrations (C) and in relative cell volume (D) following parasite 
invasion (at t=0) 796. 
 
In the first 12 – 15 h p.i., the Na+/K+ pump exhibits transport activities comparable to 
those of non-infected RBCs. In response to the infection-induced increase of cation leakage 
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through the RBC membrane, an increase of the cytosolic [Na+] stimulates the RBC Na+/K+ 
pump activity up to twice its normal value between 18 and 36 h p.i. (Fig. 1.5.B). Later on, 
between 36 h p.i. and at the end of the blood cycle, the Na+/K+ pump activity declines 
progressively whereas cation leakage through the RBC membrane continues. This decline of 
pump activity results in a dramatic increase of [Na+]i and decrease of [K+]i, respectively 
within the RBC (Fig 1.5. C). 
In particular, during the course of the infection the induced Na+ and K+ permeabilities 
(together with a decreasing host Na+/K+ - pump activity) generate Na+ and K+ concentrations 
within the host cytosol that approximate the values of the extracellular space 239,326,528,659,796. 
The exact transport rates for the Na+ / K+ - pump and the cation leakage have been determined 
experimentally 796. According to the output of a mathematical model these values point to a 
progressive equilibration of the RBC’s K+ and Na+ concentrations with the blood plasma 
levels that starts at 12 h p.i. (Fig 1.5.C). The model predicts an almost complete loss of the 
normal Na+ and K+ gradient across the RBC membrane by 36 h p.i 796. This prediction 
matches very well the high cytosolic Na+ and low K+ concentrations ([Na+]/[K+] ~11.6) 
directly measured in late trophozoite and schizont-infected RBCs using electron probe X-ray 
microanalysis of cryosections 528. As a consequence, inwardly and outwardly directed Na+ 
and K+ gradients, respectively, are built up across the plasma membrane of the parasite. In 
contrast to the infected erythrocyte, the intracellular parasite maintains a low cytosolic 
[Na+]/[K+] ratio throughout the intraerythrocytic cycle, ranging between 0.06 and 0.17 528,329.  
 
1.9.3 Prevention of premature erythrocyte hemolysis by P. falciparum 
 
Breakdown of the host membrane gradients makes the host RBC prone to swelling and 
eventually colloidosmotic hemolysis due to ~ 7 mM of non-membrane-permeating 
(impermeant) protein  prior to the maturation of the intraerythrocytic parasite (Fig. 1.5.D) 826. 
The mathematical model  predicts a relative slight cell volume decrease from 12 to 24 h p.i. 
due to the fact that the efflux of K+ exceeds the influx of Na+, followed by an increase from 
24 h p.i. onwards due to continuous Na+ gain until it reaches the critical hemolytic cell 
volume (~ 150 fl) at 46 h 796. Premature hemolysis is prevented by a concerted action of the 
parasite and the host (Fig. 1.6.). 
The parasite degrades much more host Hb than needed for its metabolism and the host 
exports the excess Hb-derived amino acids via the NPPs into the serum 543,546. By this means, 
the host-parasite interplay lowers the colloidosmotic (oncotic) pressure within the host cytosol 
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and delays host cell expansion (Fig. 1.6.B). The parasite ingests and digests about 70 - 75% of 
the host cell hemoglobin (Hb) (Fig. 1.6.A), but uses only up to 16% of the released amino 
acids for its own protein synthesis 546. Thus, the NPPs accomplish a regulatory volume 
decrease (RVD) of the volume-challenged host RBC in a similar manner as organic osmolyte 
and anion channels do in mammalian nucleated cells 804. 
 
 
A B
 
Figure 1.6. (A) Hemoglobin (Hb) digestion by Plasmodium falciparum following 
invasion. The diagram shows the decrease in Hb content (Hb) and the change in Hb concentration ([Hb]). (B) 
Predicted changes in relative cell volume of infected RBCs (▼, IRBC), host cell (○, Host) 
and parasite (●, Parasite) following invasion. 546  
 
1.10 Erythrocyte polymorphisms and protection against malaria 
tropica 
 
1.10.1 Hemoglobinopathies 
 
Hemoglobinopathies is the collective term for the inherited disorders of hemoglobin 
(Hb). They broadly fall into two main groups. The thalassemiases are classified according to 
the particular globin chains that are ineffectively synthesized into the α, β, δβ, and εδβ 
thalassemiases. The structural hemoglobin variants mostly result from single amino-acid 
substitutions in the α or β chains (HbC, HbE, HbS, or the hereditary persistence of HbF).  
In sickle cell anemia /disease (homozygous, HbS/S) and sickle cell trait (heterozygous, 
HbA/S), there is a mutation in the Hb gene, which codes for the Hbβ chain. The normal allele 
is HbA (HbβA), but for the sickle cell allele, HbS (HbβS), in the 6th codon after the start codon 
GAG is substituted by GTG, so that glutamic acid is replaced by valine at amino acid 6 (β6 
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Glu→Val). The side chain of glutamate is highly polar, whereas that of valine is distinctly 
nonpolar. In this way a hydrophobic residue comes to lie on the outside of HbS. This change 
encourages a sickling process in homozygous HbS/S RBCs that takes place at oxygen 
tensions between 15 and 40 mm Hg, commonly observed in the tissues of the human body. In 
contrast, sickling in heterozygotes HbA/S RBCs  takes places only below 15 mm Hg oxygen 
partical pressure 31,377. In the body the oxygen partial pressure drops down to 15 mmHg only 
under conditions of severe vasoconstriction or anoxemia, e.g. high altitude flights in 
unpressurized aircraft 781. Sickling is induced only in the presence of deoxyhemoglobin S 
through binding between Hb molecules by hydrophobic bonds, comparable to the process of 
formation of amyloid fibrils 617,281,55,551. In oxyhemoglobin S the complementary site (to the 
hydrophobic residue) at the EF corner of the β chain is masked. If the complementary site on 
one deoxyhemoglobin can bind to the hydrophobic residue outside of another 
deoxyhemoglobin S molecule, long fibers are formed, rigid tactoids that distort the RBC’s cell 
shape 679,589,623. Thus, polymerization of HbS, deforming RBCs into a sickle shape, occurs 
when there is a high concentration of the deoxygenated form of HbS. This is usually not the 
case for sickle cell trait, because not more than half of the hemoglobin is HbS 806. Irreversibly 
sickled cells (ISC) have irreversible membrane damage and high mean corpuscular 
hemoglobin concentration values as they are dehydrated because of water and potassium loss 
through the activation of the deoxygenation-induced cation pathway Psickle 539,538 and 
subsequently Gardos channels. ISCs are removed from the circulation by sequestration 
mechanisms, hemolysis and uptake by macrophages 714. Heterozygous sickle cell trait, 
however, provides protection against malaria mortality and severe malaria symptoms 
8,30,29,28,38,150,391,414,415,555,896,895
. 
Studies of globin gene haplotypes based on the patterns of restriction fragment-length 
polymorphisms in the β globin gene clusters 47,657,389,340 have provided important information 
on their evolution 292. The studies suggest that the mutation in HbS originated approximately 
2000 years ago with at least four sites of origin in Africa 340 and once in either the Middle 
East or India. Accordingly, the majority of the chromosomes with the βS gene have one of the 
five common haplotypes, designated as Benin, Bantu or Central African Republic, Cameroon, 
Senegal, and Arab-Indian haplotypes. However, 5 - 10% of the chromosomes have less 
common haplotypes, usually referred to as atypical haplotypes 924. The present distribution of 
the HbS gene and haplotype diversity reflects redistribution on different backgrounds by gene 
conversion and recombination and has resulted from population migration, founder effects, 
and other forms of genetic drift 291,292,630.  
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1.10.2 Genetic traits with a presumable protective role against falciparum 
malaria 
 
The clinical outcome of infectious disease is determined by a complex interaction 
between microorganism, host genetic factors and environment 413. Recent epidemiological 
studies show that the genetic background among the populations exposed to infectious agents 
may confer  partial or complete protection to disease 87,109,178. As a part of host-pathogen 
interaction, an effective immune response to infection has contributed to the development of 
host genetic diversity through selective pressure 754,895. Among the study of host factors and 
their genetic contribution to infectious diseases, one of the best known examples of 
genetically determined factors for the course of disease is found in malaria 265,605,894. The 
relationship between malaria and evolution of the human genome has attracted remarkable 
interest from physical anthropologists and human geneticists since the 1950s 366,555,571,621. 
Interest in this topic has continued up to the present 226,350,365,390,392,556,712,873,894. Experimental, 
clinical and field research has led to the paradigm that malaria is the key selective factor in 
attainment and maintenance of relatively high frequencies of several genetic traits 227.  
α-thalassemia 26,609,653,865,897,898,921;  
β-thalassemia 168,891,892,893;  
HbS (β6 Glu→Val) 8,30,29,28,38,150,391,414,415,555,896,895;  
HbE (β26 Glu→Lys) 152,174,289,341,414,415,646,736, common in Southeast Asia;  
HbC (β6 Glu→Lys) 7,68,152,275,274,302,608,611,827, common in Western Africa;  
G6PD-deficiency 34,66,152,555,610,614,726,834;  
(Melanesia) ovalocytosis as result of deletions in the band 3 (AE1) gene 27,123,194,195,320;  
the human MHC class I  HLA-Bw52 (alpha-3 domain) antigen; and   
the MHC class II HLA DRB1*1302-DBQ*0501 haplotype 391  
have reached their current gene frequency by heterozygote selection against malaria 873, 
because they confer refractoriness to the two most common forms of severe malaria - severe 
malarial anemia and cerebral malaria 227. For α-thalassemia 921, HbC, and HbE the selective 
advantage is greatest in homozygotes. These polymorphisms are a major determinant of child 
survival in malaria endemic countries. How they confer resistance towards P. falciparum 
infection has been recently reviewed 894. Other polymorphisms are under investigation 493,712: 
erythrocyte surface molecules 54,604,122,576,629,671,670; mutant membrane proteins such as 
glycophorins 668; adhesion molecules of endothelial cells like ICAM; receptors such as CD36, 
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CR1 (complement receptor 1, CD35) 180,628,803,822,931; surface molecules of platelets like 
PECAM1; mechanisms of acquired immunity via IL-4, CD40 ligand; low-affinity IIa receptor 
for Fc fragment of IgG; and mediators of innate immunity. The best-studied influence of the 
malaria parasite upon the human genome, however, is the sickle cell trait 82,400,669. 
 
1.10.3 Balanced polymorphism in the case of HbS 
 
The geographical coincidence between falciparum malaria endemicity and the 
distribution of HbS, thalassemia and G6PD deficiency has provided the stimulus for the 
formulation of the “malaria hypothesis” since the 1950s. The “malaria hypothesis” postulates 
that individuals with with various thalassemia traits 364, sickle cell trait (HbA/S) 
30,29,28,31,33,34,37,35,36
 and female heterozygotes of G6PDH deficiency whose blood contains a 
mixture of deficient and non-deficient red cells due to mosaicism 102,726 are more resistant 
than healthy people towards infection with P. falciparum 621,779. Sickle cell trait is the most 
clearcut example of a “balanced polymorphism”. The considerable selective advantages 
conferred to heterozygotes under P. falciparum pressure are balanced by the disadvantages 
suffered by the homozygotes such as gene frequency remains very high in malaria endemic 
regions. Therefore, HbS has been selected in present or recent malaria endemic areas, such as 
in the Congo 388, on the coast of Libya 612, Greece 75, Arabia 530, and India 770. In African 
tribes, sickle cell trait frequency approaches 40 %. About 4% of new-born children are sickle 
cell homozygotes. However, their viability is less than one fifth of the viability of other 
genotypes 32. The death of each homozygote removes two sickle cell genes from the 
population. In conclusion, for one generation, the removal is more than 2* 4% * 4/5 = 6.4 % 
of the genes for the ß-chain of Hb. Thus, about 15 % of the sickle cell genes are eliminated in 
each generation 33. 
Heterozygote HbA/S individuals are not protected from parasitemia 391,580,712,896 as 
they are as easily infected with P. falciparum, and show parasites just as frequently as 
subjects without the trait do 33. However, with regard to severe malaria, it has been confirmed 
that heterozygotes suffer less frequently and less severely than do normal individuals. This 
might be particularly the case when the adaptive immune system is still developing and the 
innate immune system has a dominant role, as in young children under 5 years of age 
8,171,170,290,382,391,648
. Two large cohort studies involving a total of 3000 children in Kenya have 
demonstrated that HbA/S is almost 90% protective against severe or complicated malaria, 
75% against admission to hospital, 50% against mild clinical malaria, but have no effect on 
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the prevalence of parasitemia, and no significant effect on a wide range of other childhood 
diseases. HbA/S individuals have parasite densities 4-fold lower than those with HbA/A. The 
protective effect of HbA/S is equally strong against the two most common forms of severe 
malaria - severe malarial anemia and cerebral malaria 227, resulting in reduced morbidity and 
mortality in this group of children 391,580,896. 
  
1.10.4 Mechanisms of protection from severe malaria for HbA/S carriers 
 
The protection mechanisms remain controversial. The very early theories, which until 
recently were still considered valid by some authors, held the presence of HbS per se 
responsible for the limited multiplication of the trophozoites, resulting in lower parasite 
counts in HbA/S carriers 33. Some studies suggested that invasion by the parasite induces 
sickling, either impairing parasite growth 298,300,302,669,667, or improving clearance of infected 
RBCs by the reticulo-endothelial system 572. Other studies suggested that sickling modulates 
cytoadherence and/or binding of infected HbA/S RBCs to peripheral blood mononuclear cells 
(PBMCs), this in turn influencing TNF and IFNγ levels and the immune response as a whole 
1,5
.  
 
Figure 1.7. Blood smear of HbS/S patient infected with Plasmodium falciparum.  
The blood smear revealed a few sickle cells (arrowhead) and rare red cells with P. falciparum (arrow) 116 
 
The notion that sickling per se impairs parasite growth in HbA/S RBCs was first 
questioned in the 1970s and repeatedly thereafter 17,523. Further, that sickling might occur after 
invasion of HbA/S RBCs by the parasite was disproved by Boctor and Uehlinger in 2002 116, 
who examined Giemsa stained blood smears from a P. falciparum infected 23-year-old man 
with sickle cell disease, i.e. HbS/S RBCs as an extreme of HbA/S RBCs (Fig 1.7.). They 
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found no P. falciparum in sickled RBCs, suggesting that the altered physical and biochemical 
properties of hemoglobin S cannot account for protection against P. falciparum. Moreover, 
increased free FP IX released from hemoglobin digestion is high in infected HbS/S RBCs, but 
low in infected  HbA/S and HbA/A RBCs 656.  Thus, other mechanisms involving the immune 
system must be considered responsible for the protection of sickle trait individuals from 
malaria tropica 918.  
 
1.10.4.1 Accelerated acquisition of adaptive immunity 
 
Several studies have shown a more rapid acquisition of adaptive immunity in HbA/S 
individuals 3,5,4,82,84,150,385,417,581,639,638 compared to HbA/A individuals  in malaria - endemic 
regions 129,743. In fact, a large cohort study with more than 1000 children has shown that the 
degree of HbA/S protection against clinical malaria changes with age. It is only 20% in the 
first 2 years of life, peaks at 56% around the age of 10 years, and returns thereafter to 30% in 
children elder than 10 years 895. The changing degree of protection may reflect combined 
effects of innate and adaptive immune responses. Recent advances in molecular pathology 
and studies of host immunity show that the immune mechanisms that control parasitemia are 
different from those that control pathology in malaria 743. Antibody-dependent cellular 
toxicity is necessary to reduce parasitemia 129.  Because the Fc fragment is responsible for 
cytophilic binding of antibodies to macrophages 95 or lymphoid cells 848, these antibodies 
must be of the cytophilic subclasses IgG1 and IgG3 234. 
 
1.10.4.2 Accelerated clearance by the innate immune system 
 
The instability of HbS leads to increased formation of hemichrome 381,227,226,228. 
Hemichromes are low spin derivatives of the high spin form, ferrihemoglobin, brought about 
through discrete reversible and irreversible changes of protein conformation so that atoms 
endogenous to the protein are now bound as the sixth ligand of the heme iron that usually is 
used for oxygen binding 696. Hemichromes oxidize and cluster RBC membrane protein band 3 
(AE1). This results in an increase of autologous immunoglobulin G (IgG) deposition and 
binding of complement C3b fragments, which accelerates phagocytosis of  infected HbA/S 
RBCs already at ring stage 66.  
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1.10.4.3 Impaired parasite growth  
 
Another oxidant stress model has been developed to explain the protection from 
malaria afforded by sickle cell trait 42. This model proposes that increased formation of 
oxygen radicals such as superoxide anions (O2-), or hydrogen peroxide (H2O2) in P. 
falciparum infected RBCs containing HbS results in membrane injury, so that parasite growth 
is inhibited. 
Inhibition of parasite growth in HbA/S RBCs 631 can take on various forms: (1) 
impaired merozoite liberation and altered RBC rupture, e.g. delayed release of merozoites 
from HbA/S RBCs due to increased buffering capacity of the altered hemoglobin for fatty 
acids 524; (2) reduced invasion by merozoites at low partial pressure of oxygen 
298,300,302,299,303,669,667; (3) impaired parasite survival 298,300,302,299,303,572,629,669,667,724; and / or (4) 
retardation of intracellular development within the erythrocyte 298,300,302,299,303,669,667.  
An imbalance in the MSP-1 allelic distribution of three investigated MSP1 parasite 
genotype families was attributed to reduced fitness of some parasite strains in individuals with 
sickle cell trait 640.  
 
1.10.4.4 Impaired rosette formation 
  
Modulation of cytoadherence is a rather unlikely protective mechanism 725, whereas 
impaired rosette formation was observed to a significant degree in sickle cell trait carriers 155. 
In P. falciparum infected HbA/A RBCs knob size and knob density change inversely from 
trophozoite to schizont stage. Knobs of trophozoites (24 - 36 h p.i.) have diameters from 160 - 
110 nm and densities ranging from 10 - 35 knobs / µm2. In schizonts (40 - 44 h p.i.) the knob 
size is decreased (100 - 70 nm), whereas density is increased (45 - 70 knobs / µm2) 357. 
Heterozygous P. falciparum infected HbA/S RBCs showed reduced rosetting, i.e. binding of 
uninfected RBCs to infected RBCs, forming smaller and weaker erythrocyte rosettes than 
HbA/A erythrocytes in vitro 154,155; this might reduce the risk of cerebral malaria. 
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1.11 Objective of the study  
 
The objective of this study was to elucidate the mechanisms of programmed cell death 
in erythrocytes, also referred to as eryptosis, that are induced in RBCs after infection with 
Plasmodium falciparum. In the host cell Plasmodium is confronted with a completely 
different environment in tems of redox state, electrolyte concentrations and signaling 
molecules as compared to the extracellular fluid, i.e. prior to invasion. To survive in the new 
environment, the parasite thus has to modify the host cell. For instance, it induces new 
permeability pathways (NPPs) in the host erythrocyte membrane, which provide the parasites 
with essential nutrients, facilitate disposal of metabolic waste products, and modify the 
electrolyte composition of the host cell 461.  
Oxidation of non-infected cells induces membrane permeabilities similar to those 
obseverd in infected erythrocytes 410,406,407, suggesting that the parasite accomplishes the 
alterations of host cell function at least in part by inducing oxidative stress. Recent patch-
clamp whole-cell recordings have directly demonstrated a nonselective (NSC) conductance 
(Gcat) with low but significant Ca2+ permeability in Plasmodium falciparum-infected and in 
oxidized non-infected red blood cells (RBCs) 244,243. This Gcat of infected RBC exhibits an 
about two-fold higher permeability for K+ over Na+ 461. Accordingly, the infection-induced 
NSC conductance is responsible for the cation permeability of the NPPs. The cation 
permeable subfraction of the NPPs has been characterized previously by tracer flux and 
isosmotic hemolysis experiments 796. These experiments suggested that the cation permeable 
subfraction of the NPPs impairs the Na+/ K+ pump-leak balance of the host RBC. Moreover, 
the cation leak might supply the parasite with Ca2+. Furthermore, the parasite might use this 
cation leak to decrease the colloid osmotic pressure of the erythrocyte to prevent premature 
hemolysis of the host cell 545. The functional significance of the infection-induced cation leak 
for parasite growth is still ill-defined. Therefore the first question to be answered in the 
present study was:  
(1) What is the functional significance of the infection induced increase in Ca2+-permeable 
NSC conductance (Gcat) for intraerythrocytic parasite development? 
Elevated cytosolic Ca2+ concentrations and oxidative stress have been demonstrated to 
induce eryptosis  in non-infected RBCs 207,243,507. This leads to exposure of phosphatidylserine 
(PS) on the erythrocyte surface 507,510. If and why apoptosis-like mechanisms exist in single 
cell organisms such as trypanosomes 247,286 or in erythrocytes 499,509 is still a matter of 
discussion. While viable cells retain PS in the inner leaflet of the membrane, apoptotic cells 
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are unable to maintain their membrane asymmetry, resulting in exposure of PS on their 
surface and rapid removal of these cells. Apoptosis with subsequent phagocytosis and 
degradation of infected cells may result in the elimination of intracellular pathogens and thus 
serve as host defense mechanism 346,476,739. Clearance of infected erythrocytes may similarly 
confer protection against severe malaria. The malaria parasite P. falciparum invades host 
erythrocytes to proliferate, but may also use them to hide from the host’s immune responses. 
Therefore, the induction of suicidal erythrocyte death by Plasmodium infection may be of use 
not only to the parasite but also to the host cell. As erythrocytes lack MHC molecules for 
presenting foreign antigens to fight an infection, a mechanism such as eryptosis might serve to 
protect the organism. Therefore, the next question to answer was:  
(2) Does Plasmodium infection induced eryptosis lead to increased PS exposure?  
Two eryptosis signaling pathways are known. One stimulates the Ca2+- permeable 
NSC conductance (Gcat), the other activates a sphingomyelinase that produces ceramide. An 
enhanced infection-induced NSC conductance (Gcat) has already been demonstrated (see 
above). Therefore the next question to address in this study was:  
(3) Is host sphingomyelinase activated during Plasmodium infection?  
Activation of parasite sphingomyelinase has already been shown 372. This led on to the 
next question, namely:  
(4) What is the functional significance of ceramide production in infected RBCs? 
Elevated cytosolic [Ca2+] and ceramide activate scramblase and inhibit translocase, 
resulting in PS exposure at the outer leaflet on the membrane of non-infected erythrocytes 
507,510,934
. Phospholipid scrambling of the cell membrane with subsequent PS exposure has 
been shown to be a recognition signal for the innate immune system, i.e. for macrophages to 
rapidly phagocytoze the PS exposing cells, whether they be nucleated cells 271 or erythrocytes 
115
. PS exposure contributes to the mechanisms by which aged, i.e. senescent, or injured non-
infected erythrocytes are removed by macrophages 15,16,455,454,453,516,514,635. In particular, ring 
stage infected sickle trait (HbA/S) erythrocytes 66, which show many features of senescent 
erythrocytes 565, are recognized and cleared more quickly than infected normal (HbA/A) 
erythrocytes. This may cause the partial resistance of sickle cell trait carriers 66. Accordingly, 
the aim of the second part of the present study was to determine whether enhanced eryptosis 
might be one mechanism that contributes to the partial resistance of sickle cell trait carriers. 
This threw up the following question:  
(6) Does P. falciparum infection lead to enhanced PS exposure in sickle trait erythrocytes? 
Furthermore, the objective of the study was to investigate the mechanisms of eryptosis 
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in infected HbA/A and HbA/S RBCs. Homozygous non-infected sickle (HbS/S) RBCs 
undergo eryptosis more rapidly when subjected to different stress stimuli like oxidative stress 
or hypertonic conditions 513 compared to HbA/A non-infected RBCs. Therefore the study 
examined: 
(7) Is acid and neutral sphingomyelinase differentially activated in infected HbA/A and 
HbA/S RBCs under normal culture conditions or under hypertonic conditions? 
Recent observations revealed a pivotal role of phospholipase A2 (PLA2) and 
prostaglandin E2 (PGE2) in the regulation of PS exposure on human erythrocytes during 
eryptosis 517. PLA2 releases from phospholipids arachidonic acid which is further processed 
by cyclooxygenase (COX) and prostaglandin E2 synthase (isomerase) to PGE2. In 
erythrocytes, PGE2 activates Ca2+-permeable cation channels, leading to Ca2+ entry 440,518,548 
and stimulation of a Ca2+- sensitive scramblase 133,218,517,913. Moreover, a mild course of 
malaria infection in P. falciparum infected sickle cell trait children correlates with higher 
levels of PGE2 677. The present study therefore tested whether enhanced PS exposure in P. 
falciparum infected HbA/S RBCs is Ca2+-mediated and PGE2- induced – with a special 
emphasis on ring stage parasites: 
(8) Is the infection induced Ca2+-permeable NSC channel more active in P. falciparum 
infected HbA/S than in HbA/A RBCs, especially at ring stage?  
(9) Do Plasmodium falciparum infected HbA/S erythrocytes secrete more PGE2 than do 
infected HbA/A RBCs? 
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2 Materials and Methods 
 
2.1 Materials 
 
If not stated otherwise chemicals were of the highest purity available. 
 
2.1.1 Organisms and cells used 
 
Plasmodium falciparum FCR3 429, BINH 104 strains were a kind gift from the institute 
of tropical medicine in Tuebingen, Germany. 
Banked erythrocytes and plasma (which could not be used for transfusion) were a kind 
gift from Marc Weidmann and the institute of transfusion medicine, Tuebingen, Germany. 
Acid sphingomyelinase wild-type (ASM +/+) and knock-out (ASM -/-) mice were a 
kind gift from Dr. Verena Jendrossek. They were originally obtained from Drs. R 
Kolesnick/E. Gulbins (New York) who maintained ASM -/- mice in a sv129 3 C57BL/6 
background, breeding them with genotyped heterozygous mice 402. These mice were then 
backcrossed (around 5 times) again on C57BL/6, so that only this background was left. The 
ASM +/+ and ASM -/- mice used for this study were maintained by using heterozygous 
breeding pairs and genotyped by the animal husbandry at the Ear-Nose-Throat Clinical Center 
of Tuebingen University. 
This animal model has been created by gene targeting for studying the pathogenesis 
and treatment of the Types A and B of the Niemann-Pick disease (NPD), which results from 
the deficient activity of ASM, and for investigations into the role of ASM in signal 
transduction and apoptosis. 
By eight months of age, the disease takes a severe, neurodegenerative course which 
ends lethally. Autopsy of these animals revealed complete absence of ASM activity in the 
tissues as well as elevated blood cholesterol and liver and brain sphingomyelin (SM) levels. 
The atrophy of the cerebellum and marked deficiency of Purkinje cells was evident. 
Microscopic analysis revealed 'NPD cells' in reticuloendothelial organs and characteristic 
NPD lesions in the brain 402.  Membrane defects were first observed about three months after 
birth. 
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2.1.2 Chemicals 
 
2.1.2.1 Laboratory chemicals 
 
Acetic acid (100%, glacial)   Merck Eurolab GmbH 
Adenine      Sigma, Deisenhofen  
Agarose     Carl Roth, Karlsruhe 
Azure B     Sigma-Aldrich, Taufkirchen 
Albumax II      Gibco-Invitrogen, Karlsruhe 
Annexin V-FLUOS     Boehringer, Mannheim 
Annexin V-568     Roche, Mannheim 
ATP disodium salt     Sigma, Munich 
t-butylhydroperoxide  (8 M)   Sigma, Deisenhofen 
Chloroform     Carl Roth, Karlsruhe 
CaCl2       Sigma, Deisenhofen 
Cardiolipin (from bovine heart)   Sigma, Munich 
Citrate-Phosphate-Dextrose-Stabiliser Baxter S.A. (Fenwal), Maurepas, France 
C6 – ceramide    Biomol, Hamburg 
C16- ceramide     Alexis, Lausen, Switzerland 
DETAPAC (C14H23N3O10)   Sigma (Fluka), Munich 
Dextrose monohydrate (D (+) glucose)  Sigma, Deisenhofen 
DL-Dithiothreitol (DTT) minimum 99 % Sigma, Deisenhofen  
2,4 –Dichloroisocoumarin    Biomol GmbH, Hamburg 
Dipotassium hydrogen phosphate   Merck KGaA, Darmstadt 
Dimethylsulfoxid (DMSO)    Sigma, Deisenhofen 
Disodium hydrogen phosphate anhydrous Merck KgaA, Darmstadt 
dNTP Mix  100 mM     Roche, Mannheim 
EDTA       Sigma, Steinheim 
Eosin Y     Merck  Eurolab, Darmstadt 
EIPA       Sigma, Deisenhofen 
Ethanol      Merck Eurolab, Darmstadt 
Ethidium bromide (10 mg/ml)  Carl Roth, Karlsruhe 
Epoxyquinone     Alexis, Gruenberg 
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Fluo-3/AM      Calbiochem, Bad Soden 
Gas mixture (90% N2 / 5% O2 / 5% CO2)  Hoepfner, Reutlingen; Mast, Tuebingen 
Gentamicin sulphate     Gibco InVitrogen, Karlsruhe 
Glutamine      Gibco InVitrogen, Karlsruhe 
Giemsa staining solution     Sigma, Deisenhofen 
Glycerol     Sigma-Aldrich, Taufkirchen 
HCL       Merck Eurolab, Darmstadt 
HEPES      Sigma, Deisenhofen 
HEPES/NaOH 1M solution   Sigma, Deisenhofen 
Hypoxanthine     Sigma, Deisenhofen 
Ionomycin       Sigma, Munich 
Imidazole (1,3- Diazo-2,4-cyclopentadiene) Sigma-Aldrich, Taufkirchen 
Immersion oil Type A    Cargille Laboratories, Cedar Grove, NJ, USA 
Inosine     Sigma-Aldrich, Taufkirchen 
Instamed RPMI 1640 with Glutamine Biochrom, Berlin 
Instamed RPMI 1640 with Glutamine Gibco Invitrogen, Karlsruhe 
Ionomycin       Sigma, Munich 
Isopropanol      Merck Eurolab, Darmstadt 
KCl       Sigma, Deisenhofen 
Mannitol      Sigma, Deisenhofen 
Methanol      Merck KgaA, Darmstadt 
Methylene blue    Sigma-Aldrich, Taufkirchen 
Multi Twist Top Vials 1.7 ml   Roth, Karlsruhe 
Multi Twist Top Vial Caps   Roth, Karlsruhe 
NaCl       Sigma, Deisenhofen 
Na-gluconate      Sigma, Deisenhofen 
NaHCO3     Sigma, Deisenhofen 
NaOH      Sigma Diagnostics, St Louis, MO, USA 
Na-vanadate     Sigma-Deisenhofen 
Nitrogen (Gas)    Mast, Tuebingen 
NMDG-Cl      Sigma, Deisenhofen 
n-octylglucopyranoside (C14H28O6)  Sigma (Fluka), Munich 
PBS       Gibco BRL, Karlsruhe 
Potassium dihydrogen phosphate   Merck Eurolab, Darmstadt 
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Propidiume iodide     Sigma, Munich 
PWO polymerase (5 U/µl, 2 x 250 units)  Roche, Mannheim 
RPMI medium 1640 (w/o glutamine)  Gibco-Invitrogen, Karlsruhe 
SAG-Mannitol solution    Baxter S.A. (Fenwal), Maurepas, France 
sn-1,2-diacylglycerol  kinase, recombinant, membrane  
preparation of E. coli, High Purity   Merck, Darmstadt 
Raffinose      Sigma, Deisenhofen 
Spiroepoxide      Alexis, Gruenberg 
Sphingomyelinase (50 U)    Biomol, Hamburg 
1-Stearoyl-2-arachidonoyl-sn-glycerol Alexis, Lausen, Switzerland 
Syto16 (1mM in DMSO)    Invitrogen (Molecular Probes), Karlsruhe  
TaKaRa 10x LA PCR buffer II (Mg 2+) BioWhittaker Europe, Verviers, Belgium 
TaKaRa dNTP mixture (2.5 mM each)  BioWhittaker Europe, Verviers, Belgium 
TaKaRa LA Taq-Polymerase (5U/µl)  BioWhittaker Europe, Verviers, Belgium 
Trizma base     Sigma-Aldrich, Steinheim 
Sorbitol      Sigma, Deisenhofen 
Raffinose      Sigma, Deisenhofen 
Urea       Sigma, Deisenhofen 
 
2.1.2.2 Radiochemicals 
 
[32P]γ-ATP, 250 µCi (92.5 KBq),  
dissolved in 50% Ethanol,  
3 mmol/l; 2 mCi/ml     Amersham, Braunschweig 
[32P]γ-ATP, 100 µCi (37KBq)  
dissolved in 50% Ethanol; 
3 mmol/l, 2 mCi/ml     Hartmann Analytic GmbH, Braunschweig 
45Ca2+ as CaCl2 in aqueous solution,  
specific activity: 0.185 – 1.11 TBq/g Ca  ICN Biomedicals GmbH, Eschwege 
 
2.1.2.3 Antibodies 
 
Monoclonal antibody to ceramide; 200µg/ml; 
clone MID 15B4; isotype Mouse IgM  Alexis, Gruenberg 
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Monoclonal antibody to ceramide; 200µg/ml Sigma, Munich 
Isotype matched pure mouse antibody (IgM) Alexis (Ancell), Lausen, Switzerland 
Secondary monoclonal PerCP-Cy 5.5-  
conjugated rat anti-mouse IgM antibody,  
Igh-Ca and Igh-Cb haplotypes, isotype  
rat (LOU) IgG2a’κ; 0.1 mg, 0.2 mg/ml   BD Biosciences, Heidelberg 
 
2.1.2.4 Primers 
 
Primers were procured from Invitrogen, Karlsruhe. 
 
ASM – PS 5’agccgtgtcctcttcccttccttac3’ 
ASM - PA1 5’cgagactgttgccagacatc3’ 
ASM - PA2  5’ggctacccgtgatattgctg3’ 
Glo5new  5’aactgtgttcactagcaacctc3’    
BPG2   5’atagaccaataggcagag3’    
Myco-P1 5’-gtgccagcagccgcggtaatac-3’ 
Myco-P4  5’-taccttgttacgacttcacccca-3’  
 
2.1.2.5 Kits  
 
Correlate-EIATM Prostaglandin E2  
Enzyme Immunoassay Kit    Assay Designs, Inc., Ann Arbor, MI, USA 
DNA easy tissue kit     Qiagen GmbH, Hilden  
Mycoplasma PlusTM PCR Primer Set  Stratagene, Heidelberg 
QIAamp DNA (Blood) Mini Kit   Qiagen, Hilden 
QIAamp DNA Mini Kit    Qiagen, Hilden  
 
2.1.3 Stock materials 
 
6-, 12-, 24- & 96-well plates    Greiner Bio-One, Frickenhausen  
Bottle-top filters for 0.125 l     Millipore, Schwalbach 
Bottle-top filters for 0.25 and 0.5 l  Carl Roth, Karlsruhe 
CryoTube Vials 2.0 ml    Greiner Bio-One, Frickenhausen 
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EDTA tubes      Monovette, Sarstedt 
FACS tubes      Greiner Bio-One, Frickenhausen  
Falcon tubes      Greiner Bio-One, Frickenhausen 
KodakTMX-OmatAR-5 films (V-1651496) Amersham, Braunschweig  
Patch pipettes (8 to 12 MΩ) made 
of borosilicate glass (150 TF-10)  Clark Medical Instruments, UK 
Microcentrifuge Filters Ultrafree-MC,  
NMWL 5.000 Dalton, PLCC  
cellulosic membrane    Sigma, Taufkirchen 
MµlTI Twist Top Vials (1.7 ml;  
10 x 45 mm polypropylene)   Roth, Karlsruhe 
MµlTI Twist Top Vial Caps    Roth, Karlsruhe  
Paper filter     Macherey- Nagel, Düren 
Silica Gel 60 thin-layer (HPTLC), 200µm thick, 
glass plates (without F), 10cm x 10cm CAMAG, Berlin 
Syringe sterile filter (0.22 µm)  Millipore, Schwalbach 
Scintillation vials     PerkinElmer (LAS), Rodgau-Juegesheim 
Tissue culture flasks     Greiner Bio-One, Frickenhausen 
Tissue culture flasks    Nunc, Wiesbaden 
Transfer pipettes, polyethylene, extended 
fine tip, large bulb, Bulb: 3 ml, sterile  Sigma, Deisenhofen 
Tissue culture flasks     Greiner Bio-One, Frickenhausen 
Tissue culture flasks    Nunc, Wiesbaden 
 
2.1.4 Devices 
 
Adapter for gas dosing unit EC  
for 24 Pasteur pipettes (V826.612.000) VLM, Leopoldshöhe 
Autoclave (with outlet air bacterial filter) Systec Labor Systemtechnik, Wettenberg  
8-channel-multi-pipette Research pro Eppendorf, Hamburg 
Bath sonicator (Transsonic 310)  Elma, Singen 
Biofuge pico Heraeus     Kendro laboratory products, Hanau 
β-scintillation counter Wallac 1409  PerkinElmer (LAS), Rodgau-Juegesheim 
Concentrator 5301    Eppendorf, Hamburg 
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Dissolved Oxygen Meter (DO-5509)  Lutron, Copersburg, PA, USA 
Horizontal DMZ puller    Zeitz, Augsburg 
Evaporator EVA-EC1-24-S (V832.000.002) VLM, Leopoldshöhe 
EPC 9 patch-clamp amplifier   HEKA, Lambrecht 
FACS Calibur     Becton Dickinson, Heidelberg 
Hamilton microliter syringe(100 µl, 250 µl) Carl Roth, Karlsruhe  
Hera cell incubator 37 °C    Kendro Laboratory Products, Langenselbold 
Heraeus Sepatech Centrifuge   Kendro laboratory products, Hanau 
Hair drier      Tuebingen, Germany 
Heating block HB-EC1-24-1,5-EP  
(V804.080.000)     VLM, Leopoldshöhe 
Hypercassette neutral RPN11648   Amersham, Braunschweig 
ITC 16 interface     Instrutech, USA  
Jouan Centrifuge MR 1812    Fernwald, Germany 
Light microscope Leica CM E   Leica, Solms 
Liquid β-scintillation counter Wallac 1409 Wallac, Freiburg 
PCR machine- Peltier Thermal Cycler-200  MJ Research, Waltham, MA, USA 
Rotina35 centrifuge     Hettich GmbH & Co KG, Tuttlingen 
Safety cabinet class II (Hera Safe)   Kendro Laboratory Products, Langenselbold 
Spectronic GENESYS* 6 UV-Vis  
Scanning Spectrophotometer   Thermo Electron, Bremen   
Thermomixer 5436     Eppendorf, Hamburg 
VLM-metal block- thermostat digital  
type EC-1V-130-K1R (V649.061.620) VLM, Leopoldshöhe 
 
2.1.5 Media, buffers and solutions 
 
2.1.5.1 Solutions for preparing human erythrocytes for storage 
 
Citrate-Phosphate-Dextrose-Stabilizer  (g/l aqua ad iniectabilia)  
Citrate acide – monohydrate       3.27  
Sodium citrate – monohydrate    26.30  
Sodium dihydrogen phosphate – dehydrate    2.50  
Dextrose monohydrate     25.50   
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SAG-Mannitol solution     (g/l) 
NaCl       8.77  
Dextrose monohydrate (D (+) – glucose)  9.00  
Adenine      0.169 
Mannitol      5.25  
Citrate-Phosphate-Dextrose-Stabilizer (70 ml) and SAG-Mannitol (SAGM) solution 
(110 ml) were obtained sterile in pockets connected by thin tubes, separated by a leukocyte 
filter, ready for a blood donation of 500 ml. 
 
Sterile saline solution    (in mM): 
NaCl        150  
KCl            5  
CaCl2           1.4 
MgCl2           1 
HEPES/NaOH pH 7.4      10 
Glucose        10  
The saline solution was prepared according to Egee et al. 253. The pH was adjusted to 
7.4 and the osmolarity to 320 ± 5 mOsm (kg H2O)-1 before sterile filtering the saline solution 
through a filter unit of 0.22 µm pore size. 
 
2.1.5.2 Media and solutions for the maintenance of P. falciparum in vitro culture  
 
Supplemented RPMI 1640 medium  
HEPES/NaOH      25 mM 
Gentamicin sulphate     20 µg /ml 
Glutamine        2 mM 
Hypoxanthine                  200 µM 
Albumax IITM      0.5 % 
(Human Serum     2 %) 
1 M sterile filtered CaCl2 (0.22 µm pore size) was used for preparing human serum 
from plasma. 
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 Albumax stock solution 10 x    (in g/l): 
  Instamed RPMI 1640 with Glutamine 
 NaHCO3       10.43 
 HEPES         5.96 
 D (+) glucose         2 
 Hypoxanthine        0.2 
 Albumax IITM      50 
 Gentamicin sulphate        0.01 
The pH was adjusted to 7.1 - 7.4. The sterile filtered Albumax stock solution was 
stored in 50 ml aliquots at -20 or -80°C.  
 
 Freezing solution      (in %) 
 Glycerol      28 
 Sorbitol        3 
 NaCl        0.65  
The freezing solution was sterile filtered (through 0.22 µm pore size) and stored at 
4°C. 
 
Defreezing solution      (in %) 
NaCl          3.5 
The sterile filtered defreezing solution (through 0.22 µm pore size) was stored at room 
temperature (RT). The solution was warmed up to 37°C before use. 
 
2.1.5.3 Solutions to analyze blood smears of P. falciparum infected RBCs 
 
Dipotassium hydrogenphosphate       1 M  
Potassium dihydrogenphosphate       1 M 
  
Potassium phosphate buffer of pH 7.2 0.1 M was prepared according to Sambrook et 
al. 733. Giemsa staining solution was freshly prepared from the purchased Giemsa staining 
solution by dilution 1:10 with 0.1 M potassium phosphate buffer pH 7.2, filtered over a paper 
filter. 
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FIELD’S A is a buffered solution of azure dye  (g/l) 
Methylene blue        1.6  
Azure        11  
Disodium hydrogenphosphate anhydrous     2.6  
Potassium dihydrogenphosphate      2.6  
All substances were put in a flask in a warm water bath for 30 min, left for 24 h at RT, 
and then filtered over a paper filter. 
 
FIELD’S B is a buffered solution of eosin   (g/l)  
Eosin Y         2  
Disodium hydrogen phosphate anhydrous     2.6   
Potassium dihydrogen phosphate      2.6  
The solution was filtered after dissolving in water.  
Field’s B was diluted 1 in 4 with distilled water just before use. 
 
2.1.5.4 Solutions for P. falciparum in vitro growth assays 
 
All solutions were sterile filtered (through 0.22 µm pore size) and added to the 
supplemented RPMI1640 media. Changes in media concentration resulting from the addition 
of solutions were tolerated up to a concentration loss of 10%. In cases where the addition of 
the stock solution to the RPMI medium would have diluted the supplemented RPMI medium 
by more than 10%, the relevant chemical was added directly to the supplemented medium, 
which was then sterile-filtered again. 
For the test solutions the different stock solutions or chemicals were diluted with 
sterile distilled water to obtain the final concentrations shown below. 
 
RPMI 1640 medium     (mg / l) 
INORGANIC SALTS 
Ca(N03)2 * 4 H20       100 
KCl         400 
MgSO4 * 7 H20       100 
NaCl       6000 
NaHCO3      2000 
Na2HPO4 (anhydrous)      800 
MATERIALS AND METHODS____________________________________________________________ 
 63 
OTHER COMPONENTS 
D- Glucose      2000 
Gluthathion (reduced)         1 
Phenol red           5 
AMINO ACIDS   
L-Arginin * HCl       240 
L-Asparagin (free base)       50 
L-Aspartate         20 
L-Cystin         50 
L-Glutamate         20 
Glycin          10 
L-Histidin (free base)        15 
L-Hydroxyprolin        20 
L-Isoleucin         50 
L-Leucin         50 
L-Lysin * HCl        40 
L-Methionin         15 
L-Phenylalanin        15 
L-Prolin         20 
L-Serin         30 
L-Threonin         20 
L-Tryptophan           5 
L-Tyrosin         20 
L-Valin         20 
VITAMINS 
D-Biotin           0.2 
D-Ca-Panthothenate          0.25 
Cholinchloride          3 
Folic acid           1 
i-Inositol         35 
Nicotinamid           1 
Para-Aminobenzoic acid         1 
Pyridoxal * HCl          1 
Riboflavin           0.2 
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Thiamin* HCl           1 
Vitamin B12           0.005 
 
Stock solutions (1 M): 
CaCl2        
KCl        
NaCl        
Na-gluconate       
NMDG-Cl titrated with HCl to pH 7.4   
D (+) glucose      
HEPES (titrated with TRIS (Trizma base) to pH 7.4 or titrated with NaOH to pH 7.4)  
Raffinose       
Urea   
C6-ceramide (D-erythro-N-hexanoylsphingosine) was dissolved in dimethylsulfoxid 
(DMSO) to give a 50 mM stock solution that was stored at -20°C. 
 
Synchronization solution     (in mM) 
Sorbitol isosmotic (5%)     290 
HEPES / NaOH pH 7.4       10 
Glucose          5 
When erythrocytes were to be used further, e.g. for western blots (membrane proteins) 
or for measuring 45Ca2+ uptake, the 5% sorbitol solution was supplemented with HEPES and 
glucose. This was done to prevent infected RBCs from being stressed or oxidized through 
glucose depletion. 
 
Ca- Ringer       (in mM) 
NaCl       140 
KCl            5 
HEPES         10 
MgCl2            1 
CaCl2               1 
Glucose            5  
For Hyperosmolar Ca-Ringer 650 mM sucrose was added. 
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NaCl test solution     (in mM) 
NaCl        120  
HEPES / TRIS (titrated with TRIS to pH 7.4)   30 
KCl           5 
Glucose          5 
CaCl2            1.7 
 
NMDG test solution     (in mM) 
NMDG (titrated with HCl to pH 7.4)  140 
HEPES / TRIS (titrated with TRIS to pH 7.4)   30 
KCl           5 
Glucose          5 
CaCl2            1.7 
 
KCl test solution     (in mM) 
KCl        120  
HEPES / TRIS (titrated with TRIS to pH 7.4)   30 
Glucose          5 
CaCl2            1.7  
 
Na-gluconate test solution           (in mM) 
Na-gluconate       120 
HEPES / TRIS (titrated with TRIS to pH 7.4)   30 
KCl           5 
Glucose          5 
CaCl2            1.7 
 
Raffinose test solution    (in mM)  
Raffinose       280  
HEPES / TRIS (titrated with TRIS to pH 7.4)   30 
KCl           5 
Glucose          5 
CaCl2            1.7 
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2.1.5.5 Solutions for fluorescence assisted cell sorting (FACS) analysis 
 
Annexin binding buffer     (in mM) 
NaCl        140 
HEPES / NaOH pH 7.4       10 
CaCl2           5 
 
PBS         (in mM) 
NaCl        140 
PO4 Buffer pH 7.4       10 
KCl            3  
Each tablet of 5 g PBS had to be dissolved in 500 ml distilled water, giving a final pH 7.45. 
 
Syto16 was diluted before use in a dark environment in PBS or annexin binding buffer 
to a final concentration of 10 nM - 1 µM. 
 
t-butylhydroperoxide (~ 8 M) was diluted in distilled water to a final concentration of 
1 mM just before use.  
 
Modified NaCl test solution    (in mM) 
NaCl       125 
KCl           5 
D (+) glucose          5 
CaCl2            1 
MgSO4           1 
HEPES / NaOH, pH 7.4       32 
 
Sphingomyelinase (50 U) was diluted with 140 µl sterile distilled water for use. 0.2 
Units of sphingomyelinase were applied for the positive control to detect ceramide in the 
outer RBC membrane leaflet by a monoclonal antibody to ceramide. 
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2.1.5.6 Solution for PCR and agarose gel electrophoresis 
  
dNTP Mix       (in µl) 
100 mM stock solution      20 
Distilled H2O      720 
 
TAE (TRIS-acetate-EDTA) buffer was prepared according to Sambrook et al. 733. 
TAE (TRIS-acetate) buffer 50 x stock solution (for 1 L, pH 8.5) 
TRIS (Trizma) base     242 g 
Glacial acetic acid     57.1 ml 
0.5 M EDTA (pH 8.0)    100 ml 
A concentrated (50 x) stock solution of TAE was made by weighing out 242 g TRIS 
base (MW: 121.14 g/mol) and dissolving it in approximately 750 mL distilled water. 
Carefully 57.1 ml glacial acid acid and 100 mL of 0.5 M EDTA (pH 8.0) was added and the 
solution was adjusted to a final volume of 1 L. This stock solution was stored at RT. The pH 
of this buffer was not adjusted and was about 8.5.  
 
TAE buffer working solution   (in mM) 
TRIS-acetate      40 
EDTA       1 
 
2.1.5.7 Solutions for patch-clamp experiments 
 
Standard bath NaCl solution    (in mM)  
NaCl        115  
MgCl2         10  
CaCl2           5  
HEPES / NaOH (pH 7.4)     20  
 
Na- gluconate bath solution    (in mM) 
Na-gluconate       140  
HEPES / NaOH, pH 7.4       10  
CaCl2           1  
MgCl2 (pH 7.4)         1  
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Standard pipette solution     (in mM) 
K-gluconate       140 
NaCl          10 
EGTA             1  
Mg-ATP           1 
HEPES / NaOH (pH 7.4)        5  
 
Ca-(gluconate)2 pipette solution    (in mM)  
Ca-(gluconate)2      95  
MgATP          1  
HEPES / NaOH (pH 7.4)     10  
 
EIPA Stock solution  (in DMSO)   100 mM  
Final concentration for use:         1 µM 
  
2.1.5.8 Solutions for DAG Biotrak enzyme assay  
 
2.1.5.8.1 Standard preparation 
 
Preparation of stock solutions, standards as well as the assay itself were performed in 
Multi Twist Top Vials 1.7 ml, 10 x 45 mm polypropylene microtubes with screw caps with a 
rubber seal to prevent evaporation. 
1-Stearoyl-2-arachidonoyl-sn-glycerol (DAG), a clear oil with the (total molecular) 
formula C41H72O5 (MW: 645 g/mol), was dissolved in ethanol to give a 1 mM stock solution. 
This mixture was again diluted 1:10. 
 
DAG stock solution (1 µmol/ml = 1 mM) 
DAG (15.5 µmol)     10 mg 
Ethanol 100 %     1.55 ml 
 
C16 – ceramide (D-erythro-N-palmitoylsphingosine), a white amorphous to crystalline 
solid, C34H67NO3 (MW: 519,751 g/mol) was dissolved in 37°C warm ethanol to give a 1 mM 
stock solution. This mixture was again diluted 1:10. 
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C16 - ceramide stock solution (1 µmol/ml = 1 mM) 
C16 - ceramide (9.62 µmol)     5 mg  
Ethanol 100 %     962 µl  
 
The stock solutions were stored in Multi Twist Top Vials 1.7 ml at -20°C for 
maximally two months and brought to RT just before use. 
 
Standards (pmol)    Dilution  
         0   
     123      1:810 
    370      1:270 
   1111      1:90 
   3333      1:30 
10000      1:10 
 
Chloroform was pipetted with Hamilton syringes into Multi Twist Top Vials 1.7 ml. 
For the 10000 pmol standard, 100 µl from a 1:10 dilution of the stock solution was transferred 
to a tube. The rest of the 1:10 dilution was used for a 1:3 dilution series (150 µl chloroform + 
75 µl of each dilution) to give the other standards (100 µl of each dilution). 100 µl pure 
chloroform were taken for the 0 pmol ceramide standard. 
 
2.1.5.8.2 Extraction and separation of lipids 
  
NaCl Ringer       (in mM) 
NaCl        125 
MgSO4          1.2 
HEPES        32.2 
Glucose           5 
CaCl2            1 
The solution was adjusted to pH 7.4 with NaOH. 
 
Methanolic HCl       0.1 N 
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2.1.5.8.3 Enzymatic reaction 
 
Detergent solution (Final volume: 10 ml, 240 µl aliquots, storage at -20°C) 
• cardiolipin (biphosphatidylglycerol), dissolved in ethanol at 4.8 mg/ml,  
 MW = 1467 g/mol, (C9 +(4*C18)+(13*O)+(4xO)+ 2P+(4*[(2H)*16 +3H])+19  
• n-octylglucopyranoside, MW = 292,38 g/mol, (C14H28O6) 
• DETAPAC (Diethylene triamine pentaacetic acid), MW = 393,35 g/mol, 
(C14H23N3O10), chelating agent 
 
Cardiolipin (15.28 ml)    5 mM 
DETAPAC (3.9335 mg)    1 mM 
n-octylglucopyranoside     7.5 % 
 
Cardiolipin was transferred to a 15 ml Falcon Tube and dried by a nitrogen gas stream. 
The other components were added. The volume was adjusted to 10 ml.  Cardiolipin was 
dissolved by ultrasound. 
 
sn-1,2-diacylglycerol kinase (261.8 µl aliquots, storage at -80°C) 
sn-1,2-diacylglycerol kinase was reconstituted in 238 µl sterile distilled water to 
restore the pre-lyophilization solution:   (in mM) 
NaCl        300 
Imidazole       250  
Sodium phosphate buffer, pH 7.5,     50 
containing 1 % n-decyl-ß-D-maltopyranoside. 
 
Assay buffer (20 ml sterile filtered, storage at 4°C) (in mM) 
Imidazole (1,3- Diazo-2,4-cyclopentadiene)    100 
NaCl          100  
MgCl2           25  
EGTA             2  
The solution was adjusted with HCl to pH 6.6, then brought to the final volume. 
 
DTT (20 mM, 120 µl aliquots, storage at -20°C) 
DL-DTT was dissolved on ice and directly deep-frozen. 
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Buffer for cold tracer solution     (in mM) 
Imidazole       100 
DETAPAC           1  
The buffer was adjusted to pH 6.6 with HCl and to 4/5 of the final volume. 
 
Cold tracer solution (5 mM ATP, pH 6.6, 10 ml, 110 µl aliquots, storage at -20°C)  
ATP disodium salt      5 mM  
The buffer for cold tracer solution was added. The pH was checked before adding 
dH20 to obtain the final volume. 
 
Chloroform: methanol: 1 N HCl (100:100:1)  
50 ml to stop the reaction, 50 ml to rinse in glass flasks 
 
Buffered saline solution (100 ml, sterile filtered, storage at 4°C) 
       (in mM)  
NaCl       135 
CaCl2            1.5 
MgCl2           0.5 
Glucose          5.6 
HEPES        10  
The pH was adjusted to 7.2, the volume to 100 ml. 
 
EDTA-solution (100 mM, 10 ml, sterile filtered, storage at 4°C) 
 
Reaction mix (770 µl)    (in µl) 
sn-1,2-diacylglycerol kinase     262 
Assay buffer      634 
DTT 20 mM (final concentration: 2.8 mM)   110 
 
Radioactive tracer solution (final volume 110 µl, freshly prepared before use) 
Cold ATP 5 mM (around 100µl)  
10 µCi [32P]γ-ATP was added (10 µl at reference date) for the mice experiments,  
20 µCi for human RBCs. The volume was adjusted according to the specific activity 
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of the relevant [32P]γ-ATP solution as determined by the ladders shown in Fig. 2.1. 
The lower the specific activity, the more volume was added. 
 
Figure 2.1. Specific activity of [32P] γ-ATP. 
A ruler was used to determine the specific activity of the [32P]γ-ATP solution. 
  
Chloroform: methanol (1:1)  
50 ml for the assay, 50 ml to rinse in glass flasks. 
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2.1.5.8.4 Thin-layer chromatography 
 
Running buffer: Chloroform : methanol : acetic acid  (65:15:5)  
 
2.1.5.9 Solutions for 45Ca2+ flux experiments 
 
6% Trichloroacetic acid (TCA) 
 
EGTA-free KCl/NaCl solution (1L)  (in mM) 
KCl        80 
NaCl       70 
Na-HEPES (HEPES titrated with NaOH)  10 
Glucose        5 
MgCl2          0.2 
 
KCl / NaCl solution (100 ml)    (in mM) 
KCl        80 
NaCl       70 
Na-HEPES      10 
Glucose        5 
MgCl2          0.2 
EGTA         0.1  
 
Supplemented KCl / NaCl solution (500 ml) (in mM) 
KCl        80 
NaCl       70 
Na-HEPES      10 
Glucose        5 
MgCl2          0.2 
Inosine      10  
Na-Vanadate        1 
For the KCl / NaCl solution, EGTA was added to 100 ml of EGTA-free KCl/NaCl solution. 
For the supplemented KCl / NaCl solution 10 mM inosine, 1mM Na-vanadate was added to 
500 ml EGTA-free KCl / NaCl solution.  
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2.1.6 Software 
 
CellQuest Version 9 and 10  BectonDickinson, Heidelberg 
InStat statistic program   GraphPad Software, San Diego, California, USA 
Pulse software    HEKA, Lambrecht 
 
2.2 Methods 
 
2.2.1 Preparation of human erythrocytes 
 
Banked erythrocyte concentrate from the institute of transfusion medicine (in a 280 ± 
28 ml pocket) was prepared as follows: 500 ml blood was taken from volunteers, and directly 
transferred to a pocket containing 70 ml citrate-phosphate-dextrose-stabilizer. The blood in 
the stabilizer was left for 3 h at RT, centrifuged for 10 min at RT at 4950 g with a special 
centrifuge, thus transferring the different components of the blood to different pockets. 
Plasma was obtained in one pocket and erythrocyte concentrate in another. The erythrocyte 
concentrate was conserved in 110 ml SAGM. The buffy coat was nearly completely retained 
by a filter. As storage life increases with leukodepletion 134, the erythrocyte concentrate stored 
at 4°C could be used for 42 days (expiry date) and another 14 days for parasite culture 428.  
Blood was obtained from volunteers with their informed consent, collected in EDTA –
tubes and left at RT for 3 h post collection to avoid contamination, as white cells will actively 
remove infectious material during the first 3 hours of incubation. Then the plasma was 
removed. The blood cells were washed three times in a sterile saline solution 253 (hematocrit 
25%). After each centrifugation step (450 g, 5 - 8 min at RT), the buffy coat and upper 10-
20% of the red blood cells (RBCs) were removed with a transfer pipette. The washed, 
leukocyte-depleted RBC concentrates were stored in SAGM solution (ratio: 5.5 ml SAGM / 
10 ml erythrocyte concentrate) for a maximum of 35 days at 4 °C according to official 
guidelines 564. One day before use, RBCs were washed once in original RPMI 1640-medium, 
to which was added sterile HEPES solution (final concentration: 20 mM) as necessary, 
depending on the pH. Blood from sickle cell trait patients and their controls was further 
genotyped (as described below). All experiments were performed under a class II safety 
cabinet.  
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2.2.2 In vitro culture of P. falciparum infected human erythrocytes 
 
Plasmodium falciparum FCR3 429 and BINH 104 strains were cultured according to the 
modified method of Trager and Jensen 841,842,840. Cultures were maintained by routine passage 
in fresh or banked human erythrocytes (1-2 % hematocrit), diluting the RBCs to a parasitemia 
of around 0.5 % and growing them up to a parasitemia of around 10 % in supplemented RPMI 
1640 medium at 37°C in an atmosphere of 90% N2 / 5% O2 / 5% CO2 or in an exsiccator 
according to the candle jar method 428. Only for some experiments P. falciparum was grown 
separately to higher parasitemias. Although the medium was additionally supplemented with 
2% of heat-inactivated human serum during the first part of the experiments, this was found 
unnecessary for maintaining parasite growth consistent 203. Therefore, all further experiments 
were performed with 0.5 % Albumax only. This provided batch-to-batch consistency, 
eliminated the requirement of blood group (ABO) compatibility between RBCs and the 
serum,, and reduced exposure to a potentially biohazardous blood product.  
The parasitemia was determined by FACS analysis with Syto16, by Giemsa or Field´s 
rapid staining, respectively. Syto16 is a DNA/RNA binding dye; Giemsa or Field´s rapid stain 
the parasites in methanol fixed blood smear slides. 
The dilution factors (Df) for splitting the infected RBCs suspension in order to 
maintain the P. falciparum in vitro culture were calculated as follows: 
Df  = mP * V(RBC) /  dP * dV(RBC)  
Fresh blood was added according to the following formula: dV(RBC) – (V(RBC) )/ Df 
mP: measured parasitemia; V(RBC): volume of packed erythrocytes in the culture flask;  fP: desired 
parasitemia; fV(RBC): desired volume of packed erythrocytes in the flask  
The volume of the medium was adjusted according to the degree of parasitemia and 
the time until the next medium change 557,742. Parasite culture was regularly tested for 
Mycoplasma contamination (as described below). 
 
2.2.2.1 Serum preparation from plasma 
 
The plasma was split in 45 ml aliquots in 50 ml falcon tubes and heat inactivated for 
45 min at 56°C. To each 45 ml aliquot 800 µl sterile filtered 1M CaCl2 solution was added. 
This mixture was incubated at 37°C for at least 30 min and then at 4°C overnight (ON) and 
subsequently centrifuged for 30 min / 4°C at 600 g. The supernatant (serum) was kept, while 
the white pellet discarded. If the supernatant was not clear, the liquid was centrifuged again 
for another 30 min. 
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2.2.2.2 Determination of parasitemia 
 
2.2.2.2.1 Syto16 staining 
 
RBCs were incubated with Syto16, diluted in PBS or annexin binding buffer (~20 nM 
to 1 µM) at 37°C. The staining procedure was performed for around 30 – 40 min for infected 
human RBCs (20 - 30 nM) and for around 1 h (1 µM) for mice RBCs. Syto16 green 
fluorescent nucleic acid stain bound to DNA has a maximum excitation/absorption 
wavelength of 488 nm, which corresponds to the argon line of the single-laser of the FACS 
Calibur used, and a maximum emission wavelength of 518 nm. Bound to RNA the absorption 
maximum is at 494 nm, the emission maximum at 525 nm. This green emission is detected in 
the Fluorescence 1 (FL-1) channel with a detector for an emission wavelength of 530 ± 15 
nm. FACS analysis proved a more sensitive technique for determining parasitemia than either 
Giemsa or Field´s rapid staining: 1% parasitemia counted through a light microscope 
corresponded to approximately 2 % parasitemia in FACS analysis. However, Giemsa and 
Field´s rapid staining remained useful for distinguishing parasite developmental stages.  
 
2.2.2.2.2 Giemsa stain for thin films 
 
A drop of the parasite culture was transferred to an object slide with a transfer pipette. 
With the help of a second object slide a thin blood smear was obtained. This smear was 
immediately dried by the air-flow of a hair-drier to avoid echinocytes (crenated RBCs) 
developing or parasites leaving RBCs before being dried. The blood smear was fixed in 
methanol for 1 minute and air-dried. The object slide with the blood smears were flooded with 
freshly prepared Giemsa staining solution for 25 – 30 minutes, rinsed under tap water to float 
off the stain and to prevent deposition of the precipitate on the film. The slides were vertically 
air-dried, and then examined using the 100 x objective of a Leica CME microscope with 
immersion oil. 
 
2.2.2.2.3 Field´s rapid stain 
 
Field’s rapid stain, a modification of the original Field’s stain for thick blood films, 
permits rapid staining of fixed thin films, making it a good choice for quick analyses. This 
method is suitable for examining malaria parasites, Babesia spp., Borrelia spp. and 
Leishmania spp. The air-dried, methanol-fixed films were flooded with 1 ml of 1: 4 diluted 
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Field’s stain solution B. Then an equal volume of undiluted Field’s stain solution A was 
added immediately. After 1 min the slide was well rinsed under tap water, air-dried, and 
examined with a light microscope (100 x objective, oil immersion, and 1000 x magnification). 
This method is useful for rapid presumptive species identification, showing adequate staining 
of all stages of malarial parasites including stippling (mainly Maurer’s clefts).  
Nevertheless, staining with Giemsa solution remains the method of choice for 
definitive species differentiation. As a means of distinguishing parasite stages Giemsa 
staining provided better visibility of parasites inside the erythrocytes than did Field’s rapid 
staining. 
 
2.2.2.3 Freezing parasites 
 
From time to time samples with high, i.e. ≥ 20 % parasitemia, predominantly 
containing ring stages were deep frozen in liquid nitrogen for stock purposes. The cell pellet 
obtained after centrifugation (450g / 8 min at RT) was mixed with an equal volume of 
freezing solution, sterile transferred to a 2.0 ml CryoTube Vial and directly deep frozen in 
liquid nitrogen. 
 
2.2.2.4 Defreezing parasites 
 
Four cryotubes containing infected RBCs (> 20 % parasitemia) were thawed quickly at 
37°C in a water bath. The contents were transferred to a 15 ml Falcon Tube and centrifuged 
(450g / 4 min at RT). The supernatant was discarded. A volume of sterile filtered 3.5 % NaCl 
solution equal to V(RBC) was added at a rate of 1 - 2 drops per second while gently shaking the 
tube. Finally the liquid was mixed with a pipette. After centrifugation at 450g for 4 min the 
supernatant was discarded. The RBC pellet was carefully suspended in original RPMI 1640 
medium (2*V(RBC)). Washing was repeated until the supernatant became clear. The remaining 
cell pellet was resuspended in complete medium and transferred to a culture flask. Fresh 
RBCs were added (amount depending on V(RBC)). The culture flask was filled with 90% N2 / 
5% O2 / 5% CO2. 
 
2.2.2.5 Mycoplasma detection in P. falciparum infected erythrocytes by PCR 
 
DNA was prepared from 5-10 million cells (~ 200 µl blood sample) using the QIA 
Amp DNA Mini Kit. DNA was eluted in 200 µl buffer AE.  1 µl from the elution solution was 
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used for the PCR, carried out in a final volume of 50 µl. Primers P1 and P4 were designed 
according to Spaepen et al. 787. 
 
PCR mixture       (µl) 
DNA        1 
10x PCR buffer      5 
dNTP mix       8 
Primer Myco-P1 (∼ 300 ng/µl)    1 
Primer Myco-P4 (∼ 300 ng/µl)    1 
Taq Pol   1 U      0.2 
dH2O       33 
 
PCR conditions for mycoplasma detection 
24 cycles   min   °C 
Denaturing:    1     95 
Annealing:   1     60 
Extension:   1.5    72 
 
Controls 
Each DNA with GAPDH-Primer 
Positive DNA control  
Negative DNA control  
Master Mix without DNA (only dH2O) 
 
15 µl of the PCR was run on 1 % agarose gel. A DNA fragment of around 900 bp was 
considered positive. Alternatively, the Mycoplasma PlusTM PCR Primer Set was used 
following the manufacturer’s instructions. In brief, an aliquot of the medium was boiled and 
cleaned using StrataCleanTM resin. The extract was tested in a PCR. 
 
2.2.3 Patch-clamp recording in human erythrocytes 
 
The patch clamp technique was developed by Sakman and Neher almost 30 years ago 
633,370,728
. It allows to measure transmembrane currents and voltages in voltage-clamp and 
current-clamp mode, respectively, by the use of a single glass electrode connected to an 
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extracellular reference electrode. Fig. 2.2 provides a brief introduction to the technique of 
whole-cell voltage-clamp recording in human RBCs, which was were performed in the 
present study as has been described by Huber et al. and Duranton et al. 243,410. 
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Figure 2.2. Whole-cell voltage-clamp recording in human RBCs.  
(A) Recording modes. To obtain a gigaΩ seal resistance between the pipette and the bath solution, the tip of the 
recording pipette is impressed on the RBC surface (outer left). Application of negative pressure to the pipette 
lumen aspirates the RBC membrane into the pipette tip. Under these conditions a a gigaΩ seal occasionally 
develops. This on-cell (cell-attached) mode records in intact cells the activity of individual channels residing in 
the aspirated patch (middle left). Further negative pressure or current injection disrupts the aspirated membrane, 
thus restoring the whole RBC membrane to its initial electrical conductance. Simultaneously, the RBC cytosol is 
dialyzed with the pipette solution. In whole-cell mode, recordings are made of macroscopic ion channel activity, 
i.e. macrocopic currents, over the whole RBC membrane (and at high input resistances of the activity of 
individual channels). Here the intracellular and extracellular ion concentrations are defined by the pipette and 
bath solutions, respectively (middle right). Withdrawal of the pipette excises a membrane patch from the cell 
surface. Inside-out patches are obtained when the excision starts from on-cell mode, and outside-out patches 
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when starting from whole-cell mode (outer right).  
(B)  Convention: The applied voltages refer to the electric potential between the cytoplasmic face of the 
membrane and the extracellular space. The inward currents (Iin), defined as flow of positive charge from the 
extracellular to the cytoplasmic membrane face, are negative currents and depicted as downward deflections of 
the original current traces. Consequently, flow of Cl- from the bath solution into the cell generates an outward 
current (Iout). 
(C, D) Rectification: Some channel types do not show a linear current-voltage relationship with varying voltage 
when recorded at equal concentrations of the membrane-permeating ion species on either side.  This might be 
due to various voltage-dependent phenomena: a blockade by physiological ions, a change in unitary conductance 
or a variation in open probability. As a result, the current-voltage relationship is either inwardly (C) or outwardly 
rectifying (D). 
(E) Selectivity. In the whole-cell or excised patch modes, the compositions of the pipette and bath solutions 
together determine the Nernst equilibrium potential for each ion species. In the present example, the equilibrium 
potentials for K+, Cl-, nonselective cations (NSC+), Na+ and Ca2+ are set to different voltages (intracellular and 
extracellular ion concentrations are indicated by the letter size). In the current-voltage diagram (I) an ion-
selective current can be identified by the fact that its value is zero at the ion-specific reversal potential for the 
used solutions 407. 
 
Briefly, patch pipettes (8 to 12 MΩ) made of borosilicate glass were pulled using a 
horizontal DMZ puller. Pipettes were connected via an Ag-AgCl wire to the headstage of an 
EPC 9 patch-clamp amplifier. Data acquisition and data analysis were performed using a 
computer equipped with an ITC 16 interface with Pulse software. For current measurements, 
cells were held at a holding potential (Vh) of –30 mV and 400 ms pulses from –100 to +80 
mV were applied in increments of +20 mV. Whole-cell currents were recorded at RT with 
morphologically intact late trophozoite-stage-infected erythrocytes selected optically as 
described previously 245,410. Whole-cell currents were elicited by 11 square pulses (400 ms) 
clamping the voltage from the -30 mV holding potential to voltages between -100 mV and 
+100 mV in increments of +20 mV. In the original current traces the individual current 
sweeps are superimposed and are depicted without filtering (acquisition frequency of 5 kHz). 
Currents were analyzed by averaging the values between 350 and 375 ms of each square 
pulse. The conductance was estimated by linear regression for outward currents from +40 to 
+80 mV.  
Voltages refer to the cytosolic membrane side in respect to the earthed extracellular 
side. Outward currents, defined as efflux of cations out of or influx of anions into the RBCs, 
are positive currents and depicted as upward current deflections in the original current traces. 
Inward currents are defined as flow of positive charge from the extracellular to the 
cytoplasmic membrane face. The liquid junction potentials between bath and pipette solutions 
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and between bath solution and salt bridge (filled with NaCl bath solution) were calculated 
according to Barry and Lynch 76. Data were corrected for liquid junction potentials.  
The standard bath NaCl solution and the standard pipette solution were used for 
control whole-cell recording. Some experiments were performed with a Ca-(gluconate)2 
pipette solution. After attaining whole-cell mode, cells were superfused (21°C) with Na- 
gluconate bath solution. 
 
2.2.4 In vitro P. falciparum growth assays 
 
Synchronization to ring-stage was achieved by incubation of the infected RBC in 
isosmotic sorbitol solution (5 % w/v, i.e. 290 mM) for 15 min at RT 495,401. The RBCs were 
then washed twice with original RPMI 1640 medium, and the supernatant was discarded. 
Ring stage-synchronized infected RBCs were aliquoted in 96-well plates (200 µl aliquots, 1 % 
hematocrit, 1% parasitemia) and grown for 48 h with the candle-jar technique 428 in the 
absence (control) or presence of different chemicals in concentrations as described in the 
results. Chemicals in complete culture medium were prepared double-concentrated, and then 
mixed with the same volume of synchronized parasite culture of 1 % parasitemia and 2 % 
hematocrit to give a final hematocrit of 1% and 1% parasitemia. 
Partial O2 pressure was determined with a dissolved Oxygen Meter calibrated at 
20.9% partial O2 pressure (air). This corresponds to 4.7 mg/l oxygen dissolved in distilled 
water. At flame extinction partial O2 pressure was measured as 5.4 % (1.2 mg/l dissolved 
oxygen in distilled water), which corresponds to a partial oxygen pressure of around 35 mm 
Hg, found in venous blood. These conditions provided a culture environment that will not 
induce sickling in heterozygotes HbA/S RBCs, as this occurs only below 15 mm Hg 31,377 and 
under nutrient deprivation. Accordingly sickling could not be observed (data not shown). 
In all P. falciparum in vitro re-invasion experiments (with normal or sickle trait 
RBCs), if not stated otherwise, parasites were grown for 48 h in culture medium under 
culturing conditions. Parasitemia was assessed by Syto16 staining at time 0 h, i.e. just as the 
experiment had been started, and after 48h of growth at 37°C. After 48 h a 6 µl aliquot (1 % 
hematocrit) of the well-mixed cell suspension was stained in 44 µl of Syto16 solution for 30 
min at 37°C, giving a final concentration of Syto16 of 30 nM in PBS. Prior to FACS analysis 
the samples were diluted 1: 5 with PBS. Parasitemia was defined by the percentage of RBCs 
stained with Syto16. Additionally, the percentages of annexin-binding cells were determined 
by double-staining (see below) in several growth assays. 
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The in vitro reinvasion by P. falciparum of RBCs kept in culture medium, test 
solutions with different electrolyte compositions, in supplemented RPMI medium containing 
the cation channel inhibitor EIPA, or CaCl2 ± the chelator EGTA was studied. For this 
purpose washed ring-stage synchronized infected RBCs were grown for 48 h to a parasitemia 
of about 5 - 10% (starting with a parasitemia of around 1 %). Only growth assays in which 
parasites multiplied at least 5 fold were considered. EIPA in concentrations varying from 0 to 
100 µM, or EGTA in a concentration of 1 or 2.5 mM was added to the culture medium at time 
0 h. CaCl2 (1 or 2.5 mM, respectively) was added together with EGTA (1 or 2.5 mM, 
respectively) to control for direct EGTA effects. The concentrations of free Ca2+ were 
calculated according to Fabiato et al. 266.  
Other P. falciparum in vitro growth experiments were performed in the presence of 
C6-ceramide (D-erythro-N-hexanoylsphingosine) (0 – 20 µM), in the presence of 2,4 - 
dichloroisocoumarin (DC) ± NaCl (50 mM) and varied concentrations of NaCl (0 - 100 mM), 
raffinose (0 - 200 mM) and urea (0 - 200 mM). Additional parasite growth experiments tested 
the dependence of growth on extracellular Na+, K+ and Cl- concentrations. After 24 h of 
synchronized culture, when most of the parasites were in the trophozoite stage, cells were 
spun down and the culture medium was washed twice and replaced by isosmotic NaCl, 
NMDG-Cl, Na-gluconate or raffinose test solution or mixtures of these solutions. The test 
contained undiluted 120 mM NaCl, 140 NMDG titrated with HCl to pH 7.4, 120 Na-
gluconate or 240 raffinose and in addition [in mM]: 30 Hepes, 5 glucose, and 1.7 CaCl2 (5 
KCl in the case of NMDG test solution). After 4 h, 8 h, or 16 h of incubation in these 
solutions, cells were spun down, freed from the test solution, washed with culture medium 
and further incubated for 20 h, 16 h, and 8 h, respectively, under normal culture conditions 
(the total incubation time was 48 h). Parasitemia was assessed as described above. Where not 
indicated otherwise, experiments were performed with 8h medium replacement by the test 
solution. 
 
2.2.4.1 Determination of free concentration of EIPA in parasite growth medium 
 
To determine the free EIPA concentration in parasite growth medium, EIPA was 
prepared at 0, 1, 10 and 100 µM concentration in pure distilled water or in distilled water with 
the same concentrations of ALBUMAX II (0.5%) and serum (2%) as used for the parasite 
culture medium. The latter solutions were ultracentrifuged at 1942 g at 4°C for 40 min using 
Microcentrifuge Filters Ultrafree-MC, which bind proteins, to determine the free 
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concentrations of EIPA. The absorption spectrum of EIPA was determined with 100 µM 
EIPA, dissolved in distilled water, over a range from 200 nm to 700 nm using a UV-VIS 
Scanning Spectrophotometer. Maximum absorption wavelength was at 370 nm. To obtain a 
standard curve the absorption at of different EIPA concentrations in distilled water was 
determined. Then the absorption of the used EIPA concentrations (1, 10, 100 µM) in the 
ALBUMAX/serum/water mixture were measured at 370 nm. Finally, the free EIPA 
concentration was calculated from the standard curve.  
 
2.2.4.2 Annexin binding experiments 
 
Suspensions with non-infected RBCs were stained with annexin V-FLUOS. 
Suspensions with P. falciparum infected RBCs were stained with annexin V-568 and/or with 
the DNA dye Syto16 to assess PS exposure in the outer leaflet of the RBC membrane and the 
percentage of infected RBCs, respectively.  
For annexin binding, RBCs were washed, resuspended in annexin-binding buffer, 
stained with annexin V-568 (dilution 1:50) or annexin V-FLUOS (dilution 1:100), and 
incubated for 20 min at RT in Ca2+-free annexin binding buffer. AnnexinV binding to 
negatively charged phospholipids (with a high specificity for PS) is Ca2+-dependent 
44,92,151,321,753,876
. Therefore an annexin binding buffer containing Ca2+ was used. Syto16 (final 
concentration of 30 nM) was co-incubated in the annexin binding buffer for 20 min at RT for 
double-staining purposes. Samples were diluted 1:5 with annexin binding buffer just before 
FACS analysis. Cells were analyzed by flow cytometry. Fluorescence 1, FL1 (detector for an 
emission wavelength of 530 ± 15 nm) was either an indicator of annexin V-FLUOS 
fluorescence intensity (excitation: 450 - 500 nm, emission: 515 - 565 nm) (simple staining for 
annexin); or of Syto16 fluorescence (maximum excitation wavelength: 488 nm for DNA, 494 
nm for RNA, maximum emission wavelength: 518 nm for DNA, 525 nm for RNA).  Syto16 
fluorescence was taken to reflect the degree of parasitemia. Fluorescence 2, FL2 (detector for 
an emission wavelength of 585 ± 21 nm) or FL1 was used to determine the annexin 
fluorescence of Annexin V-568 or Annexin Fluos, respectively, i.e. the percentage of PS 
exposing cells. Annexin V-568 has an absorption spectrum from 450-650 nm, a maximum at 
578 nm, an emission spectrum from 560 nm up to > 700 nm with a maximum at 603 nm. 
Double staining necessitated compensation for overlapping emission spectra by electronic 
subtraction of any unwanted spectral “spillover” from the signal of interest. Simple stained 
infected erythrocytes (with Syto16 or annexin V-568) containing dye in the relevant 
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concentrations were used as compensation controls for this multicolor study. 
To induce annexin binding according to Lang et al. 507, non-infected RBCs were 
incubated for 1 h at 37°C with the Ca2+ ionophore ionomycin (0 and 1 µM, respectively) or 
oxidized by t-butylhydroperoxide (t-BHP, 1 mM for 15 min followed by 24 h of post-
incubation) in a modified NaCl test solution consisting of ( in mM): 125 NaCl, 5 KCl, 5 D (+) 
glucose, 1 CaCl2, 1 MgSO4, 32 HEPES  titrated  to pH 7.4 with NaOH.  
 
2.2.4.3 Detection of ceramide in the RBC outer membrane leaflet by an 
monoclonal antibody to ceramide  
 
Ceramide is detected in brief as follows: A suspension with infected RBC (1,1*106 
cells; 1 µl of packed RBCs contain ~11*106 erythrocytes) was incubated with a first 
monoclonal antibody to ceramide. After washing twice, the cells were incubated with a 
secondary rat anti-mouse IgM antibody, labelled with the fluorescent PerCP-Cy5.5. In a third 
step, after washing twice, the cells were stained with Syto16 (final concentration 30 nM).   
PerCP-Cy5.5 is a tandem fluorochrome, composed of peridinin chlorophyll a protein 
(PerCP), a naturally occurring algal pigment that is excited by the 488-nm line of the FACS 
Calibur Argon ion laser (absorption maximum at 490 nm). This permits the use of conjugated 
PerCP as a third color on bench-top single-laser instruments. PerCP serves as energy donor in 
this procedure. It is coupled to the cyanine dye Cy 5.5TM, which acts as energy acceptor and 
emits fluorescence at 695 nm (within the Fluorescence 3 (FL-3) channel of BD FACS Calibur 
(detector for an emission wavelength of 650-700 nm). The key advantages of using PerCP-
Cy5.5-conjugated reagents are that they are useful for analysis on stream-in-air flow 
cytometers, do not photobleach like PerCP, and cause less Fc receptor-mediated non-specific 
staining than PE-Cy5 tandem fluorochromes. This secondary antibody was chosen to avoid 
spectral overlap with Syto16 fluorescence dye.  
To test for the quality of the anti-ceramide antibody and to determine working 
concentrations, dilutions of 1:5 (Sigma) or 1:10 (Alexis) of the first antibody together with 
different concentrations of the secondary PerCP-Cy 5.5-linked rat anti-mouse IgM antibody 
were used (0.2, 0.4, 0.6, 0.8 µg/ml). A good result of anti-ceramide staining (procedure see 
below) was obtained by using the Sigma monoclonal antibody to ceramide and a 
concentration of 0.8 µg/ml of the secondary antibody. 
In addition, appropriate compensation controls had to be prepared for this multicolor 
study. For positive control, RBCs with high parasitemia (around 15 %) of P. falciparum were 
incubated overnight (8 - 15 h) in a hyperosmolar Ca-Ringer-Solution (300 mOsm Ringer and 
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650 mOsm Sucrose). In addition, 200 µl infected and non-infected RBCs were treated with 
0.2 U Sphingomyelinase for 2 - 5 min and washed thoroughly thereafter. For negative control, 
one sample of each NaCl concentration (0, 10, 25, 50 mM) was left untreated by the first 
antibody (instead 10 µl PBS was used). Then, the secondary antibody was added to test for 
unspecific binding. For isotype control, isotype matched pure mouse antibody (IgM) (1 
µg/ml) was used as first antibody. To test for background Syto16 fluorescence and spectral 
overlap with PerCP-Cy 5.5 emission, each control was incubated with and without Syto16 (± 
Syto16) (30 nM final concentration).  
Parasite growth assays were performed as described above with 0, 10, 25, 50 mM 
NaCl (n = 6), which was added to the culture medium. 10 µl P. falciparum infected (n = 3) 
RBCs (V(RBC): 0.1 µl, i.e. 1.1*106 cells) were cooled down on ice. The samples were 
incubated for 45 - 60 min on ice with 30 µl ice-cold PBS containing 2 % human serum to 
block unspecific binding and 10 µl monoclonal antibody to ceramide (1 µg/ml from Sigma). 
Hereafter, cells were washed twice with ice cold 400 µl PBS, which contained 1 % human 
serum, and centrifuged at 225g at 4°C for 5 min.  The supernatant was discarded. RBCs were 
incubated on ice with the secondary rat anti-mouse IgM PerCP-Cy 5.5-conjugated antibody 
(0.8 µg/ml, final volume: 50 µl) for 30-45 min. The washing steps were repeated twice. 
Syto16-staining was performed (30 nM at 37°C) in a final volume of 50 µl. 200 µl PBS was 
added prior to FACS analysis. The settings were adjusted according to negative and positive 
controls to permit differentiation between 4 populations within the 4 quadrants of a dot plot (± 
Syto16 (FL1) ± ceramide (FL3)). 
 
2.2.5 In vivo proliferation of Plasmodium berghei ANKA 
 
Male and female C57BL/6 mice (2-3 months old) with ASM  knock-out (-/-) (10 
female, 7 male) or ASM wild-type (+/+) (15 female, 5 male) genotype were infected by 
intraperitoneal injection of 106 P. berghei ANKA-infected mouse erythrocytes, which had been 
deep frozen in liquid nitrogen. From the seventh day post infection, parasitemia was estimated 
daily by Syto16 DNA-RNA staining as described above, neglecting the presence of white 
blood cells (1 µM final concentration, incubation at 37°C for 30 - 60 min).  
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2.2.5.1 Analysis of genomic mice DNA  
 
DNA preparation from ear tissue or mouse tail was done using the DNA easy tissue 
kit. Briefly, DNA was eluted in 200 µl buffer. 5 µl of the elution was taken for the PCR, 
performed in a final volume 50 µl. 
 
PCR mixture      (in µl) 
Genomic DNA       5 
10x PCR buffer (+ MgSO4)      5 
dNTP mix        8 
Primer ASM - PS (100 ng/ µl)     1 
Primer ASM - PA1 (100 ng/ µl)     1 
Primer ASM - PA2 (100 ng/ µl)     1 
Distilled H2O      28 
PWO polymerase (5 U/µl)    0.2 
. 
PCR conditions for mice genotyping  
30 cycles   min   °C 
Denaturing:    1     95 
Annealing:   1     58 
Extension:   1    72 
 
 PCRs were carried out analogously with DNA of a wild-type, a heterozygote, a 
knockout mice and a negative control without any DNA. 10-15 µl of each PCR mixture was 
used for agarose (1.5 %) gel (5 µg/ml ethidium bromide) electrophoresis according to 
Sambrook et al. 733. The size of the ASM wild-type DNA fragment was 269 bp, while that of 
the ASM knockout DNA was 523 bp; in the case of heterozygous mice both fragments 
appeared. 
 
2.2.6 Genotyping of human blood samples 
 
Genomic DNA was isolated using the QIAamp DNA (Blood) Mini Kit, following the 
supplier’s instructions. Briefly, total DNA was purified from 200 µl of whole blood using 
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QIA Spin Columns fitted in 2 ml Eppendorf tubes. DNA bound to the QIAamp membrane 
was washed twice, and then eluted with elution buffer, following the supplier’s instructions. 
DNA yield was determined from the concentration of DNA in the eluate, measured by 
absorbance at 260 nm. Purity was determined by calculating the ratio of absorbance at 260 nm 
to absorbance at 280 nm. A260/A280 ratio was 1.7 to 1.9, corresponding to pure DNA.  
The HbS mutation occurs in one allele for HbA/S blood, in the 6th codon (GAG → 
GTG) after the start codon, leading to a substitution of glutamic acid by valine in the 6th 
position in the β-globin amino acid sequence (β-6). To confirm the absence or presence of the 
mutation, DNA extracted from blood of Hb A/A (7 individuals) and Hb A/S donors (5 
individuals) were PCR amplified and sequenced. Total PCR volume was 25µl. 
  
PCR mixture      (in µl) 
Genomic DNA       2.5 
TaKaRa 10x LA PCR buffer II (Mg2+ plus)    2.5 
TaKaRa dNTP mixture 2.5 mM each    2 
Primer Glo5new (20 µM)       1 
Primer BPG2 (20 µM)       1 
Primer ASM - PA2 (100 ng/ µl)     1 
Distilled H2O      28 
TaKaRa LA Taq polymerase (5 U/µl)    0.5 
 
PCR conditions for human blood genotyping  
    min   °C 
Start:    4   94 
35 cycles  
Denaturing:    1     94 
Annealing:   1     55 
Extension:   1    72 
Last extension, in addition: 2   72 
    ∞     4 
 
The PCR mixture was stored at –20°C until sequencing was performed by 4baselab, 
Reutlingen, Germany. Sequencing results of one healthy (HbA/A) and one sickle cell trait 
(HbA/S) individual are shown in Fig. 2.3. For sequencing results of all donors, see appendix. 
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A HbA/A, position 14 only one signal A 
 
B HbA/S, position 14 double signal A/T 
 
Figure 2.3. Confirmation of the genotype of the blood samples used. Sequencing results 
of an amplified DNA fragment of a healthy and a sickle cell trait individual containing 
the codon 6 of the β-hemoglobin chain. 
A-B Sequences of an amplified DNA fragment containing the codon 6 of the β-hemoglobin chain. 
Genomic DNA, extracted from whole blood of a healthy (HbA/A) and a sickle cell trait (HbA/S) individual were 
PCR amplified and sequenced. Normal hemoglobin (HbA) has the code GAG (position 13-15) for glutamine 
(A), while sickle cell hemoglobin (HbS) has the code GTG for valine. The DNA from sickle trait (HbA/S) 
therefore shows a double signal A/T at position 14 (B).  
 
2.2.7 DAG Biotrak enzyme assay for the determination of ceramide levels  
 
In principle, this radio-enzymatic assay employs abundant E. coli diacylglycerol 
(DAG) kinase and defined mixed micelle conditions. These conditions effectively solubilize 
the crude extract of ceramide and allow its quantitative conversion to [32P] phosphatic acid in 
the presence of [32P]γ-ATP and DAG-kinase, which also acts as a ceramide-kinase in this 
case. The radio-enzymatic reaction of assay is shown in Figure2.4. Following its enzyme-
catalyzed phosphorylation, the [32P] phosphatic acid reaction product is extracted and 
separated from [32P]γ-ATP, which is added in excess, by thin-layer chromatography. The 
more lipophilic product moves with the running buffer, whereas the more hydrophilic [32P]γ-
ATP remaines at the baseline. The radioactivity attributable to the [32P] phosphatic acid 
product is scratched off the plate and determined by liquid scintillation counting. The amount 
MATERIALS AND METHODS____________________________________________________________ 
 89 
of ceramide present in the sample is calculated from the amount of [32P] phosphatic acid 
produced and the specific activity of the [32P], corresponding to the standard curve. 
Figure 2.4. Radio-enzymatic reaction used in the DAG Biotrak Enzyme assay. 
The substrate used for the standard curve is C16-ceramide (D-erythro-N-palmitoylsphingosine). It is 
quantitatively converted into [32P] phosphatic acid in the presence of [32P]γ-ATP and DAG kinase. 
 
2.2.7.1 Standard preparation 
 
The prepared standards (including the zero value) were air-dried by the Eppendorf 
concentrator at 30°C for about 15 min. 
 
2.2.7.2 Extraction and separation of lipids 
 
The whole assay was performed in MµlTI Twist Top Vials with screw caps with a 
rubber seal to prevent evaporation and spill. 20 µl of erythrocyte pellet were washed twice in 
NaCl Ringer and centrifuged at 225 g for 2 min at RT. 10µl of the washed RBCs were 
suspended quantitatively in 90 µl NaCl Ringer. This was followed by a modified lipid 
extraction method 316,111 briefly described in the following: 250 µl methanol, 125 µl 
chloroform were added to the 100 µl RBC suspension using a Hamilton syringe. The samples 
were vortexed for 2 min and centrifuged at 9460g for 2 min at RT. Phase separation was 
accomplished by addition of 125 µl chloroform with a Hamilton syringe and 125 µl distilled 
water and subsequent repetition of the suspension (vortexing for 2 min) and centrifugation 
steps. The lower phase was collected with a 250 µl Hamilton microliter syringe, air-dried in a 
concentrator maintaining a temperature of 30°C for around 25 - 30 min. If no degradation of 
DAG was performed, samples were dried just before undergoing the enzymatic reaction. 
DAG was degraded by alkaline hydrolysis in 100 µl of 0.1 N methanolic HCl for 1 h 
at 37°C. The extraction protocol described above was modified here to take account of the 99 
µl methanol already present, as follows: 90 µl NaCl Ringer, 151 µl methanol and 125 µl 
chloroform were added as a first step before suspension and centrifugation. 
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After complete extraction, the lower phase was collected, dried, and stored at –20°C. 
Samples and standards were analysed by thin layer chromatography within 72 h.  
 
2.2.7.3 Enzymatic reaction 
 
To provide defined mixed micelle conditions 20 µl of detergent solution were added to 
the dried samples and standards, which were sonicated in an ice-cold ultrasound bath for 10-
30 min until the dried extract was dissolved.  
70 µl of reaction mix and 10 µl of freshly prepared radioactive tracer solution were 
added to each solubilized sample and standard, which were immediately incubated for 30 min 
at RT, i.e. 25°C, in a shaking thermomixer. The enzymatic reaction was stopped by adding 1 
ml of chloroform: methanol: 1 N HCl (100:100:1). After vortexing 170 µl of buffered saline 
solution and then 30 µl of 100 mM EDTA-solution were added. The samples were again 
vortexed for 15 s, centrifuged at RT at 6300g for 5 min. 200 µl of the lower phase was 
collected with an appropriate Hamilton microliter syringe, eventually stored at -20°C 
overnight. The organic phase was air-dried at RT overnight in an extractor hood or 
alternatively at 30°C in a heating block using a nitrogen flow for evaporation in either (the 
latter) case .  
 
2.2.7.4 Thin-layer chromatography 
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Figure 2.5. Standard curve to determine the ceramide content in pmol from scintillation 
counter measurements. Standards with a content of 0, 123, 370, 1111, 3333, and 10000 pmol ceramide 
were prepared alongside the samples to determine a standard curve. 
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9-10 dried (but not overdried!) samples were each dissolved in  20 µl 1:1 chloroform-
methanol solution and separated by thin-layer chromatography. The silica gel plate was air-
dried. An autoradiography was developed overnight. The spots of phosphatic acid of ceramide 
remaining as reaction product were detected by autoradiography, scraped off the plate and 
transferred to scintillation vials. Scraped silica gel samples of each spot were dissolved in 8 
ml of scintillation liquid. [32P] radiation was quantitatively measured in a liquid β-scintillation 
counter. The ceramide level of the RBCs was determined in terms of pmol of the radio-
enzymatically labeled ceramide using a standard curve (Fig. 2.5.) and extrapolated for 100 % 
parasitemia according to the following formula: 
Ceramide measured = [ceramide] infected * (parasitemia) % + [ceramide] non-infected measured * (100 – parasitemia) % ↔  
Ceramide infected = ([ceramide] measured - [ceramide] non-infected measured * (100 – parasitemia) %) / (parasitemia) % 
 
2.2.8 Determination of intracellular free Ca2+ concentration 
 
To determine intracellular free Ca2+ concentration, infected human HbA/A and HbA/S 
erythrocytes (24 h after ring-stage synchronization) were stained in NaCl Ringer solution with 
ethidium bromide (1 µM, 30 min / 21°C), washed, post-stained with Fluo-3/AM (2 µM, 30 
min / 21°C) and washed again. Ca2+-dependent Fluo-3- and DNA-dependent ethidium 
bromide fluorescence intensity was measured by flow cytometry. 
 
2.2.9 Determination of 45Ca2+ flux 
 
For determination of 45Ca2+ uptake into P. falciparum ring stage-synchronized human 
erythrocytes, infected RBCs were synchronized with 5% sorbitol /HEPES/glucose solution, 
washed and immediately suspended in KCl/NaCl solution to remove extracellular Ca2+. 
Around 120 µl of synchronized infected RBCs (10 µl RBCs in triplicate for 4 times points) 
were washed twice for 10 - 15 min in EGTA-free KCl/NaCl solution to remove EGTA and 
centrifuged at 225g for 5 min at RT. After this, RBCs were preincubated for 30 min (37°C) in 
supplemented EGTA-free KCl/NaCl solution and then incubated in the same solution (final 
hematocrit: ~7.4%) supplemented with radioactive tracer from a 100 mM CaCl2 stock 
solution with a specific activity of around 107 c.p.m. / mmol to reach a final free calcium 
concentration of 100 µM (~1 µCi / ml 45Ca2+).  100 µl aliquots were successively delivered 
into 1 ml ice-cold EGTA-free KCl/NaCl solution at predefined points in time (0, 10, 20 and 
30 min). The cells were washed twice using 1 ml of the same solution, and the supernatant 
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was discarded. The cells were lysed and precipitated by addition of 600 µl 6% TCA. After 
another spin (2800g for 10 min, RT), 0.5 ml of the clear supernatant (diluted 1:5 with 
scintillation liquid) was used for measuring 45Ca2+ radioactivity using a liquid β-scintillation 
counter. 
The total calcium content of the cells [CaT]i was calculated by dividing the activity of 
the samples by the specific activity of 45Ca2+ and by the number of cells. 
 
2.2.10 PGE2 measurements 
 
For PGE2 determination 517, infected HbA/A and HbA/S erythrocytes were grown to 
high parasitemia, synchronized and washed. Then they were adjusted to a hematocrit of 0.1 
%, a parasitemia of ~10%, and cultured in a 12-well plate (1 ml cell suspension / well) in 
duplicate for each time point. The supernatant was collected after 1, 3, 6, 12, 24 and 48 h. 
After incubation for 0 - 48 h at 37°C, cells were spun down at 4 °C, 225 g for 5 min and the 
supernatant was stored at -80°C. PGE2 concentrations in the supernatant were determined 
using the Correlate-EIATM Prostaglandin E2 (PGE2) Enzyme Immunoassay (EIA) Kit 
according to the manufacturer’s instructions. Briefly, the samples were diluted 1: 2.5 with 
assay buffer. Then, 100 µl sample, 50 µl alkaline phosphatase PGE2 conjugate and 50 µl 
monoclonal anti-PGE2 EIA antibody were applied to goat anti-mouse IgG microtiter plates 
and incubated at RT for 2 h. After washing, 200 µl of p-nitrophenyl phosphate substrate 
solution was added, and samples were incubated at RT for 45 min. Finally, the optical density 
at 405 nm was measured in a spectrophotometer microplate reader. PGE2 concentrations in 
the samples were calculated from a PGE2 standard curve (39.1 – 5000 pg/ml), which was 
determined alongside the experimental work. PGE2 levels in the supernatant and lysate of 
control treated erythrocytes were 98 ± 26 pg/109 infected HbA/A RBCs, 127 ± 32 pg /109 
infected HbA/S RBCs, and 26 ± 2 pg/109 non-infected HbA/A RBCs at time point 0 h, and were 
defined as 100 %.  
 
2.2.11 Data analysis and statistics 
 
Differences between means were estimated by one-way ANOVA, Bonferroni multiple 
comparison method or two-tailed Student's t-test where appropriate using the InStat statistic 
program. 
RESULTS______________________________________________________________________________ 
 93 
3. Results 
 
3.1 Dependence of P. falciparum in vitro growth on the cation 
permeability and the induction of eryptosis of the human host 
erythrocyte 
 
3.1.1 Whole-cell currents of erythrocytes induced by P. falciparum infection 
 
Patch-clamp measurements of whole-cell cation currents were performed in late-
trophozoite-infected human red blood cells (RBCs) as a means of characterizing the cation-
permeable subfraction of the New Permeability Pathways (NPPs). Infected RBCs exhibit 
whole-cell currents which are 2-3 orders of magnitude higher than those of non-infected 
RBCs. The principal current fraction of infected RBCs is anion-selective, as indicated by the 
whole-cell reversal potential which approximates the Nernst equilibrium potential for Cl- (Fig. 
3.1.A. 1st trace and corresponding I-V-curve in Fig. 3.1.B.). Replacement of Cl- in the bath by 
gluconate, i.e. removal of extracellular Cl-, changes the Cl- equilibrium potential. After this 
type of bath solution exchange, Cl- influx-generated outward currents were no longer 
detectable, whereas the current amplitude increased progressively. Some kind of cation 
conductance must have been activated, as the observed current increase was paralleled by a 
change of the current reversal potential from Cl- equilibrium potential towards 0 mV. The 
equilibrium potential for nonselective cation condutances (NSCs) is 0 mV (Fig. 3.1.A 2nd 
trace and corresponding I-V- curve in Fig. 3.1.B.). In conclusion, Plasmodium falciparum 
infected RBCs exhibit in addition to the predominant anion conductance a small cation 
conductance. Hence, these data indicate voltage-independent NSC currents in infected RBCs 
that are similar to those in non-infected RBCs stimulated by removal of extracellular Cl-. The 
current amplitudes in infected RBCs after extracellular Cl- removal demonstrate a 7 to 8-fold 
stimulation of NSC currents as compared to non-infected erythrocytes 243. 
During patch-clamp measurements in Na-gluconate bath solution combined with 
KCl/K-gluconate in the pipette, the whole cell current reversed at -25 mV, suggesting an 
approximately two-fold higher permeability for K+ than for Na+. As has been demonstrated 
recently 243, Ca2+ permeability is also due the the infection-induced cation conductance. In the 
present study, CaCl2/Ca (gluconate)2 pipette solutions generated outward currents in infected 
RBCs in the absence of Cl- in the bath solution (Fig. 3.1.C., first two traces), indicating that 
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these outward currents were carried by Ca2+ efflux and not by Cl- influx into the cell. 
Moreover, EIPA (1µM) which has been demonstrated to inhibit the infection-induced cation 
but not the anion conductance 243, inhibited the outward current (Fig. 3.1.C., 2nd and 3rd traces 
and Fig. 3.1.D.). Taken together, these data confirm previous results 243 showing the induction 
of a small Ca2+-permeable NSC conductance by infection of human RBCs with Plasmodium 
falciparum. 
 
Figure 3.1. Cl- dependent cation conductance in Plasmodium falciparum infected human 
RBCs. 
(A) Whole-cell current traces from a Plasmodium falciparum-infected RBC recorded first with NaCl (left) and 
then with Na-gluconate bath solution (right). Currents were obtained in fast whole-cell voltage-clamp mode with 
a pipette solution containing K-gluconate. The membrane potential was held at -10 mV and currents were 
elicited by 400 ms square pulses to test potentials between -100 and +100 mV. Currents of the individual voltage 
sweeps are superimposed; a thick line indicates zero current. 
(B) Mean current-voltage (I-V) relations (number of measurements (n) = 6, ± standard error (SE)) of 
Plasmodium falciparum-infected cells recorded as in (A) with NaCl (circles) and Na-gluconate bath solution 
(squares). 
(C) Whole-cell current traces from a Plasmodium falciparum-infected RBC recorded first with Ca-(gluconate)2 
pipette solution. Records were performed with NaCl (left) and Na-gluconate bath solution prior to (middle) and 
upon bath application of EIPA (1 µM, right). EIPA inhibited a Ca2+-carried outward current. 
(D) Mean outward conductance (n = 4, ± SE) of infected RBCs recorded as in (C) with Ca-(gluconate)2 in the 
pipette and bath solutions containing NaCl, Na-gluconate or Na-gluconate and EIPA (1 µM). 
 * p ≤ 0.05; paired two-tailed student’s t-test. 
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3.1.2 Sensitivity of P. falciparum in vitro growth to EIPA 
 
The infection-induced NSC conductance of RBCs was inhibited by EIPA with an IC50 
of 0.75 µM. EIPA inhibited parasite growth with an IC50 of 8.5 µM when applied throughout 
48 h of culture (Fig.3.2.A.-D.). Inhibitors of the infection-induced NPPs are much less 
effective in parasite growth assays than they are in tracer flux measurement or hemolysis 
experiments. This might be explained by the adsorption of inhibitors to serum proteins in the 
culture medium 464, a phenomenon which could also account for the low effect of EIPA on 
parasite growth in the present study. Therefore the free EIPA concentration (10 µM = 3.7 µM 
free EIPA) was determined and is shown in Fig. 3.2.E. The IC50 for free EIPA was 3 µM. 
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Figure 3.2. Inhibition of conductance and intraerythrocytic in vitro growth of 
Plasmodium falciparum by 5-(N-ethyl-N-isopropyl) amiloride (EIPA). 
(A – C) Parasitemia in % at 0 h and after 48 h of synchronized P. falciparum in vitro culture. Each curve 
represents the average of a six-fold determination (n = 6, ± SE). The applied concentrations of EIPA were 0, 1, 
10, and 100 µM. (D) Initial parasitemia has been subtracted to show relative parasitemia [% of control] observed 
in the three independent parasite growth assays (A-C, n = 18, ± SE). (E) Relative parasitemia  (n = 18, ± SE) 
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after 48 h of growth and normalized slope conductance of infected RBCs as measured by patch clamping, 
respectively, containing increasing concentrations of free EIPA (as indicated). 
 
3.1.3 Dependence of P. falciparum in vitro growth on external Ca2+ 
 
As a means of defining the functional significance of the infection-induced Ca2+ 
permeable NSC conductance the dependence of intraerythrocytic in vitro growth of 
Plasmodium falciparum on the Ca2+ concentration in culture medium was studied. Parasites 
were grown for 48h with EGTA (0, 1 or 2.5 mM, respectively) continuously present in the 
medium. EGTA severely inhibited the intraerythrocytic growth of Plasmodium falciparum, 
confirming previous results 867 (Fig. 3.3.A., B.). This effect was fully reversed upon re-
increase of extracellular Ca2+ activity by addition of 1 or 2.5 mM CaCl2, respectively, 
corresponding to the concentrations of EGTA used (Fig. 3.3.A. and B.). Thus, the observed 
inhibition of growth was evidently not due to a toxic effect of EGTA. 
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Figure 3.3. Dependence of intraeythrocytic in vitro growth of Plasmodium falciparum on 
the free Ca2+ concentration in the culture medium. 
(A) Histograms showing the fluorescence of the DNA dye Syto16 in Plasmodium falciparum infected RBCs as 
recorded by flow cytometry. Histograms are given for the RBCs at the start of the experiments (initial),  after 
48h of growth in normal culture medium (control), in medium supplemented with EGTA (2.5 mM), and in 
medium supplemented with EGTA and CaCl2 (2.5 mM each), respectively. Prior to the experiments infected 
RBCs were synchronized to the ring stage of infection and adjusted to 1% of parasitemia and a 5 % hematocrit. 
(B) Relative parasitemia (n = 11, ± SE) during 48 h of synchronized culture in normal medium (grey bar) or in 
medium supplemented with various concentrations (as indicated) of EGTA or EGTA and CaCl2. Two 
independent growth assays were carried out in five or six-fold determination, respectively.  Free calcium 
concentration was calculated according to the WEBMAXC standard webpage 672. 
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3.1.4 Dependence of P. falciparum in vitro growth on external Na+ 
 
As a means of determining the dependence of parasite growth on Na+ concentration, 
the culture medium was replaced by isosmotic NaCl or NMDG-Cl test solution for 4 h, 8 h 
and 16 h beginning after 24 h of synchronized culture (i.e. at the trophozoite stage of 
infection). The data presented in Fig. 3.4.I.A. (closed bars) suggest that replacement of the 
culture medium by isotonic NaCl test solution, which contained [in mM]: 120 NaCl, 30 
HEPES, 5 glucose, 1.7 CaCl2, 5 KCl, was tolerated by the parasites for up to 8 h. The 
dependence of growth on the electrolyte composition was then studied within an 8 h window 
(between 24 h and 32 h after synchronization) during which the medium was isosmotically 
replaced by test solutions. The only protein source for the parasites during this time interval 
was hemoglobin. Parasite growth upon replacement of the medium by NaCl test solution for 8 
h was taken to represent control conditions for the following growth assays. Replacement of 
the medium by NMDG-Cl test solution, in which 120 mM NaCl was replaced by 140 mM 
NMDG titrated with HCl to pH 7.4, dramatically inhibited growth when applied for 8h or 
longer (Fig. 3.4.I.A; open bars).  
To exclude a direct toxic effect of NMDG-Cl as a potential cause of the observed 
growth inhibition (Fig. 3.4.I.A), the medium was replaced for 8 h by NaCl isotonic test 
solution or by a 1:1 mixture of NaCl and NMDG-Cl, NaCl and raffinose, or NMDG-Cl and 
raffinose isotonic test solution, respectively. Total replacement of Na+ (NMDG-Cl/raffinose) 
inhibited 48 h parasite growth by about 80 % as compared to the growth in normal culture 
medium (Fig. 3.4.I.B.). Decrease of the extracellular Na+ concentration to about 50 % by 
substituting the medium with NaCl / raffinose or NaCl / NMDG-Cl had only little effect on 
parasite growth when compared to that obtained upon medium replacement by NaCl (Fig. 
3.4.I.B.). Most importantly, no difference between parasite growth in NaCl / raffinose and 
NaCl / NMDG-Cl was apparent (Fig. 3.4.I.B.), indicating that the effect of Na+-replacement 
was indeed due to external Na+ depletion rather than to a toxic effect of NMDG+.  
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Figure 3.4. Effect of Na+ removal from the culture medium on parasite growth. 
I. Time dependence and toxicity of N-methyl-D-glucamine (NMDG). 
(A) Relative parasitemia (n = 6, ± SE) of synchronized infected RBCs grown for 48 h in normal culture medium 
(0 h) or in culture medium replaced for 4 h, 8 h, and 16 h, respectively, by NaCl or (NMDG)-Cl test solution The 
test solutions contained [in mM]: 120 NaCl or 140 NMDG, titrated to pH 7.4 with HCl, and in addition: 30 
HEPES, 5 glucose, 1.7 CaCl2, and 5 KCl. Medium replacement started after 24 h of culture in the trophozoite 
stage of infection. 
(B) Relative parasitemia (n = 6, ± SE) of synchronized RBCs grown for 48 h in normal culture medium (gray 
bar) or in culture medium replaced for 8 h (between 24 and 32 h of culture) by NaCl test solution (closed bar) 
(with 120 mM NaCl and salts as indicated above, and by 1:1 mixtures of isotonic NMDG-Cl (72.5 mM) and 
raffinose (140 mM) test solution, NaCl  (60 mM) and NMDG-Cl (72.5 mM) test solution, or NaCl (60 mM) and 
raffinose (140 mM) test solution, respectively (as indicated; open bars). All replacement solutions contained in 
addition [in mM]: 30 HEPES, 5 glucose, 1.7 CaCl2, and 5 KCl. The only protein source during the replacement 
interval was hemoglobin.
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In order to better define how parasite growth depends on the external Na+ 
concentration, isotonic NaCl test solution (containing in [mM]: 120 NaCl, 30 Hepes, 5 
glucose, 1.7 CaCl2, 5 KCl) was progressively replaced by isosmotic NMDG-Cl or KCl test 
solutions (Fig. 3.4. II.). Instead of 120 mM NaCl the NMDG-Cl test solution contained 140 
mM NMDG titrated with HCl to pH 7.4 and the KCl test solution 120 mM KCl. As indicated 
in Fig. 3.4.I.B. the medium was replaced for 8 h after 24 h of culture. Under both 
experimental conditions, parasite growth decreased when external Na+ concentration was 
lowered. The data in Fig. 3.4.II. show that when Na+ was replaced by NMDG+ or K+ 
significantly different concentrations of external Na+ were necessary in order for parasites to 
multiply half-maximally as compared to control conditions. If NMDG replaced NaCl, the IC50 
was at 24 mM NaCl (and 112 mM NMDG). If KCl replaced NaCl, the IC50 was already at 58 
mM NaCl and 65 mM KCl.  
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Figure 3.4. Effect of Na+ removal from the culture medium on parasite growth. 
II. Concentration dependence. 
Parasite growth in synchronized infected RBCs incubated for 48 h in normal culture medium (gray bar) or in 
culture medium replaced for 8 h (between 24 and 32 h of culture) by different mixtures of isotonic NaCl and 
NMDG-Cl test solution (A) or isotonic NaCl and KCl test solution (B). The remaining NaCl, (NMDG)-Cl or 
KCl concentration are depicted, respectively. The test solutions contained (in mM): 120 NaCl, 140 (NMDG)-Cl 
(black bars) or 120 KCl (gray bars), in addition: 30 Hepes, 5 glucose, 1.7 CaCl2, and 5 KCl. The bars represent 
relative parasitemia (n = 11 - 24, ± SE) as a function of the NaCl concentration of the test solutions. Two - four 
independent growth assays were carried out in six-fold determination. 
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3.1.5 Dependence of P. falciparum in vitro growth on external Cl- 
 
In additional 8h replacement experiments the culture medium was substituted with Na-
gluconate test solution (containing in [mM]: 120 Na-gluconate, 30 Hepes, 5 glucose, 1.7 
CaCl2, 5 KCl). This was done in order to test whether the parasite requires external Cl-. Upon 
medium substitution with NMDG-Cl test solution parasite growth inhibition differed from 
that upon medium substitution with NaCl test solution. By contrast, parasite growth inhibition 
effected by substitution with Na-gluconate test solution (Fig. 3.5.) did not differ from that 
exerted by NaCl test solution. This suggests that the parasites’ development was not impaired 
by low extracellular Cl- concentration.   
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Figure 3.5. Effect of Cl- removal from the culture medium on parasite growth. 
Relative parasitemia (n = 12 – 18, ± SE) of 2 - 3 independent assays carried out in six-fold determination with 
synchronized infected RBCs grown for 48 h under normal culture conditions (gray bar) or in culture medium 
replaced for 8 h (between 24 and 32 h after synchronization) by NaCl test solution (closed bar), by NMDG-Cl 
test solution, or by Na-gluconate test solution, respectively (open bars, n. s. = not significantly different, p>0.5). 
Test solutions contained 120 mM NaCl, 140 mM NMDG (titrated with HCl to pH 7.4, or 120 mM Na-gluconate 
and in addition [in mM]: 30 Hepes, 5 glucose, 1.7 CaCl2 , and 5 KCl. 
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3.1.6 Breakdown of erythrocyte phosphatidylserine asymmetry 
 
Elevated Ca2+ permeable NSC conductance induces breakdown of the PS asymmetry 
of the RBC membrane in non-infected RBCs 244,513,512,507, which is an important feature of 
erythrocyte programmed cell death 499. In order to test whether the infection-induced Ca2+ 
permeable NSC conductance also induces a loss of phospholipid, PS exposure at the outer 
leaflet of the membrane of Plasmodium falciparum-infected RBCs was measured by annexin 
binding using a flow cytometer. For these experiments, the parasite culture was grown to high 
parasitemia, monitored by Syto16 fluorescence staining. Fig. 3.6.I. (C-F) shows individual dot 
plots of RBCs from such high parasitemia in vitro cultures.  
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Figure 3.6.I. Breakdown of the phospholipid asymmetry in the RBC membrane induced 
by infection with Plasmodium falciparum. 
(A-F) Dot plots recordings by flow cytometry of non-infected RBCs, co-culture (A-B), and of Plasmodium 
falciparum-infected RBCs (C-F). The blots were obtained from separately cultured unstained non-infected RBCs 
(A), from non-infected RBCs stained with annexin V568 fluorescence dye (annexin) alone or (B) together with 
Syto16 fluorescence dye (Syto16), from unstained infected RBCs (C), from infected RBCs stained with annexin 
V568 fluorescence dye (annexin) (D), with Syto16 fluorescence dye (Syto16) (E), or with both fluorescence 
dyes (Syto16 + annexin) (E). Annexin binds specifically to phosphatidylserine in the outer membrane leaflet and 
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and Syto16 to RNA/DNA, thus providing a measure of breakdown of phospholipid asymmetry and parasite 
infection, respectively. The dot blots show individual samples obtained by counting 100,000 RBCs. F. Mean 
percentage of annexin binding cells (n = 3 – 5, ± SE) in populations of non-infected co-cultured RBC (open bar, 
co-culture, i.e. non-infected, separately incubated cells) and of non-infected cohorts in Plasmodium falciparum -
infected RBC cultures (closed bars). Syto16-negative refers to the non-infected bystander cells; Syto16-positive 
refers to the infected RBCs in the Plasmodium falciparum infected culture, respectively. 
 
Negative controls were unstained non-infected erythrocytes that had been maintained 
in a co-culture under the same conditions as the P. falciparum in vitro culture or unstained P. 
falciparum infected RBCs, respectively. Positive controls were single stained P. falciparum 
infected RBCs with Syto 16 or with annexin V568, respectively. The fluorescence intensities 
recorded at two wavelengths (each one corresponding to the emission spectra of one dye) are 
given for unstained co-cultured non-infected (Fig. 3.6.I.A.) and double stained co-cultured 
non-infected RBCs (Fig. 3.6.I.B.), unstained infected (Fig. 3.6.I.C.), Syto16-stained infected 
(FL1), (Fig. 3.6.I.D.), annexin-stained infected (FL2) (Fig. 3.6.I.E.), and Syto16 and annexin-
stained infected (Fig. 3.6.I.E.) samples of the P. falciparum in vitro culture, clearly indicating 
at least four distinct RBC populations.  
Analysis of these populations demonstrated that non-infected co-cultured RBCs did 
not expose PS (Fig. 3.6.I.B. and G.; open bar), as the annexin-binding was close to zero; this 
amount of fluorescence is equal to background levels. Syto16-negative (i.e. non-infected 
cohorts) RBCs from the parasite culture showed a slightly elevated PS exposure (Fig. 3.6.I.F., 
upper left quadrant; Fig 3.6.I.G., closed left bar), while Syto16-positive (i.e. infected) RBCs 
exhibited a high percentage of annexin binding, i.e. PS-exposing RBCs (Fig. 3.6.I.F., upper 
right quadrant; Fig 3.6.I.G., closed right bar). 
This observation points to breakdown of the PS asymmetry of the cell membrane in 
infected RBC, which increased with the percentage of parasitemia in the in vitro culture (Fig. 
3.6.II.).  
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Figure 3.6.II. Dependence of phosphatidylserine-exposure by infected RBCs on 
parasitemia in the in vitro culture. 
Increase of phosphatidylserine (PS) exposing cells in % in relation to the increase in parasitemia in % (n = 45). 
Parasitemia and PS exposure are correlated with a correlation coefficient of (r) = 0.6489; this is within the 95% 
confidence interval, i.e. p ≤ 0.05 %. The coefficient of determination (r squared, R2) is 0.421, i.e. 42.1 % of the 
values obey a linear relationship that is shown by the trend line. 
 
A similar increase of annexin binding was observed following treatment of non-
infected RBCs with the oxidant t-BHP (1 mM for 15 min; Fig. 3.6.III.A., B.), which was 
shown to activate the Ca2+-permeable NSC conductance of non-infected RBCs 244.  
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Figure 3.6.III. Breakdown of the phospholipid asymmetry in the RBC membrane 
induced by Ca2+ permeabilization or by oxidative stress. 
(A) Histograms showing the annexin binding by non-infected control RBCs (left) and by RBCs oxidized with 
tert-butylhydroperoxide (t-BHP; right). Cells were oxidized for 15 min (1 mM t-BHP) followed by further 24 h 
of incubation in a modified NaCl test solution consisting of (in mM): 125 NaCl, 5 KCl, 5 D-glucose, 1 CaCl2, 
and 1 MgSO4. (B) Average percentage of annexin binding cells (n = 5 – 6, ± SE) in non-infected RBCs 
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populations (control) and in RBC populations permeabilized with the Ca2+ ionophore ionomycin (1µM in 
modified NaCl test solution for 1h) or oxidized with t-BHP (same protocol as in A). 
 
Incubation of non-infected RBCs with the Ca2+ ionophore ionomycin (1 µM for 1 h) 
mimicked the stimulatory effect of infection or oxidation on annexin binding (Fig. 3.6.III.B.). 
This suggests that infection-induced activation of the Ca2+-permeable NSC conductance, 
which results in increased [Ca2+]i, leads to PS exposure 913,218, thus contributing to the 
observed annexin binding of infected cells. Interestingly, EIPA (10 µM) reduced and Na-
gluconate (Cl--removal) increased annexin-binding in P. falciparum positive RBCs (data not 
shown, n = 6), providing further evidence of the involvement of the NSC cation channel in PS 
exposure. 
The possibility that annexin-binding is due to disruption of the erythrocyte membrane 
was ruled out by counterstaining P. falciparum infected RBCs with propidium-iodide, which 
was negative (data not shown), and moreover by the fact that hemolysis could not be 
observed.  
Taken together, infection stimulates a NSC conductance that plays an important role in 
the signaling pathways that converge to trigger eryptosis 499. 
 
3.1.7 Plasmodium berghei ANKA infection increases ceramide in blood with 
significant involvement of host cell acid sphingomyelinase 
 
Activation of erythrocyte sphingomyelinase has been demonstrated to belong to the 
second signaling pathway of eryptosis 255,498,499,511,510,509,519,635. P. falciparum express neutral 
sphingomyelinase (NSM) activity 526,371. During TNF- and CD95 ligand-mediated cell-death 
of nucleated cells an endosomal acid sphingomyelinase (ASM) is activated, resulting in 
enhanced intracellular ceramide levels that contribute to apoptosis 213,344,360,533. To investigate 
whether the increase in PS exposure of Plasmodium infected RBCs resulted from host 
sphingomyelinase activity, ASM wild-type (+/+) and knock-out (-/-) mice were infected with 
P. berghei ANKA.  
P. berghei ANKA infection significantly increased ceramide production in infected 
blood. Infected wild-type (ASM +/+) and knock-out (ASM -/-) mouse blood had significant 
higher ceramide levels as compared to non-infected blood. 
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Figure 3.7. P. berghei ANKA infection significantly increases ceramide levels in infected 
RBCs of ASM knock-out mice and their wild-type litter mates.  
RBCs of P. berghei ANKA infected ASM wild-type (ASM +/+) and knock-out mice (ASM -/-) were collected 
retro-orbitally and their ceramide levels were determined radioenzymatically (n = 4 – 5, ±SE). For details, see 
Materials and Methods. (A) Ceramide level in pmol in the ASM +/+ blood of control uninfected (gray bar, n = 4, 
6844 ± 5555 pmol ceramide/ 1.1 x 108 erythrocytes) and P. berghei ANKA  infected ASM +/+ mice (iASM+/+, 
open bar, n = 5, 23157 ± 1977 pmol ceramide/ 1.1 x108 erythrocytes) (B) Ceramide level in pmol in the ASM -/- 
blood of control uninfected (gray bar, n = 4, 1379 ± 597 pmol ceramide / 1.1 x 108 erythrocytes) and P. berghei 
ANKA infected ASM -/- mice (iASM-/-, closed bar, n = 5, 15676 ± 2359 pmol ceramide / 1.1 x108 erythrocytes). 
*: P ≤ 0.05; unpaired two-tailed student’s t-test. 
 
Absolute ceramide values varied considerably between the individual assays. 
Therefore, the results were normalized by defining the average ceramide level in infected 
ASM +/+ mouse blood in each assay as 100 %. Normalized ceramide levels in infected ASM 
-/- were significantly lower than those of ASM +/+ mice (Fig. 3.7.A.). This suggests that the 
sphingomyelinase of the host erythrocyte contributed significantly to the ceramide formation 
needed for parasite growth, as this decrease in ceramide production was accompanied by a 
significantly lower increase in parasitemia (Fig 3.7.B.). The increase in parasitemia differed 
significantly between ASM -/- mice and their wild-type litter mates between the 10th and 21st 
day post infection (Fig 3.7.C.). The survival rate of ASM wild-type was lower than that of 
ASM knock-out mice were similar, with 29 and 35 days maximal survival, respectively 
(Fig.3.7.D.). However, the difference was not significantly different. 
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Figure 3.8. Functional significance of host acid sphingomyelinase ceramide production 
in P. berghei ANKA infected mice.  
(A) Normalized ceramide level in infected ASM +/+ (open bar, n = 5, ±SE) and ASM -/- mouse blood (closed 
bar; n=5, 68 ± 10 % of infected ASM +/+), *: P ≤ 0.05, significant, unpaired two-tailed student’s t-test. P. 
berghei ANKA infection increased the ceramide level of infected RBC significantly less in ASM knockout mouse 
blood compared to the ceramide level in ASM wild-type mouse blood. (B) Time course of parasitemia in P. 
berghei ANKA-infected ASM -/- mice (closed triangles, n = 19, ±SE) and their wild-type littermates (open 
circles, n = 21, ±SE) (C) Increase in parasitemia as calculated from (B) by linear regression between day 10 and 
21 post infection in infected wild-type (open bar, n = 20, ∆ parasitemia [% / day] = 4.47 ± 0.22 %) and ASM -/- 
mouse blood (closed bar; n= 17; ∆ parasitemia [%/ day] = 2.84 ± 0.25 %), *** : p ≤ 0.001, two-tailed student’s 
test. (D) Survival of P. berghei ANKA-infected ASM -/- (closed triangles, n = 19, ± SE) and wild-type mice 
(open circles, n = 21, ± SE); same experiments as in (B)).  
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3.2 Enhanced entry of P. falciparum infected sickle trait (HbA/S) 
RBCs into eryptosis as compared to normal (HbA/A) host erythrocytes  
 
Sickle cell trait (HbA/S) carriers are partially protected against a severe course of 
malaria infection 1,8,17,25,29,82,84,154,185,193,226,290,296,318,387,524,555,581,602,639,677,896,895,894. This partial 
resistance results, among other potential mechanisms, from early clearance of HbA/S RBCs 
66,193,226
 mediated by the phagocytic action of monocytes and macrophages. This mechanism 
acts as a first-line defense of the innate immune system against malaria infections 782. 
Pronounced band 3 (AE1) aggregation of ring stage-infected HbA/S erythrocytes leads to 
binding of autologous IgG antibodies against band 3 and complement. These recognition 
signals (or "eat-me"-signals) facilitate phagocytosis and thus the clearance of malaria-infected 
HbA/S erythrocytes by macrophages already at ring-stage. 
As a means of testing whether enhanced suicidal erythrocyte death (eryptosis) of the 
host erythrocyte 509,499 might also contribute to the partial malaria resistance of HbA/S 
carriers, P. falciparum infected sickle trait and normal RBCs were tested for differences in 
parasite growth and PS exposure. Furthermore, ceramide level, NSC channel activity, i.e. 
Ca2+ permeability, cytosolic Ca2+ activity and PGE2 secretion were determined. 
 
3.2.1 P. falciparum infected HbA/S and HbA/A RBCs differ in 
phosphatidylserine exposure but not in growth  
 
Impaired P. falciparum growth and reinvasion into HbA/S RBCs has been considered 
as one mechanism of partial resistance of HbA/S carriers towards severe forms of P. 
falciparum malaria 298,300,669,667,193,226,381,724. However, parasite prevalence and densities are 
usually similar in asymptomatic normal (HbA/A) and HbA/S carriers 581. The results obtained 
in in vitro growth assays 298,300,669,667 could be of artefactual origin due to the hypoxanthine 
deficiency of the culture 298,300, or due to unphysiological conditions that do not mimic the 
situation in vivo 17,523. P. falciparum infected HbA/A and HbA/S RBCs were synchronized to 
ring stage and grown for 48 h under normal culture conditions as a means of testing whether 
impaired in vitro growth and reinvasion occur under optimized culturing conditions. In the 
present study, P. falciparum developed similarly in HbA/A and HbA/S RBCs, confirming the 
results of previous authors 66.  
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Figure 3.9. Normal and sickle cell trait RBCs infected with P. falciparum grown in vitro 
shows differences in phosphatidylserine exposure, but not in parasitemia.  
(A) Parasitemia of synchronized P. falciparum infected normal (HbA/A) (open boxes, n = 187, 7.4 ± 0.4 %) and 
sickle cell trait (HbA/S) (gray boxes, n = 184, 6.7 ± 0.4 %) RBCs grown for 48 h under  normal culturing 
conditions, starting with a parasitemia of 1.4 % ± 0.09 %. (B) Box-whisker plots of the average percentage of 
annexinV-binding RBCs, 44 - 54 h in culture after ring-synchronization. Same experiments as in (A). Box-
whisker plots give medians, 25th and 75th percentiles, whiskers denote the 10th and 90th percentiles. All values are 
shown. Non-infected co-cultured (cohorts) HbA/A RBCs (open plot, left side, n = 187) had a median of 2.87 % 
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of PS exposing cells. Infected HbA/A RBCs (gray plot, left side, n = 187) had a median of 4.24 % PS exposing 
cells, whereas non-infected co-cultured HbA/S RBCs (open plot, right side, n = 184) had a median of 3.54 % PS 
exposing cells. These groups were not significantly different from each other. Infected HbA/S RBCs (grey plot, 
right side, n=184) demonstrated a significantly higher median of 6.56 % PS exposing cells. The highest annexin-
binding value was 32.3 %. ***: p ≤ 0.001, the average percentage of phosphatidylserine exposing cells among 
infected HbA/S erythrocytes was very significantly higher than in any of the other groups; nonparametric 
ANOVA (Kruskal-Wallis-test). 30 independent growth assays were carried out in six-fold determination. HbA/A 
and HbA/S RBCs were matched for age and storage conditions. Two different parasite strains FCR3 and BINH 
were used. 
 
Annexin binding was determined by FACS analysis in order to investigate whether this 
human Hb gene mutation facilitates PS exposure on the outer leaflet of P. falciparum infected 
erythrocytes. In vitro infection of human erythrocytes with Plasmodium falciparum led to a 
significant increase in annexin-binding, i.e. to a higher PS exposure in infected HbA/S RBCs 
than in infected HbA/A RBCs and non-infected RBCs of either kind. Experiments were 
performed with nine different HbA/A and five different HbA/S blood samples (see appendix). 
 
3.2.2 The ceramide level of P. falciparum infected HbA/S and HbA/A RBCs 
is similar 
 
Ceramide production by sphingomyelinase stimulates either a scramblase (thereby 
enhancing the bilayer migration of PS), and/or inhibits the ATP-dependent 
aminophospholipid translocase (flipase) which actively transports PS from the outer to the 
inner membrane 510,499. Ceramide was determined radioenzymatically in non-infected and 
infected HbA/A and HbA/S RBCs (Fig. 3.10.) as a means of testing whether the enhanced PS 
exposure in infected HbA/S RBCs results from a higher sphingomyelinase activity in HbA/S 
erythrocytes. In addition, in order to test for a functional significance of ceramide for parasite 
growth, infected HbA/A and HbA/S RBCs were synchronized and grown over 48 h in the 
presence of increasing concentrations of ceramide and subjected to annexin binding assays 
(Fig. 3.11.). 
Non-infected HbA/S RBCs (open bar right, Fig. 3.10.) produced twice as much 
ceramide as non-infected HbA/A RBCs (open bar, left, Fig.3.10.). This effect was significant 
according to a two-tailed student’s t-test for normalized values. However, none of the 
observed differences, including those found in P. falciparum infected RBCs, were significant 
in analysis of variance (ANOVA) due to enormous variations between individual samples, 
especially among infected RBCs. 
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Figure 3.10. Ceramide level in non-infected and infected HbA/A and HbA/S RBCs. 
A. The C16-ceramide level of 1.1 x 108 of HbA/A and HbA/S RBCs was determined radioenzymatically with 
the DAG Biotrak enzyme assay (n = 8, ±SE, for non-infected; n = 6 for infected RBCs; 8 or 6 independent 
experiments, performed as duplicates). Ceramide concentration was determined from the whole population of P. 
falciparum infected RBC cultures, which were all grown to high parasitemias (between 11.5 % and 30 %). 
Ceramide concentrations were determined as follows, neglecting any influence of infected on non-infected cells: 
Ceramide measured = [ceramide] infected * (parasitemia) % + [ceramide] non-infected measured * (100 – parasitemia) % ↔  
Ceramide infected = ([ceramide] measured - [ceramide] non-infected measured * (100 – parasitemia) %) / (parasitemia) % 
B. Non-infected HbA/S RBCs (open bars, right, n = 8, ± SE) show a nearly two-fold  concentration of ceramide 
as compared to non-infected HbA/A RBCs (open bars, left, n = 8, ± SE). * = p ≤ 0.05; significant in student’s t-
test when values has been normalized (100 % = 1 for non-infected HbA/A RBCs). Infected RBCs (closed bars, n 
= 6, ± SE) produced more ceramide than non-infected RBCs, with a slightly higher ceramide concentration for 
infected HbA/S RBCs, which, however, was not statistically significant (ANOVA) due to enormous variations in 
the ceramide level among individual samples.  
 
3.2.3 Ceramide impairs growth of P. falciparum in vitro more  in HbA/S 
than in HbA/A erythrocytes 
 
Ceramide has been demonstrated to play an important role in regulating signaling 
pathways such as cell senescence, cell cycle arrest, and programmed cell death in mammalian 
cells and yeast. Ceramide is able to activate or inhibit protein kinases and phosphatases, ion 
transporters, and other regulatory pathways 69,371,375,472,488,319,360,790,820. It is produced either by 
SM hydrolysis or de novo synthesis. Synthesis of SM might play a role in the regulation of 
ceramide levels. By analogy, ceramide produced by Plasmodium or exogenously administered 
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ceramide and inhibition of ceramide production might modulate the intraerythrocytic 
development cycle of this parasite or induce eryptosis 371.  
Therefore, additional experiments were performed to determine the effect of 
exogenous addition of ceramide to the culture medium on parasite growth and on PS exposure 
in infected and co-cultured non-infected HbA/S and HbA/A RBCs. Moreover, the effect of 
various SMase inhibitors on parasite growth was examined. 
While increasing concentrations of short-chain cell permeable C6-ceramide did not 
induce PS exposure in non-infected RBCs (Fig. 3.11.I.A.), at concentrations greater than 10 
µM C6-ceramide stimulated PS exposure to a similar degree in infected HbA/A and infected 
HbA/S RBCs (Fig. 3.11.I.B.). Also at lower concentrations (below 10 µM) ceramide impaired 
P. falciparum in vitro growth (Fig. 3.11.II.), confirming other recent results 663.  
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Figure 3.11.I. C6-ceramide stimulated PS exposure in P. falciparum-infected HbA/S and 
HbA/A RBCs to a similar degree. 
A.B. Annexin-binding in % of non-infected (cohorts, Syto16-negative) (A) and infected (Syto16-positive) (B) 
normal (HbA/A, open circles, n = 29 - 30, ± SE) and infected sickle cell trait (HbA/S, closed triangles, n = 29 -
30, ±SE) RBCs grown for 48 h under normal culture conditions with different concentrations of C6-ceramide. 
Measured values have been normalized by subtracting annexin-binding as determined under control conditions. 
Annexin-binding of RBCs under control conditions: non-infected HbA/A = 3.4 ± 0.4, non-infected HbA/S = 4.3 
± 0.2 %, infected HbA/A = 3.3 ± 0.2 %, infected HbA/S = 19.7 ± 1.7 %. ***: P ≤ 0.05; extremely significantly 
different from control conditions, ANOVA. Five independent growth assays were carried out in six-fold 
determination. 
 
Importantly, parasite growth in HbA/S RBCs was more sensitive to exogenously 
added ceramide than parasite growth in HbA/A RBCs, suggesting that toxic concentrations of 
ceramide were reached earlier in HbA/S than in HbA/A RBCs (Fig. 3.11.II.). Relative in vitro 
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growth of P. falciparum in HbA/S RBCs was already significantly inhibited at an exogenous 
concentration of 5 µM ceramide, whereas more than 5 µM ceramide had to be applied to 
significantly inhibit parasite growth in HbA/A RBCs. 
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Figure 3.11.II. In the presence of C6-ceramide in vitro growth of P. falciparum is more 
inhibited in sickle cell trait than it is in normal infected RBCs.  
Relative parasitemia in % of control of synchronized infected RBCs grown as described in Fig. 12. (HbA/A, 
open circles, n = 24 - 33, ± SE; HbA/S, closed triangles, n = 59 - 60, ± SE). Four to 10 independent growth 
assays were carried out in six-fold determination. Two different parasite strains FCR3 and BINH were used. 
Initial parasitemia has been subtracted. 
***: p ≤ 0.001, ANOVA, relative parasitemia highly significantly different from that under control conditions (0 
µM ceramide): Relative parasitemia (HbA/A at 10 µM ceramide, open circles, n = 24) = 52.1 ± 4.4 %. Relative 
parasitemia (HbA/S at 5 µM ceramide, closed triangles, n = 60) = 74.7 ± 4 %.  
#: p ≤ 0.01; ANOVA; very significant difference in relative parasitemia between HbA/A and HbA/S RBCs under 
identical culturing conditions: Relative parasitemia (HbA/A at 15 µM ceramide, open circles, n = 24) = 30.8 ± 
2.9 %. Relative parasitemia (HbA/S at 15 µM ceramide, closed triangle, n = 59) = 1.7 ± 2.4 %.   
 
Taken together, these data suggest that the elevated PS exposure of infected HbA/S 
cells as compared to infected HbA/A cells did not result directly from elevated ceramide 
formation. Rather, ceramide in concentrations below 15 µM did not induce PS exposure (Fig. 
3.11.I.B.). P. falciparum grew normally in untreated HbA/S erythrocytes (Fig. 3.9.), whereas 
(exogenously added) ceramide inhibited parasite growth (Fig. 3.11.II.). Therefore, there is 
nothing to suggest that under normal culture conditions ceramide might reach toxic 
concentrations leading to PS exposure. 
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3.2.4 Influence of sphingomyelinase inhibitors on P. falciparum in vitro 
growth 
 
Ceramide is released by the activity of at least five forms of sphingomyelinases 
possessing either an acidic (I and II), neutral (III and IV), or basic (V) pH optimum. Isoforms 
of sphingomyelinases discovered in mammalian cells and bacteria include: 
 
I. Acid sphingomyelinase (ASM) in lysosomes or endosomal compartments 788,586,746,279;  
II. secreted Zn2+-stimulated sphingomyelinase (functions best at acidic pH, but is also 
active at neutral pH and may be a posttranslationally modified product of ASM) 741; 
III. neutral Mg2+-dependent sphingomyelinase, bound to the plasma membrane 
789,166,553,606,396,96
 and found in the nucleus 634,692;  
IV. cytosolic Mg2+-independent neutral sphingomyelinase (NSM) 919,647; and  
V. alkaline sphingomyelinase localized in the gastrointestinal tract 641,236. 
 
Apparently there is no cross-talk between the ASM and NSM ceramide-mediated 
signaling pathways in mammalian cells, but there is probably significant cross-talk between 
ceramide signaling and other signal transduction pathways (e.g. the PKC and MAP kinase 
pathways)69. However, little is known about sphingomyelinase expression and signaling 
pathways in infected erythrocytes. Therefore, the effect of exogenous addition of ASM and 
NSM inhibitors to the culture medium during parasite growth assays was investigated in the 
following experiments. 
 
3.2.4.1 Ceramide production by acid sphingomyelinase is enhanced in P. 
falciparum infected HbA/S erythrocytes under hyperosmotic conditions 
 
Infected normal and sickle trait RBCs were grown in the presence and absence of 2,4-
DC, an effective ASM inhibitor. Parasite growth inhibition was concentration dependent and 
similar in both cell types, indicating similar ASM activities in infected HbA/A and HbA/S 
RBCs (Fig. 3.12.). Parasite growth was inhibited by up to one third. These results suggest that 
ASM only contributes to a minor part to the production of ceramide (unless the ASM inhibitor 
is not very specific). 
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Figure 3.12.I. Effects of the acid sphingomyelinase inhibitor 2,4-dichloroisocoumarin 
(2,4-DC) on infected HbA/A and HbA/S RBCs.  
Influence of 2,4-Dichloroisocoumarin (2,4 DC) on parasite growth (HbA/A: open circles, n = 23 - 24, ± SE; 
HbA/S, closed triangles, n = 24, ± SE). [2,4-DC] ≥ 10 µM – 200 µM inhibits P. falciparum in vitro growth 
highly significantly (**, P ≤ 0.01), extremely significantly (***, P ≤ 0.001), i.e. by up to 33 % (relative 
parasitemia ≥ 64 %). Four independent growth assays were carried out in six-fold determination. Two different 
parasite strains FCR3 and BINH were used. 
 
PS exposure and ceramide formation are induced in non-infected RBCs by 
hyperosmotic shock 510,509,500. In the present study, hyperosmotic culture conditions 
significantly inhibited P. falciparum in vitro growth (IC50 (NaCl) =25 mM, raffinose (IC50 = 50 
mM) and urea (IC50 = 140 mM); data not shown). Moreover, 50 mM NaCl very significantly 
increased PS exposure.  
The possibility that hyperosmotic conditions might be able to disrupt the erythrocyte 
membrane, allowing annexin to bind to PS facing the cytosol, was ruled out. There was no 
hemolysis of infected RBCs under hyperosmotic conditions. Infected HbA/A RBCs, 
incubated for 8 h at 37°C under culturing conditions at 950 mOsm, i.e. with 650 mM sucrose 
added to the culture medium, showed 78.2 ± 2.3 % (n = 3) annexin-positive cells, while 17.8 
± 7.3 % (n = 3) were propidium iodide-positive 510. These results show that propidium iodide-
positive cells cannot account for the annexin-binding of infected RBCs.  
Infected HbA/S RBCs incubated in 950 mOsm overnight served as positive control for 
the detection of ceramide in the outer membrane leaflet in infected HbA/S RBCs grown for 48 
h hours in different concentrations of NaCl. Binding of monoclonal antibodies to ceramide 
was significantly increased after culturing parasites in HbA/S RBCs with an additional 50 
mM NaCl RBCs, but not in non-infected HbA/S RBCs (data not shown; n = 6; binding of 
anti-ceramide at 0 mM NaCl for infected RBCs (with 7 ± 0.46 % parasitemia) = 0.72 ± 0.16 
%, for non-infected RBCs of the same culture = 0.08 ± 0.02 %, at 50 mM NaCl (1.5 ± 0.07 % 
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parasitemia) = 5.3 % ± 0.67 %, for non-infected RBCs of the same culture = 0.15 ± 0.07 %).  
We therefore examined whether inhibition of parasite growth in hyperosmotic medium 
is mediated by activation of erythrocyte ASM. Moreover, as infected HbA/S RBCs are 
microcytic and differ in osmotic resistance from HbA/A RBCs 17, it was investigated whether 
there might be a difference in sphingomyelinase activation between infected HbA/A and 
HbA/S RBCs under hyperosmotic conditions. 
P. falciparum infected HbA/A RBCs were grown for 48 h in the presence or absence 
of an additional 50 mM NaCl or / and different concentrations of 2,4 DC (10 -200 µM). 
Addition of 50 mM NaCl to the culture medium inhibited parasite growth by 93 ± 1 %. 
Although 200 µM 2,4- DC alone decreased parasite growth, addition of 200 µM 2,4-DC 
together with additional 50 mM NaCl partially but significantly restored parasite growth (Fig. 
3.12.II.). Addition of 100 µM 3,4-DC, another ASM inhibitor, in the absence and presence of 
50 mM NaCl for 48 h to the parasite culture with HbA/A RBCs gave consistent results (data 
not shown). 
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Figure 3.12.II. Acid sphingomyelinase inhibitor 2,4-DC blunts the hyperosmotically 
induced growth inhibition in vitro of P. falciparum in HbA/A RBCs, but not in HbA/S 
RBCs.  
Relative parasite growth of synchronized infected HbA/A RBCs grown for 48 h under normal culture conditions 
(closed left bar) in the presence of 50 mM NaCl ± 2,4 DC (closed right bar without 2,4 DC, 7 ± 1 % relative 
parasitemia; and open right bar with 2,4 DC, 47 ± 15 % relative parasitemia) or 2,4 DC alone (open left bar, 67 ± 
3% relative parasitemia). (B) Relative parasite growth of synchronized infected HbA/S RBCs grown for 48 h 
under normal culture conditions (closed left bar) in the presence of 50 mM NaCl ± 2,4 DC (closed right bar 
without 2,4 DC; 7.7 ± 2.6 % relative parasitemia, and open right bar with 2,4 DC; 19 ± 9.7 % relative 
parasitemia) or 2,4 DC alone (open left bar; 80.6 ± 2.4 % relative parasitemia).  
Four independent growth assays were carried out in six-fold determination: n =24; ±SE; **: p≤0.01, ANOVA. 
Two different parasite strains FCR3 and BINH were used. 
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Similarly as with HbA/A RBCs, parasite growth in ring-synchronized HbA/S RBCs to 
which 50 mM NaCl had been added was inhibited significantly by 92.3 ± 2.6 %. DC alone 
decreased relative parasitemia less in HbA/S RBCs than in HbA/A RBCs, whereas DC up to 
200 µM was not able to blunt significantly parasite growth inhibition in HbA/S RBCs under 
identical hyperosmotic conditions, in contrast to the results obtained with HbA/A RBCs.  
NSM inhibitors, applied at concentrations facilitating about half-maximal parasite 
growth (Spiroepoxide, IC50(HbA/A) = 5 µM, IC50(HbA/S) = 3 µM and Epoxyquinone, IC50(HbA/A) 
=1.5 µM, IC50(HbA/S) = 1.5 µM) did not reverse the inhibitory effect of hyperosmotic shrinkage 
exerted by 50 mM NaCl on parasite growth in either HbA/A (n = 14 - 18) or HbA/S RBCs (n 
= 10 - 12; 2- 3 independent growth assays, data not shown). 
 
3.2.4.2 P. falciparum infected HbA/A and HbA/S RBCs differ in their 
sensitivity to neutral sphingomyelinase inhibitors 
 
Infected normal and sickle trait RBCs were grown in the presence and absence of 
epoxyquinone and spiroepoxide, both effective NSM inhibitors. Parasite growth inhibition 
was concentration dependent and similar in both cell types, but more effective in HbA/S 
RBCs.  
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Figure 3.13. The IC50 of neutral sphingomyelinase inhibitors for in vitro growth of P. 
falciparum is lower in HbA/S than in HbA/A erythrocytes.  
(A-B) Relative parasitemia [% of control] of synchronized infected HbA/A RBCs grown for 48 h under normal 
culture conditions in the presence of the neutral sphingomyelinase inhibitors (A) epoxyquinone 0 – 2.5 µM 
(HbA/A, circles, n = 18 - 53, ± SE; HbA/S, triangles,  n = 12 - 36, ± SE); and (B) spiroepoxide 0 – 10 µM 
(HbA/A, circles, n = 16 - 51, ± SE; HbA/S, triangles, n = 18 - 42, ± SE).   
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The IC50 values for the neutral SMase inhibitor epoxyquinone applied during 48 h of 
parasite growth did not differ significantly for the two cell types: IC50 (HbA/A) = 1.2 µM, IC50 
(HbA/S) = 1.0 µM (Fig. 3.13.A.). Nonetheless, the IC50 value for spiroepoxide was significantly 
lower for infected HbA/S than for infected HbA/A RBCs:  IC50 (HbA/A) = 5 µM, IC50 (HbA/A) = 3 
µM (Fig.3.13.B.). What plasmodial NSM activity has been detected so far resides at the 
parasite plasma membrane or in domains of the parasite vacuolar membrane – tubovesicular 
membrane network (PVM - TVM) 526. However, the sensitivity of parasites grown in HbA/S 
RBCs towards NSM inhibitors was increased compared to parasites grown in HbA/A RBCs. 
 
3.2.5 P. falciparum infection induces a higher Ca2+ permeability in HbA/S 
RBCs than in HbA/A RBCs  
 
PS exposure in infected HbA/S erythrocytes might be enhanced due to stronger 
activation of the infection-induced NSC channel. This channel is permeable for Ca2+ 243 and 
can be activated by PGE2 499,440,437. The following measurements were performed to determine 
whether accelerated PS exposure of P. falciparum infected HbA/S erythrocytes might be due 
to an enhanced activation of the NSC channel: cytosolic free Ca2+ concentration (Fig. 3.14.), 
Ca2+ permeability (Fig. 3.15.) and formation of PGE2 (Fig. 3.16.) of non-infected and infected 
HbA/A and HbA/S RBCs were measured.  
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Figure 3.14. Free cytosolic Ca2+ in P. falciparum-infected human HbA/A and HbA/S 
erythrocytes.  
Mean Fluo-3 fluorescence (n = 15, ± SE) reflecting the free Ca2+ concentration in non-infected (open bars) and 
infected (closed bars) HbA/A and HbA/S erythrocytes. ***: p ≤ 0.001; ANOVA. 
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The free cytosolic Ca2+ concentration (free [Ca2+]i) was determined by Fluo-3 
fluorescence. Free [Ca2+]i was calculated from the geometrical means of the fluorescence 
histograms and normalized to the value of non-infected HbA/A RBCs. Infected HbA/S RBCs 
had an elevated free [Ca2+]i around 1.5 fold of that in infected HbA/A RBCs, whereas free 
[Ca2+]i was similar in non-infected HbA/A and HbA/S RBCs (Fig. 3.14.). 
45Ca2+ uptake was determined in infected (corrected for parasitemia) and control non-
infected HbA/A and HbA/S RBCs (Fig 3. 15.) as a means of investigating the Ca2+ 
permeability of the putative NSC channel in infected HbA/A and HbA/S RBCs. The 
difference in 45Ca2+ uptake between infected HbA/A and HbA/S RBCs was particularly 
apparent in infected RBCs synchronized to ring stage of P. falciparum. In contrast, in later 
stages the differences in Ca2+ permeability between infected HbA/A and HbA/S disappeared 
(data not shown). The 30 min values of the 45Ca2+ uptake measurements were pooled (Fig. 
3.15.B.). Infected HbA/S erythrocytes, but not infected HbA/A erythrocytes markedly 
enhanced their Ca2+ permeability during the early ring phase of the parasite blood cycle.  
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Figure 3.15. Ca2+ permeability in P. falciparum-infected human HbA/A and HbA/S 
erythrocytes.  
(A) Uptake of 45Ca2+ by non-infected and ring-stage-synchronized infected HbA/A and HbA/S erythrocytes in 
individual blood samples (in quadruplicate). Non-infected HbA/A RBCs: open circles, n = 4, ± SE; non-infected 
HbA/S RBCs: open triangles, n = 4, ±SE; infected HbA/A: closed circles, n = 4, ± SE; infected HbA/S: closed 
triangles, n = 4, ± SE. (B) Uptake of 45Ca2+ by ring-stage-synchronized infected HbA/A and HbA/S erythrocytes; 
pooled data represented by box-whisker blot (30 min values, n=12). Box-whisker plots show medians and the 
25th and 75th percentiles. Whiskers denote the 10th and 90th percentiles. All values are shown. **: p ≤ 0.01; 
student’s two-tailed t-test. 
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As PGE2 is known to stimulate NSC channel activity 499,294,517,437, PGE2 release of 
ring-stage synchronized P. falciparum infected HbA/A and HbA/S RBCs was measured over 
a time period of 48 h. 
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Figure 3.16. PGE2 formation in P. falciparum-infected human HbA/A and HbA/S 
erythrocytes.  
Average time-dependent PGE2 release (n=8, ±SE) from non-infected HbA/A (closed triangles), infected HbA/A 
(open squares) and infected HbA/S (closed squares) RBCs given as % of initial values (98 ± 26 pg or 127 ± 32  
pg PGE2 secreted by 109 infected HbA/A or HbA/S RBCs, respectively; 26 ± 2 pg/109 non-infected HbA/A 
RBCs). *: P≤0.05, ANOVA between infected HbA/S and HbA/A erythrocytes. Samples were taken at 0 h, 1h, 3 
h, 6 h, 12 h, 24 h and 48 h after synchronization. 
 
Infected HbA/S RBCs released significantly more PGE2 (normalized to the initial 
values at 0 h) than infected HbA/A RBCs, in particular during the first 24 hours after ring 
synchronization (Fig. 3.16.). Non-infected control HbA/A erythrocytes incubated under the 
same culturing conditions as infected RBCs for 48 h did not show enhanced PGE2 release. 
 
These results indicate a higher activity of the infection-induced NSC channel in ring-
stage P. falciparum infected HbA/S RBCs as compared to ring-stage infected HbA/A RBCs, 
resulting in higher intracellular free Ca2+ concentrations in the former. The NSC channel 
might be stimulated through increased PGE2 release in infected sickle-trait erythrocytes. This 
most probably leads to enhanced PS exposure in infected HbA/S RBCs.  
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4 Discussion 
 
4.1 Functional significance of altered cation permeability for the 
intraerythrocytic amplification of Plasmodium falciparum  
 
An obvious function of the infection-induced cation permeability is the replacement of 
K+ by Na+ in the host erythrocyte cytosol 796. In the present study, parasite growth was 
significantly inhibited in a concentration-dependent manner when the culture medium of 
trophozoite-stage parasites was replaced for 8 hours (i.e. 24 – 32 h after synchronization) by 
mixtures of NaCl (100 % = control conditions) and N-Methyl-D-Glucamine-Chloride 
(NMDG-Cl) or KCl containing test solutions of different component ratios . In contrast to Na+ 
ions, NMDG+ ions are unable to permeate the red blood cell (RBC) membrane. Our 
experiments indicate that the inhibition of parasite growth cannot be attributed to a toxic 
effect of NMDG per se, as replacement of 50 % of the NaCl by raffinose in the test solution 
had the same effect on parasite growth as 50 % replacement by NMDG-Cl. This indicates an 
inhibitory effect of decreasing extracellular [Na+] on parasite growth. Parasite growth was not 
inhibited when the NaCl test solution containing 126.7 mM [Cl-] was substituted by Na-
gluconate test solution containing Cl- in a reduced concentration of 6.7 mM. This indicates 
that low extracellular Cl- concentrations are sufficient to maintain parasite growth.  
When NaCl was replaced by NMDG-Cl, half-maximal parasite growth (IC50) was 
reached at a residual NaCl concentration of 24 mM NaCl (24 mM NaCl + 112 mM NMDG-
Cl). When NaCl was replaced by KCl, parasites were around twice as sensitive towards the 
decrease in Na+ concentration. Parasite growth was half-maximal (IC50) at 58 mM NaCl and 
65 mM KCl. These results indicate an additive inhibitory effect of the increasing K+ 
concentration on parasite growth. These results suggest that the parasite requires not only an 
inwardly directed Na+ gradient but also an outwardly directed K+ gradient across its plasma 
membrane. The increase in [Na+] and the decrease [K+] in the host cytosol appear to benefit 
the parasite particularly during the second half of its intraerythrocytic development 796. 
Moreover, inhibition of the Na+ / K+ pump by ouabain allows parasites to develop well in 
RBCs. This suggests that P. falciparum might also prefer high [Na+] and low [K+] within the 
RBC cytosol during the first half of its blood cycle 326,812.  
Plasmodium falciparum trophozoites have high cytosolic [K+] 528. Moreover, they 
build up a plasma membrane potential by two discrete pump mechanisms that lead to 
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electrogenic extrusion of H+. One is a V-type H+ pump (H+-ATPase) 24,731, and the other a 
Mg2+-pyrophosphate complex-dependent H+ pump (H+-pyrophosphatase) 729. Hence, both 
pumps generate a concentration and electrochemical gradient of protons across the parasite’s 
plasma membrane. The K+ leak of the RBC’s membrane, i.e. the facilitated diffusion of K+ 
out of the RBC, generates a K+ diffusion potential across the parasite membrane that supports 
the electrogenic extrusion of H+ out of the parasite 729 because the parasite plasma membrane 
hyperpolarizes both with decreasing erythrocytic [K+] and increasing erythrocytic pH) 24. 
Since the parasite plasma membrane depolarizes both with increasing erythrocytic [K+] and 
decreasing erythrocytic pH, additional K+ channel activity in the parasite plasma membrane 
would increasingly short-circuit the H+ pump potential with increasing K+ concentration in the 
host RBC cytosol 407. Therefore, a low cytoplasmic [K+] in the host RBC is needed to shift 
Nernst’s K+ equilibrium potential of the parasite’s plasma membrane to negative values 407, 
i.e. to hyperpolarize the membrane. Thus, the K+ leak generates a K+ diffusion potential that 
counteracts the decrease in the erythrocytic pH generated by the H+-pumps, thus inhibiting 
membrane depolarization. In this way the K+ diffusion potential might reinforce  the H+ pump 
potential 24. Since K+ in the host RBC cytosol is replaced by Na+, the parasite might utilize the 
increasing inwardly directed Na+ gradient for Na+-coupled transport, such as Na+-coupled 
phosphate transport 732.  
Invasion of the RBCs by merozoites, and parasite amplification within the erythrocyte 
between 20 and 26 hours after invasion are both strongly dependent on the Ca2+ concentration 
in the medium 866,868,867. In line with these results, depletion of Ca2+ in the medium also halted 
parasite growth in the present study.  
In conclusion, the parasite is dependent on Ca2+ influx and adapted to high Na+ and 
low K+ concentrations extracellularly. Such conditions are also encountered by the parasite’s 
free swimming life stages, e.g. by merozoites in the blood of the mammalian host or by 
sporozoites in the hemolymphe of the mosquito vector and in human blood. On entering 
mammalian RBCs the parasite creates, as it were, an extracellular environment by increasing 
the cation permeability of the host RBC 407. 
 
4.1.1 Characterization of infection-stimulated nonselective cation 
conductance 
 
 Ca2+ accumulates within the parasite in infected RBCs 118,531,813. Trophozoites induce a 
7-8 fold increase in cation conductance of the RBC, as demonstrated by patch-clamp 
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experiments 243. Thus, amplification is facilitated by the infection-induced Ca2+-permeable 
nonselective cation (NSC) conductance of the erythrocyte membrane (Gcat) supplying the 
parasite with Ca2+ ions. The infection-induced nonselective cation (NSC) currents exhibit a 
permselectivity for monovalent cations in the rank order: Cs+ ≈ K+ > Na+ > Li+ >> NMDG; 
PK/PNa ~ 2. The channel is significantly permeable to Ca2+ and is inhibited by amiloride, 5-
(N-ethyl-N-isopropyl)amiloride (EIPA), GdCl3, and artemisinine, with sensitivity being 
highest to EIPA 244,243,242. Removal of extracellular Cl- activates Gcat. After activation, Gcat is 
2.0 ± 0.3 nS (n = 32) in infected RBC, while in non-infected control RBC it is 0.3 ± 0.05 nS 
(n=16). This points to an induction of Gcat during infection 244. Moreover, the NSC channel is 
activated by oxidative stress 507. Oxidative stress imposed by the parasite on the erythrocyte 
during infection might stimulate Gcat 405. The permselectivity, permeability and pharmacology 
of the P. falciparum infection-induced cation conductance are similar to those of the cation 
conductance induced in oxidized non-infected RBCs. This strongly suggests that the 
conductances in oxidized and infected RBCs are determined by one and the same channel 
type. However, in the present study, ring-stage infected normal (HbA/A) RBCs showed only a 
slightly increased Ca2+ permeability during patch-clamp recordings (data not shown).  
 EIPA is a very potent blocker of Gcat, as demonstrated by patch-clamp recordings 243. 
In non-infected RBCs EIPA inhibits Gcat upon Cl- removal and prevents eryptosis 512. At the 
same time EIPA blocks Na+/H+ exchangers of the host cell 665 and possibly also of the parasite 
126
. In the present study, the IC50 of EIPA observed in patch-clamp experiments on infection-
induced cation conductance was 0.75 µM. In order to test for its effect on parasite growth, 
EIPA was applied to the normal culture medium for 48 h. EIPA hindered parasite 
development after synchronization with an IC50 of 3 µM free EIPA. This suggests a 
contribution of Gcat to parasite growth. The remaining difference in the IC50 values might be 
explained by the fact that in patch-clamp experiments the instantaneous NSC currents for 
mature trophozoites were measured upon application of EIPA. By contrast, in the growth 
experiments we investigated the influence of EIPA throughout the parasite’s asexual life 
cycle. Moreover, the growth experiments permit no distinction between the influence of EIPA 
on Na+/H+ exchangers and that on the putative NSC channel.  
Taken together, the effect of EIPA on parasite growth is no proof of a contribution of 
the infection-induced cation conductance to the induced cation exchange within the host 
cytosol, since EIPA also inhibits the Na+/H+ exchangers. Therefore, inhibition of host or 
parasite Na+/H+ exchangers may be an alternative explanation for the growth inhibition by 
EIPA 407. Conversely, such an involvement of the NSC conductance would have had to be 
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excluded, if EIPA had failed to inhibit parasite growth.  
In sharp contrast to non-infected cells, Gcat of infected RBC is inhibited by new 
permeation pathway (NPP) blockers furosemide and 5-Nitro-2-(3-phenylpropylamino) 
benzoic acid (NPPB), as measured in patch-clamp experiments 243. These blockers also 
inhibited parasite growth dose-dependently (with an IC50 (NPPB) = 60 µM and an IC50 
(furosemide) around 100 µM, data not shown). The observed sensitivity to the anion channel 
inhibitors furosemide and NPPB suggests a unique channel that generates anion and cation 
currents in infected RBCs. This broad specificity channel might preferentially conduct cations 
when the concentration of permeable anionic substrates is decreased. However, infection-
induced anion and cation currents studied in patch-clamp experiments differ in their EIPA 
sensitivity and their dependence on extracellular Cl-. The removal of extracellular Cl- (i.e. in 
the bath solution) stimulates the cation currents, but not the anionic inward currents carried by 
the efflux of Cl- from the infected RBCs into the bath solution. Hemolysis and tracer flux data 
demonstrate a similar permselectivity for infected RBCs as the infection-induced cation 
currents measured by patch clamp whole cell recordings, namely in the rank order of Cs+ > K+ 
> Na+ ≈ Li+. Specifically, the K+ over Na+ permeability (PK/PNa ~ 2) observed in tracer flux 
studies of infected RBCs 465,796 matches that of the NSC currents determined by patch clamp.  
The data strongly suggest that the Cl--dependent NSC currents are the 
electrophysiological correlate of the infection-induced permeability for Ca2+, Na+ and K+. The 
NSC channel activity accounts for the dramatic changes observed in host cation 
concentrations. The characteristics of NSC permeability are very similar in non-infected 
oxidized and in infected RBCs. These similarities point to the possibility that the infection-
induced cation permeability might develop through modification of endogenous RBC cation 
channels, i.e. through oxidative stress conferred by the parasite. Mature RBCs are 
continuously exposed to high oxidative stress throughout their 120 day life span 459. As the 
NSC channel is activated by oxidative stress, the NSC channel might sense RBC age or injury 
in vivo 407. In any case, the NSC channel is a key factor in erythrocyte programmed cell death, 
also referred to as eryptosis 509, and plays a key role during P. falciparum infection.  
 
4.2 HbA/S erythrocytes do not inhibit P. falciparum in vitro growth 
 
Parasite prevalence and densities are usually similar in HbA/A and HbA/S carriers 
with mild P. falciparum infection 581. Moreover, sickling of infected HbA/S RBCs does no
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occur upon invasion. Thus, sickling cannot be the mechanism of protection 251,524,523. The 
inhibition of parasite growth in culture observed in several studies by Friedmann et al. and 
Pasvol et al. 298,300,669,667 might have been be an artifact caused by  the culturing conditions 
used 17. For example, Friedman et al. 298,300 did not add hypoxanthine to the culture medium. 
However, hypoxanthine is essential for parasite growth. Therefore, the culture medium of the 
present study was supplemented with 0.2 mM hypoxanthine. Moreover, the RBCs used were 
old. This can have influence on parasite growth (own observations). [Ca2+]i is known to 
accumulate with age 21, thus triggering cell shrinkage through Ca2+-activated K+ channels 
(GARDOS effect). As the membrane resting potential is at – 10 mV, which is close to the Cl- 
reversal potential, loss of K+ leads to hyperpolarization. This drives Cl- out of the RBC, 
followed by osmotically obliged water loss 313,776,829,542. It is only in the presence of the Ca2+ 
ionophore A23187 that the Gardos channel is activated in infected HbA/A RBCs 485,795,829. 
Friedman et al. 301 have shown that inhibition of parasite growth in HbA/S RBCs at 3% O2, 
caused by increased leakage of K+ ions from the infected RBC, is reversed in a K+-enriched 
medium 631. These results suggest that the Gardos effect might have caused the inhibition of 
parasite growth as increase of extracellular [K+] limits hyperpolarization by altering the 
reversal potential for K+ 333,501,515,625. 
Pasvol et al. 669,667 used the more appropriate medium 199 containing in particular 0.3 
mg/l hypoxanthine and 10 mg/l adenine 17. The raw data of Pasvol et al. 669 (Table 1) should 
demonstrate that under ambient oxygen tensions, parasites invade and grow similarly in 
HbA/S and HbA/A RBCs, whereas at reduced oxygen levels (5%)  invasion and, to some 
degree, growth is inhibited 669,667. However, these results are not statistically significant, as 
has already been noted elsewhere 17,523. This indicates that the hypothesis supporting the view 
of P. falciparum growth inhibition in HbA/S RBCs has not been experimentally substantiated 
to date.  
The parasite growth rate in HbA/S RBCs in a low oxygen environment (3 %) is 
comparable to that in HbA/S RBCs cultured with the candle-jar method. This has been tested 
for a time period of at least one month 655. Therefore, both methods were applied in this study. 
Consistent with Ayi et al. 66, who have shown no significant difference in P. falciparum 
growth in HbA/A and HbA/S RBCs under optimized culture conditions even over three 
asexual cycles, we, too, were unable to detect different parasite growth rates in HbA/A and 
HbA/S RBCs. 
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4.3 Functional significance of ceramide production 
 
4.3.1 Increased ceramide production in blood of P. berghei infected mice  
 
The development of Plasmodium spp. changes the lipid composition of the host cell 
membrane 774,775. The erythrocyte membrane of P. falciparum infected RBCs contains 
altogether less sphingomyelin (SM) (28.0% in non-infected RBCs versus 14.6% in infected 
RBCs), more phosphatidylcholine (PC; 31.7 % in non-infected RBCs versus 38.7% in 
infected RBCs) and more phosphatidylinositol (PI; 0.8% in non-infected RBCs versus 2.1% 
in infected RBCs) 404. In the outer membrane leaflet of trophozoite-infected RBCs PI, 
phosphatidylethanolamine (PE), and phosphatidylserine (PS) content increases, while PC 
content decreases. Moreover, schizont-infected RBCs show a further decrease in SM and 
increase in PS content of the outer membrane leaflet 575,574. The cholesterol/phospholipids 
ratio decreases by 55% because the parasite uses cholesterol 404. The unsaturation index of 
phospholipids in infected RBCs is considerably lower than in non-infected RBCs (107.5 
versus 161.0) 404. This is due to the decrease in arachidonic acid (C20:4; from 17.36 % to 7.85 
%) and docosahexaenoic acid (C22:6; from 4.34 % to 1.8 %), and increase in palmitic acid 
(C16:0) (from 21.88% to 31.21%), linoleic acid (C18:2) and oleic acid (C18:1) 404,858. This 
makes the fatty acid compositon of the infected erythrocyte membrane very similar to that of 
the parasite’s membrane 404,858.  
P. falciparum infected RBCs have a single Mg2+-dependent, membrane bound, 
parasitic neutral sphingomyelinase (NSM) 371, probably located in the parasitophorous 
vacuolar membrane (PVM), which is continous with the tubovesicular membranes (TVM) 526. 
The observed decrease in SM in the outer membrane leaflet of infected RBCs 404,858 suggests 
that SM might be hydrolysed to ceramide and phosphocholine by a sphingomyelinase of 
erythrocytic and / or parasitic origin. In mammalian cells, ceramide derived from NSM 
activity is thought to be involved in modulating phospholipase A2 (PLA2) activity, 
arachidonate mobilization, and other enzymes involved in arachidonate metabolism including 
cyclooxgenase (COX) 69. Mobilization of arachidonate and stimulation of COX might result 
in PGE2 secretion. This leads to increased NSC channel activity in RBCs and influx of Ca2+, 
thus contributing to PS exposure 517. On the other hand, arachidonate increases SM hydrolysis 
and ceramide production in mammalian cells 427. Ceramide is a signaling molecule involved 
in the second known pathway of eryptosis 519 that merges with the first one, increasing PS 
exposure. Ceramide sensitizes the scramblase to the effects of Ca2+ 509. Increase in 
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erythrocytic [Ca2+]i activates the scramblase 94,218,900,913,926, which enhances PS exchange 
within the membrane bilayers 780,900,899. The scramblase acts antagonistically to an ATP-
dependent translocase which transports PS from the outer to the inner membrane leaflet 
61,101,184,233,913,922
. Increased [Ca2+]i inhibits the translocase 108,780,832,923, thus ultimately 
stimulating PS exposure on the outer leaflet of the membrane 935. 
In order to investigate the contribution of erythrocytic acid sphingomyelinase (ASM) 
activity to ceramide formation in infected RBCs ASM wildtype (ASM +/+) and ASM 
knockout (ASM -/-) mice were infected with Plasmodium berghei ANKA and then examined 
for parasitemia, survival rate and ceramide production.  
ASM+/+ and ASM-/- mice infected with P. berghei ANKA showed a significant 
increase in ceramide production. This suggests that parasitic NSM activity most probably 
contributed to the increased ceramide level in both types of mice. The ceramide concentration 
in infected ASM+/+ RBCs was significantly higher than in infected ASM-/- RBCs. This 
suggests that the host ASM contributed significantly to enhanced ceramide levels in infected 
RBCs. ASM is secreted by leukocytes as mouse erythrocytes do not have any own ASM 
activity 520. Probably the enhanced ceramide concentration resulted in enhanced PS exposure 
in infected ASM+/+ mice. This assumption is supported by the fact that after postincubation 
ex vivo for 24 h at 4°C PS exposure is significantly higher in infected ASM+/+ blood than it is 
in infected ASM-/- blood. Freshly taken blood samples do not show any annexin-binding 734. 
This is probably due to the elimination of PS exposing RBCs within the organism. 
We investigated whether this pathway could also contribute to the observed enhanced 
PS exposure in P. falciparum infected HbA/S RBCs as compared to that in infected HbA/A 
RBCs. A twofold increase in ceramide production was measured in non-infected HbA/S as 
compared to HbA/A RBCs. The ceramide concentration in infected HbA/S and HbA/A RBCs 
was on average higher than in the respective non-infected RBCs and it was slightly higher in 
infected HbA/S than in infected HbA/A RBCs. However, in contrast to infected mouse RBCs 
the difference between non-infected and infected human RBCs was not significant, because 
ceramide concentration between individual RBC samples varied enormously, particularly in 
infected RBCs. As repeat measurements showed good within-sample consistency, the 
variation might be due to the differences in genetic background 445. Moreover, differences in 
ceramide production between infected mice and humans might also result from different 
sphingolipid compositions in the blood 205.  
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4.3.2 Ceramide is needed for Plasmodium membrane synthesis 
  
The survival rate of infected ASM-/- mice was higher than that of their wild-type 
littermates, but not significantly different. Reduced parasitemia in ASM-/- mice between the 
10th and the 21st day post infection as compared to that in their wild-type littermates correlated 
with a significantly decreased ceramide production in ASM -/- mice. This is possibly caused 
by a lack of ceramide in ASM-/- mice, since parasite membrane synthesis requires ceramide 
371
.  
As judged from available results, the parasite uses membrane components like 
ceramide and cholesterol from the host erythrocyte for its own membrane synthesis including 
the TVM 371. The TVM allows the parasite access to nutrient solutes 527, delivers 
transmembrane proteins to the PVM 525, and is thought to play a role in the metabolism and 
sorting of membrane lipids 308. The tubular structures contain a Golgi-specific SM synthase 
which is active in regions, where ceramide accumulates 260,261,367,663. The non-infected host 
erythrocyte itself is incapable of SM synthesis 663. Attempts to detect de novo ceramide 
synthesis in infected RBCs by metabolic labeling with [14C] serine and [14C] palmitate were 
not successful to date 258,860. However, a recent study was successful in demonstrating de-
novo synthesis of glycosphingolipids by P. falciparum using metabolic labeling with triated 
([3H]) serine and [3H] glucosamine 323. Although well-known inhibitors of de-novo ceramide 
biosynthesis affected the synthesis of glycosphingolipids, they were unable to arrest the 
intraerythrocytic development of the parasites in culture 323. This suggests that de novo 
synthesized ceramide does not serve as a major substrate for the SM synthase in developing 
the TVM 526, as is the case with ceramide derived from hydrolysis of host sphingomyelin and 
glycosphingolipids 404,525,574.  
 
4.3.3 Effect of neutral and acid sphingomyelinase inhibitors on parasite 
growth 
  
This study showed that the NSM inhibitors spiroepoxide and epoxyquinone effectively 
inhibited P. falciparum growth in vitro in HbA/A and HbA/S RBC. The IC50 for parasite 
growth was lower for infected HbA/S RBCs. This difference was significant for spiroepoxide 
(IC50 (HbA/A) = 5 µM versus IC50 (HbA/S) = 3 µM) but not for epoxyquinone (IC50 (HbA/A) = 1.2 µM 
versus IC50 (HbA/S) = 1.0 µM). The parasite growth inhibition was consistent with results 
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showing that scyphostatin, a mammalian NSM inhibitor, decreases parasite growth in HbA/A 
RBCs in a dose-dependent manner, as judged by [3H] hypoxanthine incorporation, with an 
IC50 value of 7 µM 372. Scyphostatin has in particular been found to inhibit the maturation 
from trophozoite to schizont stage, a phase coinciding with P. falciparum NSM expression 
372
.  
In the present study, parasite growth was more sensitive to NSM inhibitors in HbA/S 
RBCs than it was in HbA/A RBCs, while the ASM inhibitor 2,4-DC had the same effect on 
parasite growth in both RBC types when applied in normal culturing conditions. Moreover, 
application of NSM inhibitors totally stopped parasite growth, whereas 2,4 DC inhibited 
parasite growth by up to one third when applied up to a concentration of 200 µM. 
As judged by these results, parasitic NSM degrades SM from the host erythrocyte for 
its own membrane synthesis. This is essential for the parasite’s survival, as inhibition of NSM 
activity results in parasite death. Beyond this, ASM of host origin contributes significantly to 
ceramide production. It appears that ASM activity is not as important as NSM activity is for 
parasite development, since neither genetic knock-out of ASM nor the ASM inhibitor 2,4-DC 
were able to entirely stop Plasmodium growth.  
 
4.3.4 Exogenously added C6-ceramide and excess ceramide production 
inhibits growth of P. falciparum in vitro 
 
Activation of ASM by hyperosmotic shrinkage results in ceramide formation, a 
process involved in programmed cell death 213,344,360,510,533,820. Consistent with this, in the 
present study NaCl (IC50 = 128 mM, i.e. 25 mM above the regular level), raffinose (IC50 = 50 
mM) and urea (IC50 = 140 mM), each inhibited parasite growth to a similar degree in HbA/A 
and HbA/S RBCs (data not shown). Ginsburg et al. 326 has shown that this is not due to 
parasite dehydration. In the present experiments significant PS exposure was detected both in 
infected HbA/S and HbA/A RBCs but not in non-infected RBCs cultured for 48 h with 153 
mM NaCl, i.e. 50 mM above the regular level. Moreover, at 50 mM additional NaCl ceramide 
content in the outer membrane leaflet was significantly enhanced in P. falciparum infected 
HbA/S RBCs compared to that in non-infected RBCs of the same parasite culture. When 
applied at a concentration of 200 µM to HbA/A RBCs the ASM inhibitor 2,4-DC partially but 
significantly reversed the P. falciparum in vitro growth inhibition that had previously been 
induced by adding 50 mM NaCl. No significant inhibition reversal was observed in HbA/S 
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RBCs, however.  
When added for 48 h, short-chain RBC membrane permeable C6-ceramide inhibited 
P. falciparum growth in both HbA/S and HbA/A RBCs, but more so in HbA/S RBC 
(IC50(HbA/A) = 10 µM; IC50(HbA/S) = 8 µM). Consistent with the results of the present study, 
Pankova-Kholmyansky et al. 663 has shown that a membrane permeable analogue of ceramide 
C6, added for 6 h to an unsynchronized P. falciparum culture, results in inhibition of parasite 
growth in HbA/A RBCs with an IC50 value of 60 µM ceramide. Addition of ceramide 
decreases glutathione levels in infected RBCs. The antimalarial drugs artemisinine and 
mefloquine increase ceramide concentration in P. falciparum infected RBCs. Inhibitors of de 
novo synthesis of ceramide cannot counteract the antimalarial action of these two drugs. 
Conversely, low concentrations of sphingosine-1- phosphate reverse parasite growth 
inhibition for any of the three inhibitors ceramide, mefloquine and artemisinine 663. 
Sphingosine-1-phosphate, a metabolite of ceramide, is an antagonist of short chain ceramide 
in mammalian cells and also in RBCs 183,204,339,374,473,587,645,693.  
In the present study, C6-ceramide added in concentrations up to 10 µM did not induce 
PS exposure in either infected HbA/A or HbA/S RBCs. At higher concentrations, ceramide 
induced PS exposure both in P. falciparum infected HbA/S and HbA/A RBCs to a similar 
degree. However, the basal PS exposure at control conditions, i.e. normal culturing 
conditions, was significantly higher in HbA/S RBCs than in HbA/A RBCs. 
Taken together, these data suggest that inhibition of parasite growth under 
hyperosmotic conditions is due to ceramide production by erythrocytic ASM. Infected HbA/S 
RBCs might be more vulnerable to stress stimuli like osmotic stress than infected HbA/A 
RBCs, resulting in enhanced ceramide formation in infected HbA/S RBCs. Hence, additional 
stress involving increased ceramide formation would result in stronger inhibition of parasite 
growth in HbA/S RBCs than in infected HbA/A RBCs. This was confirmed in the present 
study by the finding that under similar hyperosmotic conditions inhibition of parasite growth 
in HbA/S RBCs could not be reversed by 200 µM of the ASM inhibitor 2,4 DC whereas in 
HbA/A RBCs it could. In line with this assumption, the IC50 value of ceramide for parasite 
growth was lower in HbA/S than in HbA/A RBCs.  
In conclusion, although ceramide is needed for membrane synthesis of the parasite, in 
excess it acts as a lipid second messenger in inducing parasite cell death. These lethal effects 
on infected RBCs can be reversed at signal transduction level. Considering that P. falciparum 
grew normally in HbA/S RBCs, enhanced ceramide production cannot be the cause of the 
enhanced PS exposure on infected HbA/S RBCs observed in the present study. 
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4.4 Accelerated eryptosis in P. falciparum infected HbA/S erythrocytes 
 
4.4.1 PGE2 formation of P. falciparum infected HbA/S RBCs is enhanced 
compared to that of infected HbA/A RBCs 
 
Prostaglandins (PGs) are important mediators of macrophage activity, vascular 
permeability, fever, erythropoiesis, and proinflammatory responses to infection. They play an 
important role in protective immunity 676.  
P. falciparum itself also produces PGD2, PGE2, and PGFα, as measured by enzyme 
immunoassay and gas chromatography/selected ion monitoring 460. Addition of arachidonic 
acid to the parasite cell culture markedly increases the ability of the parasite cell homogenate 
to produce PGs. Moreover, after addition of arachidonic acid, PGs are secreted from the 
infected RBCs into the culture medium. PGD2 and PGE2 accumulate at the trophozoite and 
schizont stages more actively than at the ring stage. PG production in the parasite homogenate 
is not affected by the mammalian COX inhibitors aspirin or indomethacin and is partially heat 
resistant. By contrast, mammalian PG synthesis is completely inhibited by both drugs and by 
heat treatment, suggesting that the parasite uses other enzymes to synthesize PGs than its 
mammalian host 483. These plasmodial PGs are thought to be pyrogenic and injurious to host 
defenses 460. 
Children with malaria anemia in consequence of P. falciparum infection have 
significantly lower plasma concentrations of bicyclo-PGE2 (a stable end product of PGE2 
metabolism) and leukocyte cyclooxygenase (COX2) gene expression than children with 
asymptomatic parasitemia 677. PGE2 (β-hydroxyketone) is synthesized from arachidonate via 
PGG2 and PGH2 by cyclooxygenase (prostaglandine G/H synthase) that contains two distinct 
activities: the cyclooxygenase bisdioygenates arachidonic acid PGG2, which is then reduced 
by the peroxidase to form the hydroxyl endoperoxide PGH2. Endoperoxide E isomerase 
(prostaglandine E2 synthase) act on PGH2 to produce PGE2 88,599. Children with asymptomatic 
parasitemia have the highest bicyclo-PGE2 / creatinine plasma concentration among P. 
falciparum infected children 677.  
In vivo, PGE2 induces preferential synthesis of fetal hemoglobin (HbF). An increase in 
HbF, one of the mechanisms of hydroxyurea treatment 373,658,685, has been shown to be 
beneficial in sickle cell disease due to the high O2 affinity of HbF, hindering polymerization 
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of HbS/S RBCs. An investigation of the effects of PGE2 in association with erythropoietin on 
the synthesis of fetal and adult Hb in peripheral blood-derived erythroid burst colonies from 
normal adults and from patients with sickle cell anemia, has shown a preferential synthesis of 
fetal Hb (HbF) after PGE2 treatment 206. In addition, there was an increase in the overall Hb 
synthesis in PGE2 treated colonies. Furthermore, the reactivation of HbF production by PGE2 
is more pronounced when adherent cells are included in the culture dishes 206. Thus, enhanced 
PGE2 production in P. falciparum infected sickle trait carriers might also counteract the 
effects of the accelerated destruction of erythrocytes during malaria infection. Increased HbF 
synthesis resulting in higher O2 affinity of the RBCs might reverse some of the consequences 
of anemia.  
In the present study, PGE2 release from P. falciparum infected HbA/S RBCs was 
enhanced for a period of 24 hours after ring synchronization as compared to infected HbA/A 
RBCs. The observed decrease in arachidonic acid in the erythrocyte membrane of infected 
RBCs 404 suggests that prostaglandin (PG) is synthesized by the parasite and / or the host. It 
has been previously shown that human erythrocytes synthesize PGE2 after Cl- removal 517. 
This indicates that PGE2 is, at least in part, synthesized by the erythrocyte. 
Addition of PGE2 during patch clamp experiments stimulates the NSC conductance in 
erythrocytes 517 as well as in nucleated cells 294. Culturing of these cells with PGE2 increases 
PS exposure 294,517. Gene silencing of the Ca2+-permeable transient receptor potential cation 
channel TRPC7, a NSC channel and member of the canonical subfamily of transient receptor 
potential (TRPC) channels, significantly blunts PGE2-induced triggering of PS exposure and 
DNA fragmentation in the human leukemia cell line K562 294.  
PS exposure of infected HbA/S erythrocytes involves COX activity 443. Treatment 
with diclophenac, a COX inhibitor, results in decreased PS exposure of early-stage infected 
HbA/S RBCs 443. Thus, PGE2 formation in sickle cell trait carriers may promote PS exposure, 
accelerating elimination of the parasite harboring erythrocytes. The present results might give 
a mechanistic explanation for the clinical observation that a milder clinical course of P. 
falciparum malaria in children correlates with enhanced PGE2 plasma concentrations 677,676.  
The present observations, however, do not rule out other mechanisms contributing to 
the partial resistance of sickle cell trait carriers to malaria. Platelet COX, platelet and 
endothelial cell activation could be involved, resulting in release of other prostaglandins, 
prostacyclins, thromboxanes, besides other products of platelet and endothelial cell 
metabolism 147,165,295,343,399,418,487,597,650. Together with PGE2 these substances might influence 
erythrocyte morphology and adhesion 48,120,140,248,333,349,356,430,431,430,444,443,548,651,661,683,769,785,902. 
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COX2-mediated PGE2 dependent phagocytosis of PS-exposing cells should similarly be 
sensitive to treatment with aspirin or other nonsteroidal anti-inflammatory drugs 48,278,349. In 
any case, PGE2-generating COX activity is enhanced in infected HbA/S RBCs. The increase 
in PGE2 formation plays a decisive role for the course of the infection.  
 
4.4.2 Calcium permeability is increased in ring-parasitized HbA/S as 
compared to HbA/A erythrocytes 
 
Flufenamic acid, a Ca2+ channel inhibitor, reduces PGE2-stimulated Ca2+ influx in 
erythrocytes, measured as free intracellular Ca2+ concentration with Fluo3 443. Flufenamic 
acid also inhibits eryptosis and intraerythrocytic growth of P. falciparum 444. Consistent with 
these findings it was shown in the present study that increased PGE2 formation paralleled a 
significantly stimulated Ca2+ permeability in ring-stage synchronized P. falciparum infected 
HbA/S RBCs, measured by enhanced 45Ca2+ uptake, as compared to ring-infected HbA/A 
RBCs. Moreover, ring-infected HbA/S RBCs had a 1.5 fold increase in free Ca2+ 
concentration compared to ring-infected HbA/A RBCs. At later developmental stages these 
differences disappeared. It remains to be determined whether Psickle, the deoxygenation-
induced increase in calcium permeability in HbS/S RBCs (as an extreme of HbA/S RBCs) 
141,432,436,545,539,540,801
, also plays a role in infected HbA/S RBCs. Calcium influx was 
preferentially stimulated by PGE2 in HbS/S RBC ghosts but not in HbA/A RBC ghosts, 
resulting in differing patterns of sodium and calcium transport 694,837,838. Hence, the enhanced 
45Ca2+-uptake in ring-infected HbA/S RBCs observed in the present study might be due to 
enhanced NSC and possibly Psickle permeabilty. 
 
4.4.3 Ca2+ mediated phosphatidylserine externalization  
  
Non-infected erythrocytes have a minute total pool of exchangeable Ca2+ of about 0.1 
µmol per cell 208,262,547, as compared to an extracellular [Ca2+]o of about 1 mM 735. This results 
in a Ca2+ entry rate of about 30 - 55 µmol * (liter RBCs * h)-1 225,795. The huge Ca2+ gradient 
across the plasma membrane is maintained by a Ca2+ pumping mechanism (ATPase) with an 
extrusion capacity of around 45 µmol * (liter RBCs * h)-1 547, activated by Ca2+ in the 
submicromolecular range. Thus, RBCs have exceedingly low levels of [Ca2+]i, in the range of 
20 – 50 nM 14,547,538,720. The [Ca2+]i found in erythrocytes varied depending on the applied 
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non-fluorescent or fluorescent method. Moreover, the high intrinsic autofluorescence of RBCs 
and serum required appropriate corrections 14,73,547,538,549,720. Nevertheless, except for the 
oldest, densest fraction, all values remained below 150 nM [Ca2+]i 14. This is consistent with 
the observation that only the 5 – 10 % densest cells of old RBCs showed a threefold increase 
in ionic Ca2+ 720. This increase has been mainly attributed to deficiencies in Ca2+ pumping, as 
inferred from a 50 % reduction of the maximal extrusion capacity in the oldest cells 718. This 
suggests that the GARDOS effect 313,776,829 occurs only in old HbA/A RBCs. An even greater 
accumulation of Ca2+ in HbS/S RBCs results in irreversibly sickled cells on account of the 
Gardos effect 22,248,333,661. Increasing the Ca2+ influx above 0.7 mmol / liter (≈ 1013) RBCs per 
h is sufficient to trigger the Gardos effect, reaching its maximum at a Ca2+ influx of 1.2 mmol 
* (1013 RBCs * h)-1 829. PS exposure is stimulated both by the Gardos effect and the increase 
in [Ca2+]i per se 502,515. 
PS is present only in small amounts in the outer leaflet of fresh unseparated RBCs 
(about 300 sites per cell) 114,309,562,809. This is consistent with the low annexin-binding 
observed as a measure of PS exposure 44,92,151,321,753,876  on non-infected control co-cultured 
RBCs in the present study. Treatment with the Ca2+ ionophore A23187 leads to an increase in 
PS exposure to a level of 300,000 sites per RBC 309. This is consistent with the present finding 
that treatment with the Ca2+ ionophore ionomycin induced PS exposure in a high proportion 
of RBCs. This might be the result of the synergistic action of the two known eryptosis 
signaling pathways: an increase in [Ca2+]i per se activates the scramblase and inhibits the 
translocase 507,510,934. Moreover, the Ca2+-induced Gardos effect activates the 
sphingomyelinase, resulting in ceramide formation and further stimulation of the scramblase 
507,515
. 
De Jong et al. 211 have shown that oxidation of the erythrocyte itself did not induce 
exposure of PS on the membrane surface. In fact, when inflicted in excess, this oxidative 
damage was even able to prevent Ca2+-induced PS scrambling 211. It might be that the 
excessive oxidation destroyed the lipid transporters responsible for PS migration. This would 
explain the discrepancy with our own observation that non-infected oxidized RBCs 
predominantly showed PS exposure, comparable in degree to ionomycin-treated RBCs. 
Moreover, oxidation does not interfere with Ca2+ uptake 211,422. 
Kuettner et al. 485 have revealed that non-infected RBCs pre-treated with either very 
high levels of CaCl2 or with low levels of CaCl2 (10 – 50 µM) in the presence of the 
ionophore A23187 and subsequently exposed to a peroxide generating system show an up to 
two-fold increase in lipid peroxidation in comparison to untreated RBCs, as measured by a 
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malonyldialdehyde assay. Lipid antioxidants and EGTA have both been found capable of 
preventing a significant increase in PS and PE exposure 422. Zwaal et al. 934 have shown that 
the Ca2+-mediated breakdown of phospholipid asymmetry in platelets is partly reversed by 
treating activated platelets with reducing agents. The treatment with reducing agents removes 
PS from the outer leaflet, where it was previously exposed during platelet activation 934. These 
studies suggest that an increase in [Ca2+]i results in oxidative stress, and that these two effects 
might synergistically enhance PS exposure on RBCs.  
Usually, during parasite development the erythrocytic free cytosolic calcium 
concentration, [Ca2+]i, is maintained at low levels, namely between 40 and 100 nM 312. The 
unidirectional influx of Ca2+ into infected HbA/A RBC cultured in glucose-containing media 
with vanadate-induced inhibition of the Ca2+ pump is within same the range as the influx 
observed in non-infected RBCs of the same culture, i.e. 30-55 µmol * (1013 RBCs * h)-1 795. 
Without inhibition of the Ca2+-ATPase, glucose-fed infected HbA/A RBCs show a slightly 
elevated 45Ca2+ uptake rate [15 ± 1.2 µmol * (1013 RBCs * h)-1] as compared to co-cultured 
non-infected RBCs [4 ± 1 µmol * (1013 RBCs * h)-1] 795. The elevated 45Ca2+ uptake rate is 
consistent with other studies on glucose-fed or serum-incubated infected RBCs 119,224,477,482,813.  
The Ca2+ concentration in infected RBCs rises progressively during parasite 
development and reaches values that are 10 to 20-fold greater in schizont-infected RBCs than 
in non-infected RBCs 119,531,813. However, free [Ca2+]i remains low in infected RBCs, as the 
increased Ca2+ influx is mainly sequestered within the parasite and thus buffered 
126,312,311,481,579,813,811,830
. [Ca2+]i rises only transiently during the trophozoite / schizont stage 
6,311
. Together with subsequent oxidative stress this might stimulate PS exposure on infected 
RBCs.  
Only infected RBCs bathed in glucose-free solution exhibit a significant increase in 
Ca2+ permeability. In glucose-free media, the Ca2+ influx in infected RBCs increases to about 
1 mmol * (1013 RBCs * h)-1 at approximately 30 h post-invasion and is inhibited by Ni2+. This 
elevated influx of Ca2+ into glucose-deprived infected RBC is almost an order of magnitude 
higher than the Ca2+ influx seen in non-infected erythrocytes under equivalent conditions 795. 
Several studies have shown an increased influx of Ca2+ into P. falciparum infected RBCs 
224,477,482
, reaching a net Ca2+ entry into infected RBCs that is 18 times faster than into non-
infected RBCs 224. Rather than being attributable to the NPPs the increase in Ca2+ 
permeability after glucose or ATP depletion probably results from the oxidation of energy-
depleted infected RBCs. Glucose or ATP depletion leads to oxidative stress in RBCs, as the 
fueling with NADPH via the pentose phosphate pathway is impaired. In neither case is Ca2+ 
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conductance inhibited by blockers of the NPPs, e.g. furosemide 795. Ca2+-permeable NSC 
conductances of non-infected RBCs, induced by oxidative stress, are similarly insensitive to 
NPP inhibitors, e.g. NPPB, as measured by patch-clamp whole-cell recordings 244. This 
oxidation-induced conductance of non-infected RBCs is comparable to the increased 
conductance of infected RBCs measured in glucose-free media.  
In contrast, the cation conductance of infected RBCs (Gcat) is inhibited by NPP 
blockers (furosemide and NPPB), as measured by patch-clamp recording 243. This data 
suggests that not all of the observed infection-induced increase in Ca2+ permeability can be 
attributed to the pathway developing in glucose or ATP-depleted cells. In the present study, 
heavily infected HbA/A RBCs exhibited a large proportion of PS exposing cells. PS exposure 
was half of that in oxidized or ionomycin-treated non-infected RBCs. These results indicate 
that PS exposure resulting from the infection-induced Ca2+ uptake may occur in vivo. 
Attempts to show a significant percentage of Plasmodium infected RBCs harboring PS 
at their surface have yielded inconclusive results. While some studies found no such 
indication 363,613,819,854, others demonstrated a breakdown of the phospolipid asymmetry in P. 
falciparum-infected human 434,574,747,765,762 and P knowlesi-infected rhesus monkey RBCs 
362,434
. This conflict in results was not due to the use of different methods for detecting 
changes in membrane composition, as there was some overlap for both positive and negative 
results. The performed assays were either enzymatic (PLA2 434,362,574,747,854, Sphingomyelinase 
C 574,854, PC-transfer 854, prothrombin-assay 271,574,613); fluorescent (fluorescamine labeling 
574,854
, Merocyanine 540 434, (FITC-labeled) annexin V 91,474,363,583,765,819); or chemical (2,4,6-
trinitrobenzene sulphonic acid (TNBS) 362,747. A monoclonal antibody against PS was very 
sensitive 574. However, several studies 434,435,758 that obtained results pointing towards a 
dramatic change in the phospholipids asymmetry exhibited one common feature: the absence 
of glucose in the media in which the erythrocytes were kept during experimental handling 774.  
Sherman and Prudhomme have detected only a low proportion (10%) of P. 
falciparum-infected erythrocytes showing Ca2+-dependent annexin-binding 765. They have 
concluded that parasitemias higher than 25 % and multinucleate forms of the parasite are 
necessary to obtain statistical differences for PS exposure 858. In the present study, the 
increase in annexin V-binding correlated weakly with the increase in parasitemia. However, 
PS exposure was high for P. falciparum cultures with high parasitemia, in particular for 
infected RBCs with high DNA content, indicating a late parasite stage. This finding is 
consistent with the study of Sherman and Prudhomme.  
Hence, although the infection-induced Ca2+-permeable NSC conductance is important 
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for parasite growth,, it facilitates breakdown of the phospholipid asymmetry of the host cell 
membrane 238,513,512 at mature parasite stages. Together with parasite-induced oxidative stress, 
transient increases in free [Ca2+] might induce PS scrambling. This appears plausible because 
PS exposure occurs especially under conditions of high parasitemia, which is associated with 
increased oxidative stress and ATP depletion 77,684,188,229,809. This breakdown in PS asymmetry 
suggests phospholipid scramblase activation and translocase inactivation during the course of 
infection. 
 
4.4.4 Functional significance of PS exposure in infected HbA/A RBCs 
 
Loss of phospholipid asymmetry and exposure of PE and PS on malaria-infected 
RBCs 362,434,574,747,765,762 are signals for phagocytosis 562,748,600. Phagocytosis mechanisms can 
be distinguished according to whether or not they involve opsonization-, i.e. antibody 
responses.  
The majority (75%) of adult patients with uncomplicated P. falciparum and P. vivax 
malaria are positive for anti-phospholipid antibodies (aPLA) 267. Facer et al. 267 have 
demonstrated this by ELISA using a panel of anionic and cationic phospholipids. IgG and 
IgM binding is highest to the anionic phospholipids PS, phosphatidic acid (PA), and 
cardiolipin (CL), whereas against phosphatidylinositol (PI) only low antibody levels have 
been detected. Comparison of the average concentration of IgG and IgM aPLA shows a trend 
for anti-PA > CL > PS > PC > PE > PI 267. IgG antibodies, referred to as “opsonins”, bind to 
the infected RBCs with their Fab region leaving the Fc region out. Macrophages interact with 
opsonized RBCs via their Fc γ receptors and finally internalize them.  
Schizont- and trophozoite-infected normal RBCs are recognized in part by 
opsonization-independent mechanisms which possibly involve PE / PS exposure. These 
account for about 15 – 20 % of total phagocytosis 52. A small but significant inhibition of 
monocyte phagocytosis of trophozoite-infected HbA/A RBCs in vitro is effected by PS, but 
not by PC liposomes 844. In conclusion, PS exposure directly fosters clearance of infected 
RBCs by the innate immune system, e.g. macrophages 137,271,268,269,270,283,459,660,756,853,856.  
At mature parasite stages, however, PS exposure contributes to cytoadherence: 
endothelial membrane receptors such as CD36, intercellular adhesion molecule ICAM-1 
393,394,644
, chondroitin sulphate, and secreted proteins such as thrombospondin (TSP) interact 
with erythrocyte surface molecules of infected RBCs such as clustered, modified host 
membrane band 3 (AE1) protein, adhesive neoantigens, e.g. PfEMP1 78,863, and exofacial PS 
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250,755,762,763
. PS is involved in erythrocyte-endothelium adhesion in a Ca2+-dependent manner 
179
. Hence, enhanced PS exposure might promote cytoadherence of human HbA/A RBCs 
infected with mature P. falciparum trophozoite and schizont stages to endothelial cells lining 
the post-capillary venules 762. The endothelial ligand TSP and in particular CD36 are major 
sequestration receptors for PS 250,755. PS is externalized in a time-dependent manner 
depending on the intracellular development of the parasite 250,575,574. PS externalization 
coincides with the oxidization of membrane lipids in trophozoite and schizont-infected RBCs 
348
. 
Thus, PS exposure during mature trophozoite and schizont stage plays a major role in 
microvessel sequestration in the deep tissues. In this way the parasite evades the immune 
system and avoids destruction by the spleen 394,762. Cytoadherence favors parasite 
development in a low oxygen pressure microenvironment 763. At the same time 
microcirculatory obstruction through hemostatic plug formation leads to hypoxia, metabolic 
disturbances, and multiorgan failure, all of which are detrimental to the host 394. 
 
4.4.5 Functional significance of early detection of infected HbA/S RBCs 
 
In vivo, early identification and selective removal of early ring-stage P. falciparum 
parasites by splenic macrophages result in fewer parasites reaching schizogony. This is 
thought to be a prerequisite for a mild course of malaria tropica in sickle cell trait carriers. 
During primary and subsequent secondary infections the immune system of sickle cell trait 
carriers might therefore be exposed to more antigens of the early parasite stages 624 rather than 
to neoantigens 334, which are exclusively or predominantly expressed at late trophozoite and 
schizont stages 82. Subsequent alterations in antigen processing, presentation and recognition 
might explain the observed differences in T-cell responses between infected trait carriers and 
normal individuals. T lymphocyte proliferation and IL-1 production by monocytes / 
macrophages is suppressed in general during malaria infection 39. Addition of IL-1 partially 
reverses depression responses of T-lymphocytes cultured together with other blood 
mononuclear cells from patients infected with P. falciparum and P. vivax 39. This is probably 
because in T-lymphocytes IL-1 enhances the expression of the IL-2 receptor and the 
production of other cytokines, e.g. IL-2 353. The antiproliferative effect of PGE2 on cultured 
T-lymphocytes from infected individuals in turn is minimized 39. In line with these 
observations, indomethacin, a COX inhibitor, enhances in vitro T-cell responses to several 
malaria-specific antigens 710. In P. falciparum infected sickle trait carriers the T-cell response 
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might be so adjusted as to lead to a balanced TH1/TH2 response promoting protection 83,752. 
Macrophages that phagocytose ring-stage infected RBCs are less intoxicated by 
hemozoin than those that phagocytose late-stage infected RBCs. Plasmodium parasites 
detoxify the free heme of digested Hb as polymerized ß-hematin (the pigment hemozoin) in 
their food vacuoles 252,654. Hemozoin has different ferromagnetic properties than hemoglobin 
51
. This makes it possible to separate non-infected and ring-stage infected RBCs from 
trophozoite and schizont infected RBCs with an efficacy up to 96 – 98 % by magnetic assisted 
cell sorting (MACS) 846. When monocytes/macrophages or dendritic cells phagocytose late-
trophozoite infected RBCs with high hemozoin levels they undergo functional alterations 
51,618,751,749
. Ingested hemozoin impairs macrophage motility 2,63,62,584,591 and decreases cellular 
immunity 51,84,618,752,845. Moreover, macrophages (isolated from peritoneal exudate cells) of P. 
c. chabaudi infected mice co-cultured with antigen-specific T-cell hybridomas suppress IL-2 
production by antigen-activated T-cell hybridomas 51,84,618,752,845. Macrophage ingestion of 
hemozoin from infected RBCs contributes to the cytokine-mediated pathology of malaria, 
thus aggravating the disease 63,156,426,618. AT-rich malaria DNA, bound to hemozoin, and 
presented to the Toll-like receptor 9, an endosomal receptor in cells of the innate immune 
system (in particular in dendritic cells), is highly proinflammatory, whereas synthetic ß-
hematin is ineffective in this regard 666. The inflammatory response is increased by 
modulation of macrophages’ cytokine and chemokine expression 51,164,416,425,426,424,643,690,767,817.  
The early removal of infected RBCs would prevent dysregulation of monocyte / 
macrophage function 751 and endothelial cell dysfunction 816. Finally, if ring-stage parasites 
are removed, there are no mature infected erythrocytes that adhere to myeloid dendritic cells 
and macrophages. Hence, the innate and aquired immune responses would not be down-
regulated 595,850,851. 
One reason for the impairment of monocyte / macrophage functions upon hemozoin 
ingestion is oxidative stress 751. However, this is not due to the release of iron 348,817. RBC 
lipid peroxidation is associated with the formation of toxic products such as low 
(submicromolar) concentrations of esterified monohydroxy derivatives of polyenoic fatty 
acids (OH-PUFA), hydroxyaldehydes, monohydroxy derivatives of arachidonic acid 
(hydroxyeicosatetraenoic acids = HETEs) and of linoleic acid (hydroxyoctadecadienoic acids  
= HODEs). These impair important macrophage functions such as NADPH-oxidase or iNOS 
via protein kinase C (PKC) inhibition 51,156,750,749. The concentration of OH-PUFA is 1.8 µM 
(µmoles per liter RBC or µmoles per liter RBC equivalents) in non-infected RBCs, 11.1 µM 
in ring-infected erythrocytes , 35 µM in trophozoites; and ~ 90 µM in hemozoin 749. This 
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oxidative stress might also change RBC deformability 86,649. 
Furthermore, hemozoin ingestion by phagocytosis of infected RBCs influences PGE2 
secretion. Cultured mononuclear cells isolated from maternal placental (intervillous) blood of 
P. falciparum infected women show a decrease in PGE2 secretion as compared to cultured 
intervillous blood mononuclear cells (IVBMC) of non-infected women 678. Cultured IVBMC 
from women with a positive antenatal peripheral parasitemia who are negative for placental 
malaria at term produce the highest PGE2 levels. In placental malaria, cultured IVBMC which 
have ingested medium quantities of hemozoin by phagocytosis of infected RBCs during 
natural infection show no signficant changes in secretion of PGE2 or either one of the 
regulatory cytokines TNFα and IL-10. By contrast, cultured IVBMC which have ingested 
large quantities of hemozoin show depressed secretion of PGE2, IL-10 and TNFα 678. In 
cultured peripheral blood mononuclear cells (PBMCs) of P. falciparum-infected children, the 
mechanism of PGE2 supression is not due to decreased cell viability, measured in terms of 
mitochondrial bioactivity, but to the inhibition of de novo cyclooxygenase 2 (COX2) 
transcription 452. At the same time, cultured PBMCs that have ingested hemozoin by 
phagocytosis of infected RBCs overproduce IL-10. Application of IL-10 antibodies to 
neutralize this overproduction failed to restore PGE2 production by cultured PBMCs. 
Therefore, the molecular mechanisms that reduce PGE2 secretion are probably independent of 
those that increase IL-10 production 452. Moreover, the results of Keller et al. 452 on cultured 
PBMCs appear contradictory to the study of Perkins et al. 678 on cultured IVBMCs. However, 
in vivo, the plasma level of IL-10, known as a suppressor of COX2 expression, is inversely 
correlated with the plasma level of PGE2 677.  
Healthy P. falciparum-exposed children have elevated levels of bicyclo-PGE2 / TNFα 
compared to children with malaria anemia 451. Hemozoin ingested by PBMCs through 
phagocytosis of infected RBCs induces PGE2 suppression, which facilitates TNFα 
overexpression. This is associated with enhanced malaria anemia. In line with this, cultured 
PBMCs that have ingested P. falciparum hemozoin show decreased TNFα expression when 
treated with PGE2 451. These results, too, appear contradictory to the study of Perkins et al. 678 
on cultured IVBMCs. In all three studies, however, PGE2 secretion by the BMCs was reduced 
after ingestion of high levels of hemozoin. Moreover, children with cerebral malaria have also 
significant lower levels of bicyclo-PGE2 than children with asymptomatic parasitemia 675. 
Taken together, these studies indicate the importance of early removal of infected 
RBCs 66,152 for the patient’s resistance to P. falciparum infection. Identification and clearance 
of early (i.e. ring) stage-infected erythrocytes by the innate immune system subsequently 
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lowers the hemozoin load in phagocytes, resulting in less oxidative stress 348, more PGE2 
production and a modified cytokine and chemokine release.  
 
4.4.5.1 Band 3 (AE1) aggregation in HbA/A, HbA/S and P. falciparum infected 
erythrocytes upon “oxidative ageing” and Ca2+ influx 
 
Ageing leads to changes in RBCs 136 that resemble changes observed during malaria 
infection. In non-infected RBCs these changes result in a moderately decreased surface area, 
volume and cell water loss, and thus to reduced deformability and increased RBC density 
19,20,21,94,146,276,499,517,514,681,791,934
. Moreover, ageing RBC show PS exposure, increase in [Na+]i, 
decrease in [K+]i, and ATP depletion 240,398,763,877,912.  
In addition, the decreased expression of blood group antigen in senescent RBCs is 
associated with a loss of up to 10 % surface sialic acid residues 41,175,181,315,563,568,855 695. This 
might cause unmasking of the penultimate beta-galactosyl residues and expression of a 
particular antigen in ageing RBCs 93,105.  
Finally, ageing in RBCs is associated with the exposure of a peptidic cryptic epitope, 
referred to as “senescent antigen”. Exposure occurs through the cytoplasmic cleavage of band 
3 protein (anion exchanger 1 = AE1). This cleavage involves a change in the tertiary structure 
of band 3 448,446,447,448,449. Band 3 is a membrane protein that not only functions as a 
transporter (HCO3– / Cl – antiporter) but is also essential for membrane stability 680. In this 
way, it is involved in controlling the size, shape, integrity, flexibility, and durability of the 
RBC membrane as well as such processes as cell-cell interactions and membrane fusion 136. In 
RBCs undergoing oxidative stress, oxidized protein hydrolase (acylpeptide hydrolase) cleaves 
band 3 proteins 304,305,306. RBCs’ antioxidative defenses become weaker with ageing 237. 
Senescent RBCs show alterations similar to those observed in oxidized cells 
134,211,386,459,490,507,566,567,872
. Remarkably, human RBCs infected with the malaria parasite P. 
falciparum undergo an identical “oxidative ageing” process 332,763.  
“Oxidative ageing” is caused by formation of hemichomes (oxidized / denaturated Hb) 
bound to the membrane. This leads to aggregation of band 3 (AE1) and subsequent deposition 
of autologous IgG antibodies and complement C3b fragments. These effects are reversed by 
treatment with mercaptoethanol 763. The age- or P. falciparum-infection-dependent clustering 
of the membrane spanning region of the band 3 protein serves as a recognition site for IgG 
accumulation of naturally circulating anti-band 3 autoantibodies 105,456,818. While the amount 
of anti-band 3 IgG is not sufficient to elicit Fc-mediated phagocytosis, these antibodies with a 
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high affinity for complement fragment C3 are able to activate the alternative complement 
pathway 332,447. Activation of the alternative complement pathway results in deposition of C3b 
on the RBC membrane in a IgG dose-dependent manner. Covalently bound C3b/IgG (anti-
band 3)-complexes on the RBCs surface are recognized by complement receptor type 1 (CR1) 
of macrophages 66,844. Consistent with these results, inactivation of complement convertases 
or blockage of CR1 lead to considerable inhibition of opsonization-dependent phagocytosis 
52,566,567
.  
Accelerated “oxidative ageing” of P. falciparum infected RBCs occurs in genetic 
disorders 412 such as sickle cell trait, ß-thalassemia trait, X-chromosomal linked G6PD-
deficiency 53, and HbH disease (Hb Hammersmith, a Hb mutant where phenylalanine at CD1, 
adjacent to heme, is replaced by serine). Accelerated “oxidative ageing” facilitates 
phagocytosis of infected HbA/S and glucose-6- phosphate-dehydrogenase (G6PDH)-deficient 
RBCs by macrophages already at ring stage, thus indirectly limiting the intraerythrocytic 
lifetime of the parasite 66,152 and reducing the fatal consequences of malaria infection.  
The accelerated oxidative (biochemical) changes observed by Ayi et al. 66 in infected 
HbA/S RBCs might have been potentiated by an increase in erythrocytic free [Ca2+]i 21,459,719, 
since changes in the topology of band 3 (AE1) by cross-linking are sufficient to expose 
binding sites to anti-band 3 antibodies 403,705. After treatment with the Ca2+ ionophore A23187 
membrane proteins are crosslinked by transamidase action or by oxidation of sulphydryl 
groups resulting from an increase in malonyldialdehyde, which in turn is caused by 
peroxidation of polyunsaturated fatty 19. Analogous changes can be observed in the dense 
fraction of HbS/S RBCs and to a lesser extent in dense, i.e. old HbA/A RBCs 700,702. The 
oxidative effects observed by Allan et al. upon treatment with the Ca2+ ionophore 19 and by 
Rank et al. 700 or Raval et al. 702 in sickle RBCs might be due to a decrease in GSH levels. 
This decrease might have been indirectly facilitated by Ca2+, which decreases cellular ATP 
levels by activation of the Ca2+ pump (ATPase) 21. Decreased ATP levels might decrease the 
supply of the cell with NADPH (by the pentosephosphate pathway) for replenishing the GSH 
pool, thus weakening its antioxidative defense. In the present study, an increase in 
erythrocytic free [Ca2+]i was shown in ring-infected HbA/S RBCs. In non-infected cells, the 
third exofacial loop of the 55 kDa transmembrane domain of band 3 (AE1) that contains the 
amino acid sequences HPLQKTY and YVKRVK, 547–553 and 824–829, respectively, and 
the amino acid sequence 534 – 547: YETFSKLIKIFQDH are exposed upon calcium loading, 
changes in ionic strength of the medium, treatment with acridine orange and ageing 763. 
Amino acid residues 547-553 and 824-829 act as epitopes in senescent cells 449. The 
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synthetic peptide 534-547 blocks the in vitro binding of HbS/S RBCs to human umbilical vein 
endothelial cells, and a monoclonal antibody against this peptide immunostains HbS/S RBCs 
823
. The band 3 (AE1) sequences 547–553 and 824–829, and 534–547 are cryptic in intact 
human cells, but are exposed during intracellular development of P. falciparum 763. Naturally 
occurring anti-band 3 autoantibodies bind to an 85 kDa and a > 250 kDa antigen of band 3 
protein on the surface of P. falciparum infected RBCs 906,908,909.  
Monoclonal and polyclonal antibodies raised against these three sequences of the 
transmembrane region of AE1 block the adherence of P. falciparum-infected RBCs 198,249,904 
both in vitro and in vivo. The antibodies detect RBCs infected with P. falciparum, but do not 
react with the surface of non-infected RBCs 201,200. Further, the synthetic peptide 534-547 
blocks in vitro the adherence of mature-stage P. falciparum infected RBCs to CD36 and to 
human brain endothelial cells, but not to TSP 905. Finally, in vivo, sera of individuals living in 
a malaria-endemic region (The Gambia) also recognize peptide motifs of the human 
erythrocyte anion transport protein (band 3). These sera react strongly with residues 534-560, 
638-660, and 808-842 199. Thus, antibodies against modified band 3 protein play a role in 
protective immunity during P. falciparum infection 199,397,904. The band 3 protein, in turn, 
might be modified earlier in infected HbA/S RBCs than in infected HbA/A RBCs because of 
the enhanced Ca2+ influx into infected HbA/S RBCs at ring stage. 
 
4.4.5.2 Functional significance of enhanced PS exposure in infected HbA/S RBCs 
 
PS exposure plays a major role in the recognition and removal of aged RBCs by 
phagocytosis, mainly by Kupffer cells in the liver 459. Sickle as well as thalassemic RBCs and, 
to a lesser extent, RBCs with G6PDH deficiency are exquisitely sensitive to PS exposure 
promoting stimuli such as osmotic shock, oxidative stress and/or energy depletion 210,513. 
Increased PS exposure of human RBCs has been shown in α and ß-thalassemia 124,492, and in 
another anemic condition, hereditary hydrocytosis, an uncommon variant of hereditary 
stomatocytosis 310. All these traits confer a partial resistance towards malaria tropica.  
In the present study, increase in Ca2+ permeability and in erythrocytic free Ca2+ 
concentration, which together mediate PS exposure, were particularly enhanced in ring-stage 
infected HbA/S RBCs. Infected HbA/S RBCs grown for 44 – 54 h after ring synchronization 
(with a parasitemia of around 7 %) exposed significantly more PS than did infected HbA/A or 
non-infected HbA/A or HbA/S RBCs. The significant difference in PS exposure between 
infected HbA/S and HbA/A RBCs has been confirmed for ring-stage as well as for late-stage 
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parasites in experiments with glucose-containing Ca-Ringer 443. These data corroborate the 
results of the present study. Furthermore, infected HbA/S RBCs are cleared faster in in vitro 
phagocytosis experiments 443. The subsequent elimination of intracellular pathogens could 
serve as a host defense mechanism 115,250,268,269,346,345,476,499,509,603,662,739,862. Ionomycin-treated 
PS-exposing RBCs are rapidly cleared in vitro and in vivo from circulating peripheral blood 
and sequestrated into the spleen 443,514. Coating of PS by annexinV delays the clearance of 
ionomycin-treated mouse RBCs 443. Thus, enhanced Ca2+-dependent PS exposure induced by 
PGE2 formation might contribute to the enhanced early removal of P. falciparum infected 
HbA/S RBCs from the circulation at ring-stage. The infected HbA/S RBCs might be removed 
in a nonopsonic manner by macrophages via the monocyte / macrophage scavenger and 
pattern recognition receptor CD36 65,268,272,596 in concert with previously reported mechanisms 
of phagocytosis. These other mechanisms, i.e. amplified ‘eat-me’ signals, are the enhanced 
surface exposure of the P. falciparum protein PfEMP1 273, which binds to CD36 596, and 
accelerated “oxidative ageing” as described above 66,844. 
Taken together, the observed significant increase in PGE2 secretion and subsequently 
enhanced Ca2+ influx in ring-infected HbA/S RBCs results in increased free [Ca2+]i . This in 
turn facilitates an ageing and eryptotic process that has an earlier onset in infected HbA/S 
RBCs than in infected HbA/A RBCs – a difference that is crucial to the protection of sickle 
cell trait carriers against P. falciparum infection. 
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5 Conclusions 
 
In the first part of my thesis, I investigated the activation of erythrocyte nonselective 
cation (NSC) permeability and of sphingomyelinase by Plasmodium falciparum infection. 
Both are involved in programmed cell death in erythrocytes, also referred to as eryptosis 
499,509
, and meet four requirements for parasite growth at the same time: 
i) Development of an inwardly directed Na+ and an outwardly directed K+ ion gradient across 
the parasite plasma membrane, this in turn making the parasite dependent on high [Na+] and 
low [K+] extracellularly 132. 
ii) The presence of Ca2+ ions in the culture medium and a Ca2+ permeability conferred by a 
NSC conductance 132. 
iii) Increased ceramide formation (detected in the blood of P. berghei ANKA infected mice). 
iv) Activity of parasitic neutral sphingomyelinase and host acid sphingomyelinase, probably 
to provide ceramide for membrane synthesis 371.    
In the second part of my doctoral thesis I investigated differences in the induction of 
eryptosis in normal (HbA/A) and sickle trait (HbA/S) P. falciparum infected red blood cells 
(RBCs). The results were as follows:  
i) P. falciparum did not develop differently in HbA/A and HbA/S RBCs, but infected HbA/S 
RBCs showed enhanced PS exposure. 
ii)  The host ceramide pathway played only a minor role in causing PS exposure in infected 
RBCs under normal culturing conditions.  
iii) Although parasite growth was dependent on ceramide, extragenously applied ceramide 
inhibited P. falciparum in vitro growth, and more so in HbA/S RBCs than in HbA/A RBCs.  
iv) Infected HbA/S RBCs secreted more prostaglandin E2 (PGE2) than did infected HbA/A 
RBCs, probably significantly contributing to the selective advantage of P. falciparum infected 
sickle cell trait carriers. Increased PGE2 levels are associated with a mild course of malaria 
infection 677.  
v) The increased PGE2 levels enhanced the infection-induced Ca2+ influx into ring-stage 
infected HbA/S RBCs. This promoted the observed increase in PS exposure on the outer 
membrane leaflet of infected HbA/S RBCs as compared to infected HbA/A RBCs. 
These observations show that the accelerated eryptosis of P. falciparum infected 
HbA/S RBCs is caused by enhanced activation of a NSC permeability during ring stage. 
Enhanced PS exposure acts as an “eat-me” signal for macrophages. Together with other 
signals 66, it triggers the early recognition and removal of ring-stage infected HbA/S RBCs 443.
SUMMARY____________________________________________________________________________ 
 145 
6 Summary 
 
Plasmodium falciparum, an intracellular protozoan parasite, causes the lethal form of 
malaria. It mostly affects children up to 5 years of age, with a death toll of 1 million per year 
or more than 2700 per day in this age group 139,888. Thus, every 32 seconds a child dies of 
malaria. However, sickle cell trait (HbA/S) children are strongly protected against severe 
malaria, i.e. severe malarial anemia 227 and cerebral malaria 36,896. The parasite is transmitted 
by the female Anopheles mosquito to the human host, where it replicates once in the liver (9-
14 days) and then in erythrocytes. The early asexual erythrocyte stage (up to 15 h post 
invasion) is termed ring stage. This is followed by the trophozoite and the schizont stages (~ 
40 h post invasion). P. falciparum multiplies asexually every 48 hours up to 32-fold. The 
parasite induces new permeability pathways (NPPs) in the erythrocyte membrane to meet its 
need for nutrients and disposal of waste products. Among these is a Ca2+-permeable 
nonselective cation (NSC) channel 85,243,407,793. NSC conductance is stimulated by the 
formation of prostaglandin E2 (PGE2). However, this triggers also one pathway of erythrocyte 
programmed cell death, also referred to as eryptosis 507. An increase in erythrocytic [Ca2+]i 
inhibits an ATP-dependent translocase which transports PS from the outer to the inner 
membrane leaflet. It also activates a scramblase which enhances phosphatidylserine (PS) 
exchange within the membrane bilayer, thus acting antagonistically to the translocase 499. In 
effect, an increase in [Ca2+]i thus leads to PS exposure on the outer leaflet of the membrane 
935
.  
The first part of the study investigated the dependence of P. falciparum in vitro growth 
on NSC Ca2+-permeable channel activity. 5-(N-ethyl-N-isopropyl) amiloride (EIPA), a potent 
cation channel blocker, inhibited NSC conductance (IC50 ~ 0.75 µM) as well as in vitro 
growth of P. falciparum (IC50 ~ 3 µM). EGTA, a Ca2+ chelating agent, also inhibited parasite 
in vitro growth. To test for the significance of extracellular [Na+] or [K+] on parasite growth, 
replacement of the culture medium by NaCl containing test solution for 8 h during the 
trophozoite stage (24 to 32 h post ring-synchronization) provided the control conditions for 
the following experiments. When the NaCl containing test solution was replaced by mixtures 
of NaCl and N-Methyl-D-Glucamine-Chloride (NMDG-Cl) or KCl of different component 
ratios, parasite growth was inhibited, indicating an inhibitory effect of decreasing [Na+]. 
(NMDG)+ does not permeate the red blood cell (RBC) membrane. In the present study, it did 
not show any toxic effect per se on parasite growth. Replacement of NaCl by KCl inhibited 
parasite growth even stronger than replacement by NMDG-Cl. Replacement with KCl 
SUMMARY____________________________________________________________________________ 
 146 
resulted in half-maximal growth at a residual [NaCl] about twice as great as in the case of 
replacement with NMDG-Cl (IC50(NaCl/KCl) = 58 mM NaCl / 65 mM KCl; IC50(NaCl/NMDG-Cl) = 
24 mM NaCl / 112 mM (NMDG)-Cl). This indicates an additive inhibitory effect of 
increasing [K+] on parasite growth. Hence, the parasite requires not only an inwardly directed 
Ca2+- and Na+-gradient, but also an outwardly directed K+-gradient of for its development 
within the RBC. The necessary ion exchange is probably accomplished by an EIPA sensitive 
cation channel that has a permselectivity of PK/PNa ~ 2 243.  
Treatment with the Ca2+-ionophor ionomycin, oxidation of non-infected RBC or high 
parasitemia led to breakdown of PS asymmetry, as judged by annexin-binding 132. 
Furthermore, the study explored whether in Plasmodium infected RBCs a second 
known signaling pathway of eryptosis is induced. This pathway involves sphingomyelinase 
activation that cleaves ceramide of sphingomyelin. Ceramide stimulates the scramblase and 
sensitizes it to the effects of Ca2+, thus contributing to PS exposure on the outer RBC 
membrane leaflet. Interestingly, P. berghei ANKA infection of mice significantly increased the 
ceramide level in acid sphingomyelinase knock-out (ASM-/-) and wild-type (+/+) mouse 
blood, probably by neutral sphingomyelinase activity (NSM) of the parasite 371,372. In mice, 
ASM is secreted by leukocytes 520. The blood of infected ASM -/- mice produced significantly 
less ceramide than the blood of infected ASM +/+ mice. Increase in parasitemia between the 
10th and 21st day post infection was significantly slower in ASM -/- mice than it was in ASM 
+/+ mice. This is probably due to a lack of ceramide in ASM-/- mice, since the parasite 
requires ceramide for its membrane synthesis 260,261,367,371,663.  
In the case of normal (HbA/A) RBCs infected with ring-stage P. falciparum, 
macrophages recognize the PS-exposing infected RBCs and remove them in a nonopsonic 
manner via the scavenger and pattern recognition receptor CD36 65,268,269,270. In the case of 
infected HbA/S RBCs the enhanced PS exposure resulting from accelerated eryptosis could 
reinforce the removal. 
Therefore, the aim of the study was to explore differences in the induction of eryptosis 
between HbA/A and HbA/S infected erythrocytes. Although ring-stage synchronized parasites 
grew similarly in HbA/S and HbA/A RBCs, PS exposure was significantly enhanced in 
infected HbA/S RBCs. Differences in sphingomyelinase activity were detected between 
infected HbA/S and HbA/A RBCs. However, the enhanced enzyme activity seems not to be 
involved in the enhanced PS exposure in infected HbA/S RBCs. Although the parasite 
requires ceramide for membrane synthesis 371, ceramide in the culture medium inhibits 
parasite growth, and more so in HbA/S than in HbA/A RBCs.  
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Ring-infected HbA/S RBCs showed enhanced 45Ca2+ uptake and a 1.5-fold increase in 
free cytosolic Ca2+ concentration, [Ca2+]i, compared to ring-infected HbA/A RBCs. Hence, the 
enhanced PS exposure in infected HbA/S RBCs results from an enhanced NSC Ca2+-
permeable conductance. Moreover, infected HbA/S RBCs produced more PGE2 than did 
infected HbA/A RBCs. This resulted in enhanced NSC channel activity of ring-stage infected 
HbA/S RBCs as compared to HbA/A RBCs. Interestingly, elevated PGE2 plasma levels are 
correlated with a decrease of severe malaria in children with P. falciparum infection 677. 
Enhanced PGE2-induced PS exposure on infected HbA/S RBCs accelerates their removal at 
the ring-stage of the parasite 443. In addition, accelerated “oxidative ageing” of the host 
erythrocyte stimulates phagocytosis of ring-infected HbA/S RBCs 66,763. This first-line 
defense of the host affords a crucial protection against the lethal consequences of P. 
falciparum infection to infected sickle cell trait carriers. 
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7 Zusammenfassung 
 
Plasmodium falciparum, ein intrazellulärer einzelliger Parasit, ist Erreger der letalen 
Form von Malaria. Vor allem Kinder im Alter bis zu 5 Jahren sind davon betroffen mit 
Todesfällen von rund 1 Million im Jahr 139,888, was mehr als 2700 Todesfällen am Tag 
entspricht. Folglich stirbt etwa alle 32 Sekunden ein Kind an Malaria. Kinder mit 
heterozygoter Sichelzellanämie (HbA/S) sind hingegen gut geschützt vor den Folgen 
lebensbedrohlicher Malaria, d.h. schwerer Anämie 227 und zerebraler Malaria 36,896. Der 
Parasit wird durch die weibliche Anopheles-Mücke übertragen, durchläuft zunächst ein 
Leberstadium (9-14 Tage) und vermehrt sich dann in den Erythrozyten. Das früheste 
asexuelle Erythrozytenstadium (bis zu 15 Stunden nach Invasion) wird Ringstadium genannt, 
die späteren Stadien sind Trophozoiten, dann Schizonten (~ 40 Stunden nach Invasion). P. 
falciparum vermehrt sich asexuell bis zu 32 mal innerhalb von 48 h. Der Parasit induziert 
neue Permeabilitäten (NPPs) in der Erythrozytenmembran, um seinen Bedarf an Nährstoffen 
zu decken und um Abfallprodukte zu entsorgen. Ein nicht selektiver Kationenkanal gehört zu 
den NPPs 85,243,407,793. Die nichtselektive Kationenleitfähigkeit wird durch Bildung von PGE2 
(Prostaglandin E2) stimuliert. Dies induziert aber auch einen Signalweg für den 
programmierten Zelltod von Erythrozyten, auch Eryptose genannt 507. Ein Anstieg in der 
erythrozytären Kalziumkonzentration, [Ca2+]i, inhibiert eine ATP-abhängige Translokase, die 
Phosphatidylserin (PS) von der äußeren zur inneren Membranschicht transportiert, und 
aktiviert eine Scramblase, die den Austausch von PS zwischen den Membranschichten erhöht, 
und damit der Translokase entgegenwirkt 499. Demzufolge führt ein Anstieg der [Ca2+]i zu PS-
Exposition in der äußeren Membranschicht des Erythrozyten 935. 
Der erste Teil der Studie untersuchte die Abhängigkeit des in vitro Wachstums von P. 
falciparum von der nichtselektiven Ca2+-durchlässigen Kationenkanalaktivität. 5-(N-Ethyl-N-
Isopropyl)-Amilorid (EIPA), ein effektiver Kationenkanalblocker, hemmte sowohl die 
Kationenleitfähigkeit (IC50 ~ 0.75 µM) als auch das Parasitenwachstum (IC50 ~ 3µM) in vitro. 
Darüberhinaus wurde das Parasitenwachstum durch EGTA, einen Ca2+-Chelatbildner, 
beeinträchtigt. Um die Bedeutung von extrazellulärer [Na+] oder [K+] auf das 
Parasitenwachstum zu überprüfen, bildete der Austausch des Kulturmediums durch NaCl-
haltige Testlösung über 8 h während des Trophozoitenstadiums (24 bis 32 h nach 
Synchronisation) die Kontrollbedingung für die folgenden Versuche. Wurde die NaCl-haltige 
Testlösung durch N-Methyl-D-Glukamin-Chlorid (NMDG)-Cl oder KCl-haltige Testlösung in 
verschiedenen Mischungsverhältnissen ersetzt, wurde das Parasitenwachstum inhibiert, was 
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auf einen inhibitorischen Effekt von abfallender [Na+] hindeutet. (NMDG)+ durchdringt die 
Erythrozytenmembran nicht. In dieser Studie wirkte es selbst nicht toxisch auf das 
Parasitenwachstum. Der Austausch von NaCl durch KCl inhibierte das Parasitenwachstum 
stärker als die Substitution von NaCl durch (NMDG)-Cl. Beim Austausch durch KCl war die 
verbleibende NaCl-Konzentration, die für halbmaximales Parasitenwachstum benötigt wurde, 
ungefähr doppelt so hoch wie beim Austausch durch NMDG-Cl (IC50(NaCl/KCl) = 58 mM NaCl 
/ 65 mM KCl; IC50(NaCl/NMDG-Cl) = 24 mM NaCl / 112 mM (NMDG)-Cl). Das deutet auf einen 
zusätzlichen inhibitorischen Effekt der ansteigenden [K+] auf das Parasitenwachstum. 
Demzufolge benötigt der Parasit nicht nur einen einwärts gerichteten Ca2+ und Na+-
Gradienten, sondern auch einen auswärts gerichteten K+-Gradienten zur Entwicklung 
innerhalb des Erythrozyten. Der dafür  notwendige Ionenaustausch wird wahrscheinlich 
bewerkstelligt durch einen EIPA-sensitiven Kationenkanal, der eine Permselektivität von 
PK/PNa~2 besitzt 243.  
Behandlung mit dem Kalziumionophor Ionomycin bzw.  Oxidation von nicht 
infizierten Erythrozyten oder eine hohe Infektionsrate, führte zum Zusammenbrechen der PS 
Asymmetrie, wie aus der gemessenen Annexinbindung geschlossen werden konnte 132. 
Weiterhin untersuchte die Studie, ob in Plasmodium-infizierten-Erythrozyten ein  
zweiter bekannter Signalweg der Eryptose induziert ist. Dieser Signalweg führt zu einer 
Sphingomyelinaseaktivierung, die Ceramid aus Sphingomyelin freisetzt. Ceramid stimuliert 
die Scramblase und erhöht ihre Aktivierung durch Ca2+. Damit trägt Ceramid zur PS- 
Exposition in der äußeren Membranschicht des Erythrozyten bei. Interessanterweise steigerte 
eine P. berghei ANKA-Infektion sowohl signifikant den Ceramid-Gehalt im Blut von saurer-
Sphingomyelinase-defizienten- (ASM -/-) als auch im Blut von Wildtyp-(ASM +/+) Mäusen 
wahrscheinlich durch die neutrale Sphingomyelinase-Aktivität des Parasiten 371,372.  In 
Mäusen wird ASM von Leukozyten sezerniert. 520. Das Blut infizierter ASM-/- Mäuse enthielt 
signifikant weniger Ceramid als das Blut von infizierten ASM +/+ Mäusen. Der Anstieg der 
Parasitämie zwischen dem 10. und dem 21. Tag nach Infektion in ASM -/- Mäusen  war 
signifikant verringert im Vergleich zum Anstieg der Parasitämie in ASM +/+ Mäusen. Dies ist 
höchstwahrscheinlich durch einen Ceramidmangel verursacht, da der Parasit zur 
Membransynthese Ceramid benötigt 260,261,367,371,663.  
Im Fall von P. falciparum-infizierten normalen (HbA/A) Erythrozyten im 
Ringstadium erkennen Makrophagen die PS-exponierenden Erythrozyten mit dem sog. 
Scavenger-Rezeptor oder Mustererkennungsrezeptor CD36 und phagozytieren diese Zellen 
65,268,269,270
. Erhöhte PS-Exposition aufgrund beschleunigter Eryptose in infizierten HbA/S 
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Erythrozyten könnte diesen Mechanismus verstärken.  
Deshalb war das Ziel dieser Studie, Unterschiede in der Induktion der Eryptose 
zwischen HbA/A und HbA/S P. falciparum-infizierten-Erythrozyten aufzudecken. Obwohl 
sich im Ringstadium-synchronisierte-Parasiten in HbA/S- und HbA/A-Erythrozyten in 
gleichem Maße vermehrten, war die PS-Exposition in infizierten HbA/S-Erythrozyten 
signifikant erhöht. Unterschiede in der Sphingomyelinaseaktivität zwischen infizierten 
HbA/S- und HbA/A-Erythrozyten wurden beobachtet. Jedoch scheint die erhöhte 
Enzymaktivität nicht ursächlich die erhöhte PS-Exposition von infizierten HbA/S- 
Erythrozyten zu bedingen. Obwohl der Parasit Ceramid zur Membransynthese benötigt 371, 
hemmt Ceramid im Kulturmedium das Parasitenwachstum, und zwar verstärkt in HbA/S-
Erythrozyten. 
Ring-infizierte-HbA/S-Erythrozyten zeigten erhöhte Ca2+-Aufnahme und einen 1,5- 
fachen Anstieg der freien zytosolischen Ca2+-Konzentration, [Ca2+]i, im Vergleich zu Ring-
infizierten-HbA/A-Erythrozyten. Demzufolge resultiert die erhöhte PS-Exposition in 
infizierten HbA/S-Erythrozyten aus einer erhöhten nichtselektiven Ca2+-durchlässigen 
Kationenleitfähigkeit. Darüberhinaus war die PGE2-Bildung von infizierten HbA/S-
Erythrozyten höher als die von infizierten HbA/A-Erythrozyten. Demnach führen erhöhte 
PGE2-Konzentrationen zu erhöhter nichtselektiver Kationenkanalaktivität von Ring-
infizierten-HbA/S-Erythrozyten. Interessanterweise korrelieren erhöhte PGE2-Plasmaspiegel 
mit einem Rückgang von schwerer Malaria bei Kindern, die mit P. falciparum infiziert sind 
677
. PGE2-induzierte PS-Exposition in infizierten HbA/S Erythrozyten bewirkt deren effektive 
Beseitigung schon im Ringstadium des Parasiten 443. Zusätzlich erhöht beschleunigtes 
„oxidatives Altern“ des Wirtserythrozyten die Phagozytose von Ring-infizierten HbA/S 
Erythrozyten 66,763. Diese Abwehrmechanismen des Wirts bedeuten einen entscheidenden 
Schutz gegenüber den tödlichen Konsequenzen einer P. falciparum-Infektion für infizierte 
Sichelzellgen-Überträger. 
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8 Appendix 
 
Protozoa
Protalveolata
Gregarinea Coccidea
Neogregarinida
Eugregarinida
Archigregarinida
Aseptatina
Monocystis
Gregarina
Phylum
Eucoccidia
Adeleina
Adeleidae
Eimeriina
Lankesterellidae
Aggregatidae
Eimeriidae
Sarcosystidae
Toxoplasma
Besnoitia
Sarcocystis
Frenkelia
Hammondia
Cystoisospora
Class
Order
Suborder
Family
Genus
Protococcidia
Septatina
Haemogreagarinidae
Plasmodiidae
Plasmodium
Leucocytozoon
Haemoproteus
Piroplasmida
Babesia
Theileria
Karyolysus
Haemogregarina
Orcheobius
Adelea
Globidium
Cryptosporidiidae
Adelina
Klossia
Hepatozoon
Isospora
Monocystidae
Gregarinidae
Lipotrophidae
Babesidae
Theileriidae
Mattesia
Kingdom Fungi Plantae Chromista
Alveolata
Myzozoa
BiciliataSubkingdom
Infrakingdom
Subphylum
Ciliophora
Dinozoa
Empire Eukaryota
Sarcomastigota
Rhizaria Excavata
Apicomplexa
ApicomonadaInfraphylum Sporozoa
Hematozoa
Dinoflagellata
Haemosporida
Animalia
 
Figure 8.1. Classification of Plasmodium 157,158,159,160,161,162,534,535. 
 
The infraphylum sporozoa (about 4,000 known species) (Fig.8.1.) belongs to the 
subphylum apicomplexa. Sporozoa are characterized by an apical complex (see parasgraph 
1.4.) with a conoid. The conoid is a funnel of rods, composed of two electron dense polar 
rings and criss-cross spiral of trough-shaped tubulin rods that extend subpellicularly from the 
polar rings parallel to the long axis of the cell. The funnel of rods functions presumably as a 
support for the cell - except in the genus Babesia and Theileria (former Aconoidasida). 
Furthermore, sporozoa are characterized by dioecious sex and gliding motility. This is to say 
that motile forms of sporozoa crawl along the substratum in a non-ameboid fashion as they do 
not have flagella or pseudopods or cilia and lack any visible means of locomotion beside 
flagellated gametes 162.  
The phylum myzozoa (myzocytotic = sucking life) consists of the subphyla 
apicomplexa and dinozoa. Myzozoa and the phylum ciliophora belong to the infrakingdom of 
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alveolata 160. Located just underneath their plasma membrane all myzozoa have a diminished 
mouth termed the micropore, two inner membranes and flattened vesicle-like structures 
termed cortical alveolae. These cortical alveolae support the outer pellicle, forming a semi-
rigid pellicle. The ancestral alveolate most probably had a colorless plastid, called the 
apicoplast in apicomplexa. The plastid has an approximately 35 kb genome with an operon 
organization very similar to red algae plastid genomes 594. The apicoplast is probably 
inherited from a common sporozoan and chromist ancestor, a chromalveolate 159,277,376. This 
would mean that the apicoplast has a common origin with the chloroplasts in dinoflagellates. 
Such an apicoplast is present in eimeriid coccidea 241, piroplasmida 342 and Plasmodium 903 
and might well be present in some apicomonads. In the other main sporozoan clade that 
includes both Cryptosporidium and gregarines the apicoplast appears to be lost 928.  
 
P. bergheiP. rodhani
P. chabaudi
P. cynomolgi
P. falciparum P. gallinaceum
P. knowlesi
P. iophurae
P. malariae
P. ovale P. relictum
P. vivax P. yoelii
Humans RodentsPrimates Avians
Species
arthropod vector
vertebrate host
AedesAnopheles Culex
P. fallax
P. brasilianum
P. simium
New World
Monkeys
P. fragile
Old World
Monkeys
 
Figure 8.2. Plasmodium spp., their vertebrate and arthropod hosts.  
 
 
 
Figure 8.3. Eggs, larvae, pupae, adult from Anopheles in comparison to Aedes and Culex 
833
. 
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 Malaria tropica Malaria 
tertiana 
Malaria 
tertiana 
Malaria 
quatarna 
Species P. falciparum P. vivax P. ovale P. malariae 
Incubation days 
(range) 
6 - 14 d 8-20 d or up to 
6-12 months 
12 - 20 d or 
longer 
14 – 40 d or 
longer 
Exoerythrocytic 
cycle (days) 
5.5 -7 d 6 -8 d  9 d 12 -16 d 
No. of 
merozoites per 
liver cell 
(215) 
40,000 
(213) 
8, 000 - 10,000 
(214) 
15,000 
(211) 
2,000  
Erythrocytic 
cycle (hours) 
48 h (irregular) 42 - 48 h 49 - 50 h 72 h   
RBC 
preference 
younger cells, 
but can invade 
cells of all ages 
Reticulocytes Reticulocytes older cells  
 
Relapses 
(years) 
No 
 (no late 
relapses) 
Yes  
(up to 3 -4 
years) 
Yes  
(up to 4.5 years)   
regular up to 20 
years (even up 
to 52 years) 
Fever 
periodicity 
(hours) 
48 h  48 h 48 h  72 h 
Febrile 
duration 
(hours) 
16 - 36 h or 
longer 
8 – 12 h 8 – 12 h 8 – 10 h 
Severity of 
primary attack 
severe in non-
immune 
individuals 
mild to severe mild mild 
 
Mortality high  low low low 
Drug 
Resistance 
++ + - - 
Distribution worldwide in 
the tropics 
worldwide in 
the tropics, 
subtropics, and 
temperate zone 
Western coast of 
Africa  
rarest species, in 
the (sub)tropics, 
endemic, within 
restricted areas 
Table 8.1. Most important characteristics of human malaria. 
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 P. berghei P. falciparum 
Merozoites per 
blood schizont 
12 -18 8 -32 
Reticulocyte 
preference 
Yes No 
Synchronous 
blood cycle 
No Yes 
Mean diameter of 
schizonts in µm 
27 45 
Sporozoite size  
in µM 
11 12 
Sequestration 
 
Yes Yes 
Table 8.2. P. berghei, P. falciparum - Quick comparison. 
 
COMPOUND ASSOCIATED PROBLEMS 
Quinolines 
Quinine (Fig.8.5.A.; Trade names: Nivaquine, 
Malaraquine, Aralem, etc.) 
Quinine sulphate 
 
Quinidine gluconate (dextroisomer) 
 
Mefloquine (quinoline-methanol derivative) 
(Fig.8.5.B.; Trade names: Lariam; 
Mephaquine) 
8-Aminoquinolines (Fig.8.4) 
Primaquine  
 
 
Pamaquine (no longer available) 
(First synthetic antimalarial drug) 
4-Aminoquinolines 
Chloroquine (Trade name: Aralen) 
(Fig. 8.6.) 
 
Drug of last resort (originally from cinchona 
tree). 
Side-effects: tinnitus; ineffective due to parasite 
resistance 601.  
Limited availability; requires cardiac monitoring 
601
. 
Side-effects: psychoses; ineffective due to 
parasite resistance in Indochina, Africa 601. 
Undergoing Phase IV clinical trials in 1998 601. 
Undergoing preclinical trials in 1998 601. 
Eliminate hypnozoites of P. vivax or P. ovale 
after 14 days treatment or more; narrow 
therapeutic index; not used in G6PD-deficient 
patients 601; ineffective due to parasite 
resistance. 
Ineffective due to parasite resistance worldwide 
except in Central America 878,915; prior to 
resistance development it was the drug of choice 
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Amodiaquine (Trade name: Camoquine) 
 
for treating non-severe or uncomplicated malaria 
and for chemoprophylaxis. 
Relatively widely available compound. 
 
Halofantrine (Phenanthrene-methanol)  
(Trade name: Halfen). 
 
Desbutylhalofantrine 
Cardiotoxicity637; poor resorption; sporadic 
ineffective due to parasite resistance 601. 
Undergoing Phase IV clinical trials in 1998 601. 
Undergoing Phase I clinical trials in 1998 601. 
Antifolates  
Anti-dihydrofolate synthase (DHFR) 
(Fig. 8.7.A.) 
Proguanil (Paludrine) (Prodrug) 
 
Chlorproguanil 
Cycloguanil  
Proguanil analogs  
Pyrimethamine 
Trimethoprim  
WR99210 847  
WR238605 
Anti-Dihydroopterate synthase (DHPS) 
(analogues of para-aminobenzoic acid ) 
(Fig. 8.7.B.) 
Sulfadoxine 
Dapsone  
Combinations 
Chlorproguanil/dapsone (Lap-dap) 
Sulfamethaxole/trimethoprim (Co-
trimoxazole) 
Sulfalene/pyrimethamine (Metakelfin) 
 
 
 
Sulfadoxine/pyrimethamine (SP, Fansidar) 
 
 
 
 
 
Causing rapidly developing resistance of  
Plasmodium, if used alone 354. 
Side effects: mouth ulcers; ineffective due to 
parasite resistance 601. 
Undergoing preclinical trials in 1998 601. 
 
 
 
Undergoing Phase III clinical trials in 1998 601. 
 
 
 
 
 
 
If used in combination, drugs act synergistically, 
possibly overcoming individual resistances; 
furthermore, a higher cure rate, a lower 
likelihood of inducing parasite resistance, 
pharmacokinetic and pharmacodynamic 
advantages over the individual components.  
112,871
. 
Severely allergenic; ineffective due to parasite 
resistance worldwide 601. 
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Atovaquone (hydroxynapthoquinone, an 
analogue of ubiquinone) 
 
Combination: Malorone:  
250 mg atovaquone + 100 mg proguanil 
113,293,560,697
 
 
Used for the treatment of opportunistic infections 
in immunosuppressed patients; effective against 
chloroquine-resistant parasites; parasite resistance 
develops rapidly if used alone (polymorphism in 
the gene for cytochrome b 792); usually given in 
combination with proguanil 560,697. 
Endoperoxides (Sesquiterpene lactone) 
Artemisinine (Fig.8.8.A.; qinghaosu; shrub 
Artemisia annua) 709,886 
Artemisinic acid, Artemether 
Artelinic Acid  
Arteether 
 
Artesunate (Fig. 8.8.B.) 
Artemisinine-based combination 
therapy 
Artemether-lumefantrine (fluoro-methanol) 
(Co-artem; Alamet) 607,821 
Artesunate-mefloquine 
Artesunate-amodiaquine 
Artesunate-sulfadoxine/ pyrimethamine 
Chlorproguanil hydrochloride / dapson 
artesunate 
 
 
Neurotoxic; if given alone development of 
resistance of P. falciparum; high recrudescence 
rates. 
Undergoing Phase I clinical trials in 1998 601. 
Less neurotoxic than artemether; undergoing 
Phase III clinical trials in 1998 601. 
Undergoing Phase II clinical trials in 1998 601. 
 
 
Combination with long half-life drug mandatory, 
combination slows development of drug 
resistance of P. falciparum; responsible for 
decreased malaria transmission levels in South-
East Asia 887,637. 
 
 
 
Synthetic peroxides 
Trioxane; Tetraoxane 
 
Undergoing preclinical trials in 1998 601. 
 
Antibiotics 593,699,698 
Tetracycline; Doxycycline (Cotrifazid)  
(Fig. 8.9.) 
 
 
Clindamycin 
Isoniazid; Rifampicin 
Azithromyin (analog of erthromycine) 
 
Improved cure rates in combination with quinine 
112
. Doxycycline is phototoxic; not used in 
pregnant women and children; gastrointestinal 
intolerance 601. Undergoing Phase IV clinical trials 
in 1998 601. 
Parasites respond slowly; high recurrence rates 
479,478
. 
Limited use; efficacy remains to be defined. 
Undergoing Phase II clinical trials in 1998 601. 
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Acridine analogues 
Pyronaridine (Acridine type 
benzonaphthyridine) 
Dihydroacridinedione;Quinacrine 
Floxacrine analogs  
 
 
100 % effective in one trial in Cameroon 711, 63 % 
and 88 % effective in Thailand 559. Undergoing 
Phase II clinical trials in 1998 601. 
Undergoing preclinical trials in 1998 601.  
Table 8.3. Treatment of malaria. 
 
A B
 
Figure 8.4. (A) Primaquine. N-(6-methoxyquinolin-8-yl) pentane-1,4-diamine. (B) Pamaquine. 
N,N-diethyl-N'-(6-methoxyquinolin-8-yl)pentane-1,4-diamine) was the first synthetic antimalaria drug. It is no 
longer available. Like primaquine, pamaquine causes hemeolytic anemia in patients with G6PDH deficiency. 
 
A B
 
Figure 8.5. (A) Quinine. (2-ethenyl-4-azabicyclo[2.2.2]oct-5-yl)- (6-methoxyquinolin-4-yl)-methanol. 
(B) Mefloquine. 2,8-bis(trifluoromethyl)quinolin-4-yl]-(2- piperidyl)methanol. 
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Figure 8.6. Chloroquine. N'-(7-chloroquinolin-4-yl)-N,N-diethyl-pentane-1,4-diamine. 
 
 
Figure 8.7. (A) DHFR and (B) DHPS inhibitors. (A) Chemical reaction catalyzed by dihydrofolate 
reductase (DHFR) and structures of selected antimalarial DHFR inhibitors. The prodrug proguanil is converted 
to the DHFR inhibitor cycloguanil. (B) Chemical reaction catalyzed by dihydropteroate synthase (DHPS), 
together with the structures of the DHPS inhibitors sulfadoxine and dapsone 847. 
 
A B
 
Figure 8.8. (A) Artemisinine. (3R,5aS,6R,8aS,9R,12S,12aR)-octahydro-3,6,9-trimethyl-3,12-epoxy-12H-
pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one 480,642. (B) Artesunate. 
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Figure 8.9. Doxycycline. (2-(amino-hydroxy-methylidene)-4-dimethylamino-5,10,11,12a-tetrahydroxy-6-
methyl- 4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione. 
 
H+
Na+
Na+
K+
K+
Cl-
Ca 2+
Cl-
HCO3-
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Ca 2+
NSC
Cl-
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K+
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Na+2Cl-K+
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Diffusion
(channel proteins) FacilitatedDiffusion
(carrier proteins)
Transporters
Pumps
Channels
H20
 
Figure 8.10.  Principal pumps, channels and transporters of human erythrocytes. With 
permission modified from Tanneur et al. 814. 
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A HbA/A, position 14 only one signal A 
 
 
B HbA/A, position 22 only one signal A 
 
 
C HbA/A, position 14 only one signal A 
 
 
D HbA/A, position 14 only one signal A 
 
 
E HbA/A, position 8 only one signal A 
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F HbA/A, position 14 only one signal A 
 
 
G HbA/A, position 15 only one signal A 
 
 
H HbA/S, position 14 double signal A/T 
 
 
I HbA/S, position 11 double signal A/T 
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J HbA/S, position 11 double signal A/T 
 
 
K HbA/S, position 29 double signal A/T 
 
 
L HbA/S, position 0 double signal A/T 
 
 
Figure 8.11. Confirmation of the genotype of the blood samples used. Sequencing results 
of an amplified DNA fragment of healthy and sickle cell trait individuals, containing the 
codon 6 of the β-hemoglobin chain. 
A-L. Sequences of an amplified DNA fragment containing the codon 6 of the β-hemoglobin chain. Genomic 
DNA, extracted from whole blood of healthy (HbA/A) and sickle cell trait (HbA/S) individuals were PCR 
amplified and sequenced. See Material and Methods for details. Normal hemoglobin (HbA) has the code GAG 
(position 13-15 A) for glutamine (A - G), while sickle cell hemoglobin (HbS) has the code GTG for valine. The 
DNA from sickle trait (HbA/S) RBCs (H – L) therefore shows a double signal A/T at position 14 (H). 
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